<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Genomics</journal-id><journal-id journal-id-type="publisher-id">CG</journal-id><journal-title>Current Genomics</journal-title><issn pub-type="ppub">1389-2029</issn><issn pub-type="epub">1875-5488</issn><publisher><publisher-name>Bentham Science Publishers Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19412416</article-id><article-id pub-id-type="pmc">2647153</article-id><article-id pub-id-type="publisher-id">CG-8-429</article-id><article-id pub-id-type="doi">10.2174/138920207783591717</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Genetic and Environmental Factors in Complex Neurodevelopmental Disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van Loo</surname><given-names>K.M.J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martens</surname><given-names>G.J.M</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff">Department of Molecular Animal Physiology, Donders Institute for Neuroscience, Nijmegen Center for Molecular Life Sciences (NCMLS), Faculty of Science, Radboud University Nijmegen, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Department of Molecular Animal Physiology, Donders Institute for Neuroscience and Nijmegen Center for Molecular Life Sciences (NCMLS), Radboud University Nijmegen, 193 RT, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands; Tel: 31-24-3610564; Fax: 31-24-3615317; E-mail: <email xlink:href="g.martens@ncmls.ru.nl">g.martens@ncmls.ru.nl</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2007</year></pub-date><volume>8</volume><issue>7</issue><fpage>429</fpage><lpage>444</lpage><history><date date-type="received"><day>25</day><month>10</month><year>2007</year></date><date date-type="rev-recd"><day>7</day><month>11</month><year>2007</year></date><date date-type="accepted"><day>9</day><month>11</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9;2007 Bentham Science Publishers Ltd.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.5/">http://creativecommons.org/licenses/by/2.5/</uri>) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Complex neurodevelopmental disorders, such as schizophrenia, autism, attention deficit (hyperactivity) disorder, (manic) depressive illness and addiction, are thought to result from an interaction between genetic and environmental factors. Association studies on candidate genes and genome-wide linkage analyses have identified many susceptibility chromosomal regions and genes, but considerable efforts to replicate association have been surprisingly often disappointing. Here, we summarize the current knowledge of the genetic contribution to complex neurodevelopmental disorders, focusing on the findings from association and linkage studies. Furthermore, the contribution of the interaction of the genetic with environmental and epigenetic factors to the aetiology of complex neurodevelopmental disorders as well as suggestions for future research are discussed.</p></abstract><kwd-group><title>Key Words</title><kwd>Neurodevelopmental disorders</kwd><kwd>susceptibility genes</kwd><kwd>environmental factors</kwd><kwd>gene-environment interactions</kwd><kwd>association studies</kwd><kwd>linkage analysis.</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The term neurodevelopmental disorder is a relatively new term and includes a group of disorders with severely affected behavioral features caused by alterations in early brain development. Most neurodevelopmental disorders are associated with a life-long endurance and have a severe impact on normal brain functioning, leading to affected behavior often resulting in large economical, emotional and physical problems, not only for the individual but also for the family and society as a whole. The various neurodevelopmental disorders show similar features, including brain dysfunctioning (such as difficulties in sensor and motor systems, problems with speech and language) and a number of cognitive impairments (e.g. in learning and organizational skills)<italic>.</italic> Schizophrenia, autistic disorders, attention deficit hyperactivity disorder (ADHD), bipolar disorder, mental retardation and Tourette&#x02019;s syndrome are some of the more common neurodevelopmental disorders, but also Rett syndrome, immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome and X-linked alpha thalassemia/mental retardation (ATR-X) syndrome are considered neurodevelopmental disorders (Table <bold><xref ref-type="table" rid="T1">1</xref></bold>).</p></sec><sec><title>NEURODEVELOPMENTAL DISORDERS AND GENETIC AETIOLOGY </title><p>Neurodevelopmental disorders can be divided into four subgroups, based on their (mostly hypothetical) genetic aetiology (Table <bold><xref ref-type="table" rid="T1">1</xref></bold>). The first subgroup is characterized by aneuploidy (an abnormal number of chromosomes). The most well-known neurodevelopmental aneuploidy is Down&#x02019;s syndrome with a trisomy of chromosome 21<italic>.</italic> Disorders of the second subgroup contain chromosomal micro-deletions, such as the deletion of chromosomal region 7q11.2 (which harbours more than 20 genes) in William&#x02019;s-Beuren syndrome. In each neurodevelopmental disorder of the third subgroup, only a single gene is affected. For example, the fragile X syndrome is a genetic disorder caused by a mutation (CGG repeat expansion) of the fragile X mental retardation 1 (FMR1) gene on the X chromosome. The neurodevelopmental disorders with a complex aetiology, such as autism and schizophrenia, comprise the fourth subgroup and are thought to be caused by (a combination of) genetic, environmental and epigenetic factors. In this review, we focus on the neurodevelopmental disorders with a complex aetiology and the current thoughts on their genetic, environmental and epigenetic aetiologies. </p></sec><sec><title>IDENTIFICATION OF SUSCEPTIBILITY LOCI AND GENES </title><p>Twin, family and adoption studies have revealed an unambiguous role for genetic factors in the aetiology of complex neurodevelopmental disorders that can even exceed an estimated heritability of 90% (in autism; Table <bold><xref ref-type="table" rid="T2">2</xref></bold>). Although a genetic component is thus clearly involved in the aetiology of a complex neurodevelopmental disorder, it is still elusive which gene (or genes) is responsible for its pathogenesis. Historically, the dopamine and also the glutamate neurotransmission system have often been implicated to play a role in neurodevelopmental pathogenesis. However, since many recently identified susceptibility genes have been found not to be related to either of the two neurotransmitter systems, restriction to these systems is no longer justified. To identify susceptibility genes and to better understand the pathophysiology of complex neurodevelopmental disorders, many studies utilizing genetic, biochemical, pharmacological, neurological and cognitive neuroscience techniques have been performed. In this section, we summarize the genetic approaches that have been used to identify risk factors at specific loci and genes.</p><sec><title>Linkage Studies</title><p>Linkage analysis is a method to locate disease-related loci using DNA markers across the genome that travel with a disease within families. The main advantage of linkage analysis is that it involves family-based analysis, and thus eliminates the problem of ethnical stratification. However, linkage analysis has a relatively low power to detect small-effect variations [<xref ref-type="bibr" rid="R1">1</xref>].</p></sec><sec><title>Association Studies</title><p>Numerous association studies have been performed to test for association between genetic variations and neurodevelopmental disorders [<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3"> 3</xref>]. Compared to linkage analysis, one important advantage of association studies concerns its improved power when equal cohort sizes are used [<xref ref-type="bibr" rid="R4">4</xref>]. In association studies, the genotype or allele frequencies of genetic variations between patients and controls (non-related individuals; case-control design) or between parents and their offspring (related individuals; family-based design) is compared. For the case-control design, a more than by chance predicted difference in the frequency of a single-nucleotide polymorphism (SNP) between the cases and controls indicates that the specific polymorphism may increase or decrease risk for the disorder, or is in linkage disequilibrium with a nearby genetic variant. The frequencies of genetic varations may vary among individuals from a different geographical or ethnical background and therefore a well-defined cohort is necessary. For family-based association studies, the parents function as the controls for the affected offspring (so-called trio-study). If the SNP is transmitted from the parents to the offspring as expected by chance alone, no association with the disorder is present. Transmission of the SNP at a higher degree than expected by chance suggests association of the genetic marker with the affected phenotype. </p><p>Having decided on the study design and study samples, the next step is to select appropriate candidate genes. In general, a gene is selected with some <italic>a priori</italic> relationship with the disorder, based on its localization (i.e. the gene is located in a chromosomal region with a significant linkage), or proposed function in the pathogenesis of the disorder (e.g. the gene belongs to the dopamine or serotonin pathway in association studies for schizophrenia pathogenesis). Genome-wide association (GWA) studies can now also be performed, whereby large numbers of DNA polymorphisms are analyzed in one experiment. </p></sec><sec><title>Copy Number Variations</title><p>Recently, it became clear that besides mutations and SNPs (both coding and non-coding alterations) also genomic rearrangements and gene-dosage imbalances (duplications, deletions and inversions) play a role in the pathogenesis of a number of nervous system disorders [reviewed in <xref ref-type="bibr" rid="R5">5</xref>]. These structural variants are common and ubiquitous in the genome and can range from kilobases to megabases in size. The human genome contains at least 1447 copy-number variants (CNVs), covering 360 megabases and comprising 12% of the genome [<xref ref-type="bibr" rid="R6">6</xref>]. Previous knowledge of CNVs in relation to diseases was limited due to insufficient methods to detect CNVs. Only large CNVs detected with cytogenetic techniques, such as G-banding (Giemsa staining) and fluorescence in situ hybridization, have been previously identified. The advent of high-resolution genome-wide methods has significantly improved the power to detect CNVs. </p><p>At present, one of the most attractive techniques to detect CNVs is comparative genome hybridization (CGH) using DNA microarrays containing genomic DNA probes (e.g. bacterial artificial chromosome clones, cDNA clones or oligonucleotides). The CGH technology allows a genome-wide screening with a relatively high resolution (with the resolution depending on the number, distribution and lengths of the probes present on the array), and may be particularly useful for the identification of CNVs that are too small to detect <italic>via </italic>routine cytogenetic analyses. Another type of array that can be used for detecting CNVs is the genome-wide SNP array. Besides normal SNP analysis (i.e. the identification of a single-base polymorphism), these arrays also give intensity information and thereby the corresponding copy number of a genomic region. Once CNVs have been detected, studies for locus-specific CNV association have to be designed, such as targeted quantitative and semiquantitative PCR, multiplex ligation-dependent probe amplification or dynamic allele-specific hybridization.</p></sec><sec><title>mRNA and Protein Expression Profiling </title><p>The principle of mRNA and protein profiling is to identify genes that are differentially expressed in selected tissues of cases and (matched) controls. One of the promising strategies is the use of human post-mortem brain tissues, from which nowadays good quality mRNA can be extracted for microarray analysis [<xref ref-type="bibr" rid="R7">7</xref>]. However, when performing such studies one has to be aware of the possibility that the differential expression could be caused by years of medicine usage or by pre- or post-mortem artifacts.</p></sec><sec><title>Animal Models</title><p>The use of animal models for the analysis of complex neurodevelopmental disorders appears to be an attractive alternative to circumvent the problems encountered when human material is used for mRNA or protein profiling. However, animals do not exhibit higher-order functions, some of which may be associated with complex human disorders. Nevertheless, one can take advantage of specific characteristics (endophenotypes) of an animal model to study the genetic and environmental factors that lead to a particular phenotypic outcome.</p><p>Several categories of animal models may be employed, including models based on a behavioral selection (e.g. the endophenotype prepulse inhibition), on a pharmacological selection (e.g. the psychotic effects of drugs, such as amphetamine) or on brain lesions (e.g. animal models with disconnections of the hippocampus). In addition, genetic animal models &#x02013; with targeted genetic manipulations of specific genes - can be used, including knockout and transgenic models. Genetically modified animals can be subjected to a whole battery of behavioral tests to understand the role of a gene in neurodevelopmental aetiology. Furthermore, such models can be used to study environmental manipulations, including maternal or chronic stress paradigms.</p></sec></sec><sec><title>SUSCEPTIBILITY LOCI AND GENES OF COMPLEX NEURODEVELOPMENTAL DISORDERS </title><p>In the past decades, an impressive amount of linkage and association studies have been performed. However, conclusive evidence from the numerous genetic linkage and association studies has not yet been obtained. The studies have continuously led to inconsistent and controversial findings. In the next paragraphs, the genetic aetiology of the complex neurodevelopmental disorders is summarized. However, because positive associations are often published more easily one has to realize publication bias and the fact that even results obtained by meta-analysis may represent false positives.</p><sec><title>Autism</title><p>Autism has a prevalence of ~0.6% in the general population and is four times more prevalent in boys than in girls. Together with four other disorders (Asperger&#x02019;s disorder, childhood disintegrative disorder, Rett syndrome and Personality Disorder Not Otherwise Specified) it belongs to the group of Pervasive Developmental Disorders (PDD). Autism is the most common PDD and usually appears during the first three years of life. Its symptoms include impairments in verbal and nonverbal communication, lack of social interaction, and restricted and stereotypical behaviour [<xref ref-type="bibr" rid="R8">8</xref>]. Though autism is one of the most hereditary disorders in psychiatry, with an estimated heritability of up to 90% (Table <bold><xref ref-type="table" rid="T2">2</xref></bold>) [<xref ref-type="bibr" rid="R9">9</xref>], the search for susceptibility genes has proven to be complex. Until now, a number of chromosomal loci have been identified that may represent regions predisposing to autism, including regions on chromosome 1p12-p21.1, 1q21-q44, 2q24.1-q33.1, 3q21.3-q29, 4q21.3-q35.1, 5p12-p15.33, 6q14.3-q23.2, 7q21.2q36.2, 10p12.1-p14, 10q23.3-q26.3, 13q12.13-q33.1, 15q13.1-q26.1, 16p12.1-p13.3, 17q11.1-q21.2, 19p13.11-p13.3 and 19q12-q13.12 [reviewed in <xref ref-type="bibr" rid="R10">10</xref>]. Although most susceptibility regions have been studied in more detail <italic>via </italic>the candidate-gene approach (e.g. the Reelin gene on chromosome 7q22 and the serotonin transporter gene (SLC6A4) on chromosome 17q11.1-q12), no gene has been found to clearly contribute to autism susceptibility. Recently, the first GWA studies for autism have been reported with significant associations, including CNVs, found in several genetic loci [<xref ref-type="bibr" rid="R11">11</xref>-<xref ref-type="bibr" rid="R13">13</xref>], but the results have been inconclusive. Thus, despite the high heritability estimates for autism, its genetic aetiology still needs to be elucidated.</p></sec><sec><title>Schizophrenia </title><p>Schizophrenia is a common mental disorder affecting approximately 1% of the population [<xref ref-type="bibr" rid="R14">14</xref>]. It generally emerges between 16 and 30 years of age and is characterized by three main symptoms: cognitive disturbances, psychosis and negative symptoms [<xref ref-type="bibr" rid="R15">15</xref>]. Unfortunately, there are no genetic markers available for diagnosing schizophrenia. Therefore, diagnosis can only be based on clinical symptoms using the Diagnostic and Statistical manual for mental disorders version IV (DSM-IV, 2000) or the International Classification of Disease version 10 (ICD-10, 1992).</p><p>The first genetic studies on schizophrenia date back from 1916 and addressed the question whether the disorder has a genetic aetiology. Many subsequent family, twin and adoption studies clearly revealed the importance of a genetic component in schizophrenia [<xref ref-type="bibr" rid="R16">16</xref>] with an estimated heritability of around 80% (Table <bold><xref ref-type="table" rid="T2">2</xref></bold>) [<xref ref-type="bibr" rid="R17">17</xref>], but the responsible gene (or genes) is still elusive. Although many susceptibility loci have been identified, numerous inconsistent and controversial findings have been reported. The genes most often reported to be related to schizophrenia are the genes encoding disrupted in schizophrenia 1 (DISC1; 1q42.1), neuregulin-1 (NRG1; 8p12), dysbindin (DTNBP1; 6p22.3), D-amino acid oxidase activator (DAOA or G72; 13q34), D-amino-acid oxidase (DAO; 12q24), regulator of G-protein signaling 4 (RGS4; 1q23.3) and the dopamine-catabolizing enzyme catechol-O-methyl transferase (COMT; 22q11.21) [reviewed in reviewed in <xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19"> 19</xref>]. However, relative risk effects of the variations range between 1.5 to 2.0, indicating only small-effect sizes. Recently, the first GWA study for schizophrenia using the Affymetrix GeneChip 500K Mapping Array Set on 178 schizophrenic patients and 144 controls has been reported. One SNP (rs4129148) close to the colony stimulating factor 2 receptor alpha chain gene (CSF2RA) on chromosome Xp22.32 and Yp11.3 showed association beyond the genome-wide significance threshold [<xref ref-type="bibr" rid="R20">20</xref>]. Independent replications to confirm this finding are however necessary. (For a more detailed overview of the genes reported to be associated with schizophrenia, we refer to <uri xlink:type="simple" xlink:href="http://www.polygenicpathways.co.uk/schizgenesandfunc.html)">http://www.polygenicpathways.co.uk/schizgenesandfunc.html)</uri>.</p></sec><sec><title>Bipolar Disorder</title><p>Bipolar disorder, also known as manic-depressive illness, is a severe mental disorder characterized by recurrent manic and depressive episodes causing dramatic mood swings. The prevalence of bipolar disorder is estimated to be 0.8-2.6% [<xref ref-type="bibr" rid="R21">21</xref>]. Although some have their first symptoms in childhood, most patients develop episodes in late adolescence or early adulthood. Bipolar disorder patients show many clinical features that are similar to those of schizophrenic patients, such as age of onset, psychotic symptoms, episodic courses of illness and a lifelong endurance. However, also clear distinctions exist between the two disorders. For example, bipolar disorder manifests as an impairment of mood, whereas schizophrenia is a primary disorder of cognition. Furthermore, most bipolar patients benefit from lithium therapy, whereas schizophrenics seldom do.</p><p>Twin and family studies have shown that bipolar disorder tends to run in families with an estimated genetic hereditary of 63% [<xref ref-type="bibr" rid="R22">22</xref>]. Interestingly, besides the shared clinical symptoms, bipolar disorder and schizophrenia may also share a genetic background [<xref ref-type="bibr" rid="R23">23</xref>]. A number of promising susceptibility genes for schizophrenia have been reported to associate with bipolar disorder as well, including G72, DAO, DISC1, NRG1, RGS4, COMT, neural cell adhesion molecule 1 (NCAM1; 11q23.1), brain-derived neurotrophic factor (BDNF; 11p13) glutamate receptor, metabotropic 3 and 4 (GRM3; 7q21.1-q21.2 and GRM4; 6p21.3), glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B; 12p12), megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1; 22q13.33), synaptogyrin 1 (SYNGR1; 22q13.1) and solute carrier family 12 (potassium/chloride transporters), member 6 (SLC12A6; 15q13-q15) [reviewed in reviewed in <xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R24"> 24</xref>]. Recently, The Wellcome Trust Case Control Consortium reported a GWA study on bipolar disorder using the Affymetrix GeneChip 500K Mapping Array Set and found one chromosomal region with strong evidence of association (16p12) and 13 regions with moderate association (2p25, 2q12, 2q14, 2q37, 3p23, 3q27, 6p21, 8p12, 9q32, 14q22, 14q32, 16q12 and 20p13) [<xref ref-type="bibr" rid="R25">25</xref>]. (For a complete list of the genetic associations with bipolar disorder, we refer to <uri xlink:type="simple" xlink:href="http://www.polygenicpathways.co.uk/Bipolargenes.html)">http://www.polygenicpathways.co.uk/Bipolargenes.html)</uri>.</p></sec><sec><title>Major Depression</title><p>Like bipolar disorder, depression is a major mood disorder. Although many clinical aspects are comparable between major depression and bipolar disorder, a number of characteristics are different between the two disorders: depression is much more heterogeneous, has a higher environmental contribution and has a higher prevalence with an overall lifetime risk of 16.2% in the United States [<xref ref-type="bibr" rid="R26">26</xref>]. Since the genetic contribution to major depression is only ~37% [<xref ref-type="bibr" rid="R27">27</xref>] and the illness is highly heterogeneous, unravelling its genetic pathogenesis is extremely difficult. To date, no clear genetic risk factors for major depression have been identified. Most studies have focused on well-known polymorphisms that have been hypothesized to associate with other psychiatric disorders. For example, the Val66Met variant in the BDNF gene, the short allele of the SLC6A4 gene, and the Val158Met variation in the COMT gene have been studied in depression cohorts [<xref ref-type="bibr" rid="R28">28</xref>-<xref ref-type="bibr" rid="R30">30</xref>], but the results are contradictory [<xref ref-type="bibr" rid="R31">31</xref>-<xref ref-type="bibr" rid="R33">33</xref>].</p></sec><sec><title>ADHD</title><p>ADHD was first described in 1845 and affects up to 1 in 20 children [<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35"> 35</xref>]. The principal problem for children with ADHD is the impairment to control their behaviour, due to inattention, hyperactivity and impulsivity. According to the DSM-IV guidelines, these symptoms should appear early in a child&#x02019;s life, before age 7, and should continue for at least 6 months, otherwise the diagnosis ADHD is not justified. Other disorders often accompany ADHD, including learning disabilities, oppositional defiant disorder, conduct disorder, Tourette&#x02019;s syndrome and/or depressive illness.</p><p>Twin studies have indicated a relatively high genetic contribution reaching an average of 70% [<xref ref-type="bibr" rid="R36">36</xref>]. Thus far, many candidate gene studies on ADHD have focused on the dopamine and serotonin pathways. Meta-analyses of the available data have suggested several of the genes belonging to either pathway to be involved in ADHD pathogenesis, including the dopamine receptors D4 (DRD4; 11p15.5) and D5 (DRD5; 4p16.1), SLC6A4, the dopamine transporter (DAT or SLC6A3; 5p15.3), the 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B; 6q13), dopamine beta-hydroxylase (DBH; 9q34) and synaptosomal-associated protein of 25kDa (SNAP25; 20p12-p11.2) [reviewed in <xref ref-type="bibr" rid="R36">36</xref>]. In addition, recently a large candidate gene analysis was performed involving 1,038 SNPs and spanning 51 candidate genes (belonging to the circadian rhythm genes and the dopamine, norepinephrine or serotonin pathways) that confirmed association with DRD4 and DAT1 [<xref ref-type="bibr" rid="R37">37</xref>], the two most replicated associations. </p></sec><sec><title>Tourette&#x02019;s Syndrome </title><p>Tourette&#x02019;s syndrome (also called Gilles de la Tourette syndrome) is a neuropsychiatric disorder that occurs with an estimated prevalence of 1% among school-age children [<xref ref-type="bibr" rid="R38">38</xref>], is characterized by multiple chronic tics (involuntary movements and vocalizations) and is often accompanied by other behavioural disorders, including ADHD and obsessive-compulsive disorder (OCD) [<xref ref-type="bibr" rid="R34">34</xref>]. Although family and twin studies have suggested a contribution of genetic factors in Tourette&#x02019;s syndrome, its precise contribution rate remains unclear [<xref ref-type="bibr" rid="R39">39</xref>]. Until now, most association studies have focussed on candidate genes belonging to the dopaminergic pathway, and showed several positive associations for the DAT, monoamine oxidase A (MAOA; Xp11.3) and the dopamine receptors D2 (DRD2; 11q23), D3 (DRD3; 3q13.3) and D4 [<xref ref-type="bibr" rid="R40">40</xref>-<xref ref-type="bibr" rid="R47">47</xref>]. However, since not all subsequent replication studies were positive [<xref ref-type="bibr" rid="R48">48</xref>-<xref ref-type="bibr" rid="R53">53</xref>] and other genes were found to associate as well [<xref ref-type="bibr" rid="R54">54</xref>], the contribution of the dopaminergic pathway to Tourette&#x02019;s syndrome remains to be established. </p></sec><sec><title>Dyslexia (Reading Disability)</title><p>Dyslexia affects 5&#x02013;10% of school-age children [<xref ref-type="bibr" rid="R55">55</xref>] and is characterized by problems with word recognition and spelling. Linkage studies have revealed a number of chromosomal susceptibility loci for dyslexia (1p34-p36, 2p16-p15, 3p12-q12, 6p21, 6q13-q16, 11p15, 15q21, 18p11 and Xq27) [reviewed in <xref ref-type="bibr" rid="R56">56</xref>]. Within and near these loci several genes have been studied using association analyses, resulting in a few candidate genes for dyslexia: dyslexia susceptibility 1 candidate 1 (DYX1C1; 15q21) [<xref ref-type="bibr" rid="R57">57</xref>], roundabout Drosophila homolog 1 (ROBO1; 3p12) [<xref ref-type="bibr" rid="R58">58</xref>] and doublecortin domain-containing protein 2 (DCDC2; 6p22.1) [<xref ref-type="bibr" rid="R59">59</xref>], but again the results are not conclusive and therefore the genetic aetiology of dyslexia is currently still unclear.</p></sec><sec><title>Epilepsy (Seizure Disorder)</title><p>Epilepsy is a heterogeneous group of disorders with abnormal electrical brain activity. In adults, temporal lobe epilepsy (TLE) is the most common form of epilepsy with an age of onset in late childhood or adolescence. In childhood, the most common form of epilepsy is febrile seizures (FSs), with a prevalence of 2-5% in Western countries and an estimated heritability of 70% [<xref ref-type="bibr" rid="R60">60</xref>]. Genetic linkage analyses have identified a number of loci for familial FS, including the loci on chromosome 19p13.3, 2q23-q24, 5q14-q15 and 18p11.2 containing the genes encoding casein kinase I gamma 2 isoform (CSNK1G2; 19p13.3), sodium channel, voltage-gated, type I, alpha subunit (SCN1A; 2q24.3), G protein-coupled receptor 98 (GPR98; 5q13) and inositol(myo)-1(or 4)-monophosphatase 2 (IMPA2; 18p11.2), respectively [<xref ref-type="bibr" rid="R61">61</xref>-<xref ref-type="bibr" rid="R64">64</xref>]. Although linkage of these loci has been replicated in some other familial cases, only for CSNK1G2 and IMPA2 association was found in subsequent association analysis [<xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R65"> 65</xref>]. In addition, a number of other candidate genes have been identified <italic>via </italic>association studies, including the genes encoding cholinergic receptor nicotinic alpha 4 (CHRNA4; 20q13.2-q13.3), gamma-aminobutyric acid A receptor gamma 2 (GABRG2; 5q31.1-q33.1) and -beta 3 (GABRB3; 15q11.2-q12), interleukin 1 beta (IL1B; 2q14) and interleukin 1 receptor antagonist (IL1RN; 2q14.2) [<xref ref-type="bibr" rid="R66">66</xref>-<xref ref-type="bibr" rid="R70">70</xref>]. However, the latter associations could not be replicated in subsequent cohorts [<xref ref-type="bibr" rid="R71">71</xref>-<xref ref-type="bibr" rid="R75">75</xref>].</p></sec><sec><title>Mental Retardation</title><p>Mental retardation (MR) occurs in approximately 2-3% of the population in developed countries [<xref ref-type="bibr" rid="R76">76</xref>]. For the diagnosis MR a number of criteria have to be fulfilled, including an IQ lower than 70 and behavioural disabilities that are already evident in childhood. The underlying causes of MR can be diverse, varying from inborn causes such as Down&#x02019;s syndrome, Fragile X syndrome and fetal alcohol syndrome (these three causes are responsible for 30% of the MR cases [<xref ref-type="bibr" rid="R77">77</xref>]), but also malnutrition and problems during pregnancy or birth can increase the risk for MR [<xref ref-type="bibr" rid="R78">78</xref>].</p><p>Although it is evident that a genetic factor is involved in the aetiology of MR and the genetic cause of a number of subtypes has been identified (e.g. trisomy of chromosome 21 in Down&#x02019;s syndrome), the majority of cases have an unknown genetic aetiology. Since MR has a clearly X-linked inheritance pattern and is more often found in males than females, variations in the X-chromosome may increase the risk for MR. A number of X-linked genes have been identified as susceptibility genes for MR, including fragile X mental retardation 2 (FMR2; Xq28), oligophrenin 1 (OPHN1; Xq12), p21 (CDKN1A)-activated kinase 3 (PAK3; Xq22.3-23), GDP dissociation inhibitor 1 (GDI1; Xq28), Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 (ARHGEF6; Xq26), ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3; Xp22.2-p22.1), interleukin 1 receptor accessory protein-like 1 (IL1RAPL1; Xp22.1-p21.3), tetraspanin 7 (TSPAN7; Xp11.4), methyl CpG binding protein 2 (MECP2; Xq28), acyl-CoA synthetase long-chain family member 4 (ACSL4; Xq22.3-q23) and aristaless related homeobox (ARX; Xp21) [<xref ref-type="bibr" rid="R79">79</xref>-<xref ref-type="bibr" rid="R89">89</xref>]. However, many other genes are likely linked to MR.</p></sec><sec><title>Addictive Disorders</title><p>Many twin studies have been performed on addictive disorders (both alcohol and drug abuse), which indicated heritability levels of 50-60% in alcohol consumption [<xref ref-type="bibr" rid="R90">90</xref>] and up to 70% in severe smoking [<xref ref-type="bibr" rid="R91">91</xref>]. Since the dopaminergic pathway plays a central role in the reward system, the genes involved in this pathway are thought to be susceptibility genes for addictive disorders. Indeed, a number of studies have identified polymorphisms in this pathway that infer susceptibility to addiction: genetic variations in the DRD2, DRD3, COMT and DAT1 genes have been reported to associate with smoking, alcoholism, cocaine abuse and heroin addiction [<xref ref-type="bibr" rid="R92">92</xref>-<xref ref-type="bibr" rid="R101">101</xref>]. Nevertheless, despite the large number of studies reporting association, meta-analyses have shown that the effects are only weak or not significant [<xref ref-type="bibr" rid="R102">102</xref>,<xref ref-type="bibr" rid="R103"> 103</xref>].</p></sec><sec><title>Fetal Alcohol Syndrome</title><p>During pregnancy, alcohol use by the mother may lead to fetal alcohol syndrome (FAS) that occurs at a rate of 0.5-2 individuals per 1000 live births. A number of family, twin and animal studies have suggested a genetic component in FAS pathogenesis, one of the main candidate genes being the alcohol dehydrogenase 1B (ADH1B) gene located on chromosome 4q21-q23. However, whereas some studies report a protective effect for a number of ADH1B subtypes, others were not successful in reproducing these results [reviewed in <xref ref-type="bibr" rid="R104">104</xref>]. Besides ADH1B, other candidate genes have been suggested as risk factors for FAS pathogenesis, such as the cytochrome P450 2E1 gene (CYP2E1; 10q24.3-qter) [<xref ref-type="bibr" rid="R105">105</xref>,<xref ref-type="bibr" rid="R106"> 106</xref>]. </p></sec><sec><title>Anxiety Disorders</title><p>Panic disorder, OCD, separation anxiety, overanxious disorder, agoraphobia and other phobias all belong to the group of anxiety disorders and are relatively common (lifetime prevalence of 25% [<xref ref-type="bibr" rid="R107">107</xref>]). Twin studies have indicated that a genetic factor is involved in anxiety disorders, but the genetic contribution to the disorders is only modest (30-40%) [<xref ref-type="bibr" rid="R108">108</xref>]. Yet, many linkage and association studies have been performed to determine the chromosomal locations or genes involved in the pathogenesis of the various subtypes of anxiety disorders. Panic disorder showed significant linkage to chromosomal regions 9q31, 13q and 22q [<xref ref-type="bibr" rid="R109">109</xref>,<xref ref-type="bibr" rid="R110"> 110</xref>], for OCD linkage was reported to chromosome 1q, 3q27-28, 6q, 7p, 9p24, 10p15, 14 and 15q [<xref ref-type="bibr" rid="R111">111</xref>-<xref ref-type="bibr" rid="R114">114</xref>], and for other anxiety disorders linkage was observed for chromosome 14p (simple phobia) [<xref ref-type="bibr" rid="R115">115</xref>], 16 (social phobia) [<xref ref-type="bibr" rid="R116">116</xref>], 1q, 4q, 7p, 12q and 13q (neuroticism) [<xref ref-type="bibr" rid="R117">117</xref>] and 8p21-23 (harm avoidance) [<xref ref-type="bibr" rid="R118">118</xref>]. Recently, also genome-wide linkage analyses on individuals with a broad anxiety phenotype rather than based on the DSM-IV anxiety disorder diagnosis have been performed and significant linkage was observed for chromosome 14 [<xref ref-type="bibr" rid="R119">119</xref>] and 4q31-q34 [<xref ref-type="bibr" rid="R120">120</xref>]. </p><p>Besides linkage analysis, many case-control design studies on candidate genes for anxiety pathogenesis have been performed. For panic disorder, a positive association was found for the serotonin receptors HTR1A (5q11.2-q13) and HTR2A (13q14-q21) [<xref ref-type="bibr" rid="R121">121</xref>,<xref ref-type="bibr" rid="R122"> 122</xref>], COMT [<xref ref-type="bibr" rid="R123">123</xref>], the neuropeptide cholecystokinin (CCK; 3p22-p21.3) [<xref ref-type="bibr" rid="R124">124</xref>], the adenosine A2a receptor (ADORA2A; 22q11.23) [<xref ref-type="bibr" rid="R125">125</xref>], MAOA [<xref ref-type="bibr" rid="R126">126</xref>], the nuclear transcription factor cAMP-responsive element modulator (CREM; 10p11.21) [<xref ref-type="bibr" rid="R127">127</xref>], the peripheral benzodiazepine receptor (PBR or TSPO; 22q13.31) [<xref ref-type="bibr" rid="R128">128</xref>], glutamic acid decarboxylase 1 (GAD1; 2q31) [<xref ref-type="bibr" rid="R129">129</xref>], diazepam binding inhibitor (DBI; 2q12-q21) [<xref ref-type="bibr" rid="R130">130</xref>], calmodulin-dependent protein kinase kinase b (CaMKKb; 12q24.2) [<xref ref-type="bibr" rid="R131">131</xref>] and angiotensin-converting enzyme (ACE; 17q23.3) [<xref ref-type="bibr" rid="R132">132</xref>]. In addition, an association analysis of 90 SNPs located in 21 candidate genes revealed eight SNPs to be associated with panic disorder (located in the CCK, serotonin and dopamine systems), but all with a minor individual effect [<xref ref-type="bibr" rid="R133">133</xref>]. </p><p>Besides association with panic disorder, a number of susceptibility genes have been found to associate with other subtypes within anxiety disorders as well, such as the serotonin system in OCD and neuroticism [<xref ref-type="bibr" rid="R134">134</xref>-<xref ref-type="bibr" rid="R139">139</xref>], MAOA in generalized anxiety disorder and neuroticism [<xref ref-type="bibr" rid="R140">140</xref>,<xref ref-type="bibr" rid="R141"> 141</xref>], COMT in neuroticism and phobic anxiety [<xref ref-type="bibr" rid="R141">141</xref>,<xref ref-type="bibr" rid="R142"> 142</xref>] and BDNF in anxiety-related personality traits [<xref ref-type="bibr" rid="R143">143</xref>,<xref ref-type="bibr" rid="R144"> 144</xref>]. </p></sec><sec><title>Posttraumatic Stress Disorder </title><p>Posttraumatic stress disorder (PTSD) can occur in a subset of individuals exposed to extreme traumatic events [<xref ref-type="bibr" rid="R145">145</xref>], and has a lifetime incidence of ~9&#x02013;15% [<xref ref-type="bibr" rid="R146">146</xref>,<xref ref-type="bibr" rid="R147"> 147</xref>], and an estimated genetic inheritance of ~30% [<xref ref-type="bibr" rid="R148">148</xref>]. Susceptibility genes for PTSD have not yet been identified, but to date the number of individuals screened is low, while the few genetic studies that have been performed mainly focussed on key candidate genes, including BDNF, neuropeptide Y (NPY; 7p15.1), the glucocorticoid receptor (NR3C1; 5q31.3), and components of the serotonin and dopamine pathways [<xref ref-type="bibr" rid="R149">149</xref>-<xref ref-type="bibr" rid="R153">153</xref>].</p></sec><sec><title>Eating Disorders</title><p>Anorexia and bulimia nervosa are two major eating disorders with still unknown risk factors. For a long time, eating disorders have been considered to be caused by sociocultural factors. However, it has recently become clear that also genetics may play a substantial role in its aetiology. Family and twin studies have shown that heritability estimates for eating disorders vary from 48% to 74% in anorexia nervosa and from 55% to 83% in bulimia nervosa [<xref ref-type="bibr" rid="R154">154</xref>-<xref ref-type="bibr" rid="R157">157</xref>]. Since serotonin plays an important role in mood and feeding, genetic variations in the serotonergic pathway are thought to lead to eating disturbances. Indeed, a number of positive associations with the serotonin receptors HTR2A and HTR2C (Xq24), and also with the serotonin transporter gene have been reported [<xref ref-type="bibr" rid="R158">158</xref>-<xref ref-type="bibr" rid="R160">160</xref>], however, replication was not always successful [<xref ref-type="bibr" rid="R161">161</xref>,<xref ref-type="bibr" rid="R162"> 162</xref>]. Furthermore, associations were found for BDNF [<xref ref-type="bibr" rid="R163">163</xref>,<xref ref-type="bibr" rid="R164"> 164</xref>], the growth hormone secretagogue receptor (ghrelin receptor or GHSR; 3q26.31) [<xref ref-type="bibr" rid="R165">165</xref>] and COMT [<xref ref-type="bibr" rid="R166">166</xref>,<xref ref-type="bibr" rid="R167"> 167</xref>]. </p></sec><sec><title>Spina Bifida</title><p>Spina bifida is caused by unsuccessful closure of the neural tube during early development (between embryonic day 17 and 30) and occurs with a frequency of 1-2 cases per 1000 births. The exact aetiology of spina bifida is poorly understood, but it is clear that both genetic and environmental factors are involved [<xref ref-type="bibr" rid="R168">168</xref>]. Since individuals with spina bifida often die prenatal or early postnatal and thus hardly any families exist with several affected members, this disease could well be the most difficult complex disorder to study at the genetic level. Based on animal and epidemiological studies, genes involved in folic acid (folate), vitamin B12 and homocysteine metabolism, or genes involved in neurulation have been hypothesized to play a role in spina bifida genesis [reviewed in <xref ref-type="bibr" rid="R169">169</xref>]<italic>.</italic> However, until now, only a few genes have been reported to represent risk factors for spina bifida, including 5,10-methylenetetrahydrofolate reductase (MTHFR; 1p36.3) [<xref ref-type="bibr" rid="R170">170</xref>], methionine synthase reductase (MTRR; 5p15.3-p15.2) [<xref ref-type="bibr" rid="R171">171</xref>], platelet-derived growth factor receptor alpha (PDGFRA; 4q11-q13) [<xref ref-type="bibr" rid="R172">172</xref>] endothelial nitric oxide synthase 3 (NOS3; 7q36) [<xref ref-type="bibr" rid="R173">173</xref>] protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1; 6q24-q25) [<xref ref-type="bibr" rid="R174">174</xref>] and cofilin 1 (non-muscle) (CFL1; 11q13) [<xref ref-type="bibr" rid="R175">175</xref>]. </p></sec><sec><title>Hydrocephalus</title><p>Hydrocephalus occurs at a frequency of approximately 0.5 in 1000 births [<xref ref-type="bibr" rid="R176">176</xref>,<xref ref-type="bibr" rid="R177"> 177</xref>] and is characterized by abnormal flow or resorption of cerebrospinal fluid. It is considered a heterogeneous complex disorder [<xref ref-type="bibr" rid="R178">178</xref>] with genetic and environmental aetiologies [<xref ref-type="bibr" rid="R179">179</xref>,<xref ref-type="bibr" rid="R180"> 180</xref>]. Although approximately 37% of the hydrocephalus cases have a possible genetic aetiology [<xref ref-type="bibr" rid="R180">180</xref>], clear susceptibility genes for hydrocephalus have not been identified yet. Studies in animal models have suggested several loci as susceptibility regions for hydrocephalus, but these regions have not yet been reported as susceptibility regions in human [reviewed in <xref ref-type="bibr" rid="R181">181</xref>]. </p></sec></sec><sec><title>COMPLEX NEURODEVELOPMENTAL DISORDERS AND THE ENVIRONMENT</title><p>Since in general complex neurodevelopmental disorders have an estimated heritability lower than 100% (Table <bold><xref ref-type="table" rid="T2">2</xref></bold>), their aetiology includes another component that is thought to be primarily the environment (e.g. stressful life events). Numerous factors acting during early development of a foetus may contribute to the genesis of a neurodevelopmental disorder, including insufficient maternal nutrition, daily smoking, viral infection and repeated psychological stress [<xref ref-type="bibr" rid="R182">182</xref>]. Most environmental vulnerability factors are however difficult to assign and quantify.</p><p>The type and timing of the early environmental risk factors to which an organism is exposed appear to determine the phenotypic outcome. For example, a prenatal exposure of 9-days-pregnant mice to a sublethal intranasal administration of influenza virus led to both short-term and long-lasting deleterious effects on the developing brain structures and to abnormal behavior in the offspring of the mice [<xref ref-type="bibr" rid="R183">183</xref>]. Besides risk factors during early (prenatal) development, also obstetrical complications, including the use of resuscitation or an incubator, premature membrane rupture, diabetes, rhesus incompatibility, bleeding, preterm birth or caesarean birth, may increase the vulnerability to neurodevelopmental disorders [<xref ref-type="bibr" rid="R184">184</xref>,<xref ref-type="bibr" rid="R185"> 185</xref>].</p><p>One obvious gene-environment link concerns the season in which birth took place. An excess of winter-spring births in bipolar disorder and schizophrenia has been observed [<xref ref-type="bibr" rid="R186">186</xref>]. A similar tendency has been found in schizoaffective disorder (December-March), major depression (March-May) and autism (March) [reviewed in <xref ref-type="bibr" rid="R187">187</xref>]. Besides the season of birth, also the place of birth is thought to be associated. Urban&#x02013;born (and brought-up) subjects are more susceptible to neurodevelopmental disorders than rural-born (and brought-up) subjects [<xref ref-type="bibr" rid="R188">188</xref>]. Furthermore, risk factors like immigration and adoption may contribute to the development of psychiatric disorders [<xref ref-type="bibr" rid="R189">189</xref>,<xref ref-type="bibr" rid="R190"> 190</xref>].</p></sec><sec><title>GENE-ENVIRONMENT INTERACTIONS IN COMPLEX NEURODEVELOPMENTAL DISORDERS</title><p>One of the reasons that the genetic and environmental factors in complex neurodevelopmental disorders are difficult to define is the fact that the two factors may interact. However, such an interaction may be complex and act at various levels. For instance, genetic and environmental factors may have an additive effect, genetic factors may affect the influence of the environment on a phenotype or environmental factors may modulate the expression of genetic variants. </p><p>An example of a gene-environment interaction concerns the influence of stressful life events on depressive individuals with a functional polymorphism in the promoter region of the serotonin transporter gene. Individuals with the short allele have been found to respond differently to stressful life events (e.g. childhood maltreatment) and as such are more vulnerable to develop depressive symptoms than individuals with the long allele [<xref ref-type="bibr" rid="R29">29</xref>]. A second example of gene-environment interaction is the valine/methionine polymorphism (SNP rs4680) in the COMT gene. Upon cannabis use, individuals carrying the valine allele have a higher chance to exhibit psychotic symptoms and to develop schizophreniform disorders when compared to individuals with two methionine alleles [<xref ref-type="bibr" rid="R191">191</xref>]. </p></sec><sec><title>COMPLEX NEURODEVELOPMENTAL DISORDERS AND EPIGENETICS</title><p>Epigenetics is defined as heritable changes in gene expression patterns that occur without changing the DNA sequence itself [<xref ref-type="bibr" rid="R192">192</xref>], and includes DNA methylation and posttranslational modifications of histone proteins. DNA methylation, i.e. a covalent binding of a methyl group to the 5-position of the cytosine ring within the sequence 5&#x02019;-CG-3&#x02019; (CpG), can be tissue- and cell-type specific and is found in all vertebrates, and many invertebrates and plants. CpG clusters with a minimum of 200 base pairs, a CG percentage greater than 50% and an observed/expected CpG ratio greater than 0.6 are called CpG islands. These islands are often found in gene promoter regions and can protect single CpGs within a CpG island from DNA methylation. </p><p>An apparent link between the methylation status and gene transcription levels has led to the speculation that alterations in the methylation pattern (epimutations) might contribute to altered gene expression. Such epimutations are thought to occur upon exposure to environmental risk factors, including early developmental stress. Since early embryos seem to be particularly sensitive to epimutations [<xref ref-type="bibr" rid="R193">193</xref>,<xref ref-type="bibr" rid="R194"> 194</xref>], this factor should be considered for the aetiology of neurodevelopmental disorders. For instance, epigenetic alterations are responsible for a number of neurodevelopmental disorders with single-gene defects, such as Rett Syndrome, ICF Syndrome, Fragile X Syndrome and ATR-X Syndrome [<xref ref-type="bibr" rid="R195">195</xref>-<xref ref-type="bibr" rid="R198">198</xref>]. A role for DNA methylation has also been proposed in connection with complex neurodevelopmental disorders. For example, spina bifida can be caused by a lack of folate [reviewed in <xref ref-type="bibr" rid="R199">199</xref>], a compound needed for the generation of S-adenosylmethionine (SAM) that donates the methyl group in the DNA methylation process. Also, some patients with depressive illness and schizophrenia display lower serum folate levels [<xref ref-type="bibr" rid="R200">200</xref>]. Animal models further provide evidence for a possible link between epigenetics and neurodevelopmental disorders. Following a diet with L-methionine, a precursor in the biosynthesis of SAM, the reeler mouse (a model for schizophrenia) showed increased promoter methylation of the reelin gene, reduced reelin expression and a declined prepulse inhibition of startle. These effects could subsequently be reversed by valproic acid, a mood-stabilizing drug used for treatment of epilepsy, bipolar disorder and schizophrenia [<xref ref-type="bibr" rid="R201">201</xref>]. In addition, the adult offspring of rat mothers that showed high licking and grooming (LG) and arched-back nursing (ABN) (two forms of maternal behaviour in the rat that serve as the basis for the individuals programming of the stress response) are less fearful, have a lower hypothalamic-pituitary-adrenal response to stress, and have a lower DNA methylation status in the promoter region of the glucocorticoid receptor gene when compared to the offspring of low-LG and -ABN mothers [<xref ref-type="bibr" rid="R202">202</xref>]. Thus, alterations in epigenetic profiles may contribute to the generation of complex neurodevelopmental disorders. </p></sec><sec><title>COMPLICATING FACTORS IN ASSOCIATION STUDIES</title><p>Although numerous studies suggest that genetic variants play a significant role in the aetiology of complex neurodevelopmental disorders, in almost all cases the precise genetic background remains to be identified. Several factors (see below) have greatly complicated the identification of the genetic basis of neurodevelopmental disorders.</p><sec><title>Definition of Phenotype</title><p>In the genetics of psychiatric disorders, the definition of a phenotype is one of the main problems. Most genetic studies use patient characterization according to the DSM-IV or ICD-10 criteria. However, investigators nowadays believe that the phenotype should be specified in more detail, since most neurodevelopmental disorders include a number of intermediate clinical subtypes and distinct phenotypical parameters (endophenotypes) [<xref ref-type="bibr" rid="R203">203</xref>], presumably each with a different genetic background. Such endophenotypes may help in the identification of risk factors, although the effectiveness of this approach has recently been questioned [<xref ref-type="bibr" rid="R204">204</xref>]. Nevertheless, analysis of an endophenotypically defined group of patients may increase replication efficacy.</p></sec><sec><title>Population Stratification </title><p>Genetic variations often occur among (geographically or ethnically) different populations and this fact may thus increase the difficulty in data interpretation as well. For correct stratification and successful replication, it is therefore highly important that samples are clinically, geographically and ethnically well characterized.</p></sec><sec><title>Gene-Environment Interactions</title><p>Another complicating factor in the identification of susceptibility genes for neurodevelopmental disorders concerns the possibility of multifactorial gene-plus-environment interactions, as mentioned above. Unfortunately, such interactions are still difficult to quantify and interpret. </p></sec><sec><title>Multiple Genes Hypothesis</title><p>The search for susceptibility genes is further complicated when the aetiology of a complex neurodevelopmental disorder can not be explained by a single genetic variant with a relatively large effect but is rather caused by an interplay of a number of genes with small (additive) effects. For schizophrenia pathogenesis, the essential parameters for single- and multiple-locus models have been calculated and an interaction of about three different genes together with the environment was predicted to underly this disorder [<xref ref-type="bibr" rid="R205">205</xref>]. Not surprisingly, in general the greater the number of genes involved the more difficult their identification will be and larger (or additional) cohorts will be necessary to reach significant association. In addition, besides the possibility that multiple susceptibility genes are involved, individuals may be affected by the absence of protective alleles, while epistasis may also play a role.</p></sec><sec><title>Common Disease-Common Variant or Rare-Variant Hypothesis</title><p>At present, it is not clear whether only a relatively small number of common genetic variants are linked to the aetiology of neurodevelopmental disorders (known as the &#x0201c;common disease-common variant hypothesis&#x0201d;, often abbreviated CD-CV) [<xref ref-type="bibr" rid="R206">206</xref>,<xref ref-type="bibr" rid="R207"> 207</xref>], or if a large number of rare genetic variants is involved (&#x0201c;rare-variant-hypothesis&#x0201d; or heterogeneity hypothesis) [<xref ref-type="bibr" rid="R208">208</xref>]. In case of CD-CV, association analyses (e.g. GWA studies) may detect genetic variants if the studies contain enough power. It is clear that association analyses will be more difficult in rare variant cases [<xref ref-type="bibr" rid="R209">209</xref>].</p></sec></sec><sec><title>CONCLUSIONS AND FUTURE DIRECTIONS</title><p>Our summary of the current knowledge of the genetic, environmental and epigenetic contribution to the aetiology of neurodevelopmental disorders illustrates that unravelling the pathogenesis of these disorders is highly complex. Although further insights into the degree of the genetic contribution to the aetiology of neurodevelopmental disorders has been obtained, the identities of the genes involved and thus diagnostic markers are mostly lacking. </p><p>Up to now, in general, a presumptive susceptibility gene appears to be linked to a single neurodevelopmental disorder. However, the existence of a single susceptibility gene for both schizophrenia and bipolar disorder [reviewed in <xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R24"> 24</xref>] illustrates that we probably have to await the results of future genetic research for a definitive conclusion concerning this issue. The future results will also reveal which pathways are involved in the complex disorders.</p><p>For a better understanding of the aetiologies involved, it will be fruitful to obtain detailed clinical, ethnical and geographical information on large groups of individuals. In addition, the environmental factors need to be well defined and documented. However, until now our knowledge of the relevant environmental risk factors is rather limited. Clearly, close collaborations between psychiatrists and genetic researchers are required. </p><p>Undoubtedly, in the near future many more GWA studies with the 500K and even larger SNP arrays will be reported. Such studies will however not cover all genetic variations in the genome [<xref ref-type="bibr" rid="R210">210</xref>], because SNPs with a low minor allele frequency (MAF) (&#x0003c;0.05) are usually not included on the arrays, thereby excluding analysis of rare genetic variants. This is unfortunate, since the rare genetic variants are generally considered to have a higher chance of being causative [<xref ref-type="bibr" rid="R211">211</xref>]. Thus, candidate gene approaches of selected SNPs with a low prevalence may increase the chances to identify functional genetic variants. Because one would expect that causal SNPs have an effect in any population, a further consideration may involve a choice of SNPs with a low MAF in all ethnical populations. In this connection, one has to be aware of the possibility that such a SNP may need an additional polymorphism(s) to explain the phenotype (multiple genes hypothesis), while the additional genetic variation(s) may not be present in a particular ethnical population. One of the practical problems in dealing with low-MAF SNPs concerns the sample size necessary to obtain reliable association data, i.e. the lower the MAF the more samples are required to reach statistical significance. It is likely that inclusion of potentially functional SNPs (non-synonymous SNPs and SNPs in gene promoter regions or exon-intron boundaries) will increase the success rate in the analysis. At present, chips containing 20,000 non-synonymous human SNPs from ~11,000 genes are already available (<uri xlink:type="simple" xlink:href="www.affymetrix.com">www.affymetrix.com</uri>).</p><p>This review has attempted to provide an overview of the aetiologies of complex neurodevelopmental disorders. Clearly, many questions remain unanswered with respect to the pathogenesis of such disorders. Nevertheless, it is to be expected that within the next years the tsunami of genetic research will lead to more insights into the susceptibility genes. This new information can then be applied to start new research strategies, including the use of genetically manipulated cells or animal model systems carrying the susceptibility gene for functional studies on the pathways involved. Eventually, the acquired understanding of the molecular mechanisms underlying complex disorders may lead to translational research, including the design of gene/pathway-specific drugs and the application of disease-preventing strategies.</p></sec></body><back><ack><title>ACKNOWLEDGEMENT</title><p>We thank the Dutch Top Institute Pharma for support (project number T5-209).</p></ack><glossary><title>ABBREVIATIONS</title><def-list><def-item><term id="A1">ABN</term><def><p>= Arched-back nursing</p></def></def-item><def-item><term id="A2">ADH1B</term><def><p>= Alcohol dehydrogenase 1B</p></def></def-item><def-item><term id="A3">ADHD</term><def><p>= Attention deficit hyperactivity disorder</p></def></def-item><def-item><term id="A4">ATR-X</term><def><p>= X-linked alpha thalassemia/mental retardation</p></def></def-item><def-item><term id="A5">BDNF</term><def><p>= Brain-derived neurotrophic factor</p></def></def-item><def-item><term id="A6">CCK</term><def><p>= Cholecystokinin</p></def></def-item><def-item><term id="A7">CD-CV</term><def><p>= Common disease-common variant</p></def></def-item><def-item><term id="A8">CGH</term><def><p>= Comparative genome hybridization</p></def></def-item><def-item><term id="A9">CNV</term><def><p>= Copy-number variants</p></def></def-item><def-item><term id="A10">COMT</term><def><p>= Catechol-O-methyl transferase</p></def></def-item><def-item><term id="A11">CSNK1G2</term><def><p>= Casein kinase I gamma 2 isoform</p></def></def-item><def-item><term id="A12">DAO</term><def><p>= D-amino-acid oxidase</p></def></def-item><def-item><term id="A13">DAOA</term><def><p>= D-amino acid oxidase activator</p></def></def-item><def-item><term id="A14">DAT</term><def><p>= Dopamine transporter</p></def></def-item><def-item><term id="A15">DISC1</term><def><p>= Disrupted in schizophrenia 1</p></def></def-item><def-item><term id="A16">DRD2</term><def><p>= Dopamine receptor D2</p></def></def-item><def-item><term id="A17">DRD3</term><def><p>= Dopamine receptor D3</p></def></def-item><def-item><term id="A18">DRD4</term><def><p>= Dopamine receptor D4</p></def></def-item><def-item><term id="A19">DSM</term><def><p>= Diagnostic and Statistical manual for mental disorders</p></def></def-item><def-item><term id="A20">FAS</term><def><p>= Fetal alcohol syndrome</p></def></def-item><def-item><term id="A21">FMR1</term><def><p>= Fragile X mental retardation 1</p></def></def-item><def-item><term id="A22">FS</term><def><p>= Febrile seizures</p></def></def-item><def-item><term id="A23">GWA</term><def><p>= Genome-wide association</p></def></def-item><def-item><term id="A24">HTR2A</term><def><p>= 5-hydroxytryptamine (serotonin) receptor 2A</p></def></def-item><def-item><term id="A25">ICD</term><def><p>= International Classification of Disease</p></def></def-item><def-item><term id="A26">ICF</term><def><p>= Immunodeficiency, centromeric region instability, facial anomalies</p></def></def-item><def-item><term id="A27">IMPA2</term><def><p>= Inositol(myo)-1(or 4)-monophosphatase 2</p></def></def-item><def-item><term id="A28">LG</term><def><p>= Licking and grooming</p></def></def-item><def-item><term id="A29">MAF</term><def><p>= Minor allele frequency</p></def></def-item><def-item><term id="A30">MAOA</term><def><p>= Monoamine oxidase A</p></def></def-item><def-item><term id="A31">MeCP2</term><def><p>= Methyl CpG binding protein 2</p></def></def-item><def-item><term id="A32">MR</term><def><p>= Mental retardation</p></def></def-item><def-item><term id="A33">NRG1</term><def><p>= Neuregulin-1</p></def></def-item><def-item><term id="A34">OCD</term><def><p>= Obsessive-compulsive disorder</p></def></def-item><def-item><term id="A35">PDD</term><def><p>= Pervasive developmental disorders</p></def></def-item><def-item><term id="A36">PTSD</term><def><p>= Posttraumatic stress disorder</p></def></def-item><def-item><term id="A37">RGS4</term><def><p>= Regulator of G-protein signalling 4</p></def></def-item><def-item><term id="A38">SAM</term><def><p>= S-adenosylmethionine</p></def></def-item><def-item><term id="A39">SLC6A4</term><def><p>= Serotonin transporter</p></def></def-item><def-item><term id="A40">SNP</term><def><p>= Single-nucleotide polymorphism</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N.</given-names></name><name><surname>Merikangas</surname><given-names>K</given-names></name></person-group><article-title>The future of genetic studies of complex human diseases</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>1516</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8801636</pub-id></citation></ref><ref id="R2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>N.</given-names></name><name><surname>Owen</surname><given-names>M.J</given-names></name></person-group><article-title>Modern molecular genetic approaches to psychiatric disease</article-title><source>Br. Med. Bull</source><year>1996</year><volume>52</volume><fpage>434</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">8949248</pub-id></citation></ref><ref id="R3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>M.J.</given-names></name><name><surname>Craddock</surname><given-names>N</given-names></name></person-group><article-title>Modern molecular genetic approaches to complex traits: implications for psychiatric disorders</article-title><source>Mol. Psychiatry</source><year>1996</year><volume>1</volume><fpage>21</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9118311</pub-id></citation></ref><ref id="R4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N.J</given-names></name></person-group><article-title>Searching for genetic determinants in the new millennium</article-title><source>Nature</source><year>2000</year><volume>405</volume><fpage>847</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10866211</pub-id></citation></ref><ref id="R5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.A.</given-names></name><name><surname>Lupski</surname><given-names>J.R</given-names></name></person-group><article-title>Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders</article-title><source>Neuron</source><year>2006</year><volume>52</volume><fpage>103</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17015230</pub-id></citation></ref><ref id="R6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redon</surname><given-names>R.</given-names></name><name><surname>Ishikawa</surname><given-names>S.</given-names></name><name><surname>Fitch</surname><given-names>K.R.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Perry</surname><given-names>G.H.</given-names></name><name><surname>Andrews</surname><given-names>T.D.</given-names></name><name><surname>Fiegler</surname><given-names>H.</given-names></name><name><surname>Shapero</surname><given-names>M.H.</given-names></name><name><surname>Carson</surname><given-names>A.R.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Cho</surname><given-names>E.K.</given-names></name><name><surname>Dallaire</surname><given-names>S.</given-names></name><name><surname>Freeman</surname><given-names>J.L.</given-names></name><name><surname>Gonzalez</surname><given-names>J.R.</given-names></name><name><surname>Gratacos</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Kalaitzopoulos</surname><given-names>D.</given-names></name><name><surname>Komura</surname><given-names>D.</given-names></name><name><surname>MacDonald</surname><given-names>J.R.</given-names></name><name><surname>Marshall</surname><given-names>C.R.</given-names></name><name><surname>Mei</surname><given-names>R.</given-names></name><name><surname>Montgomery</surname><given-names>L.</given-names></name><name><surname>Nishimura</surname><given-names>K.</given-names></name><name><surname>Okamura</surname><given-names>K.</given-names></name><name><surname>Shen</surname><given-names>F.</given-names></name><name><surname>Somerville</surname><given-names>M.J.</given-names></name><name><surname>Tchinda</surname><given-names>J.</given-names></name><name><surname>Valsesia</surname><given-names>A.</given-names></name><name><surname>Woodwark</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zerjal</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Armengol</surname><given-names>L.</given-names></name><name><surname>Conrad</surname><given-names>D.F.</given-names></name><name><surname>Estivill</surname><given-names>X.</given-names></name><name><surname>Tyler-Smith</surname><given-names>C.</given-names></name><name><surname>Carter</surname><given-names>N.P.</given-names></name><name><surname>Aburatani</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>K.W.</given-names></name><name><surname>Scherer</surname><given-names>S.W.</given-names></name><name><surname>Hurles</surname><given-names>M.E</given-names></name></person-group><article-title>Global variation in copy number in the human genome</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>444</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17122850</pub-id></citation></ref><ref id="R7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tkachev</surname><given-names>D.</given-names></name><name><surname>Mimmack</surname><given-names>M.L.</given-names></name><name><surname>Ryan</surname><given-names>M.M.</given-names></name><name><surname>Wayland</surname><given-names>M.</given-names></name><name><surname>Freeman</surname><given-names>T.</given-names></name><name><surname>Jones</surname><given-names>P.B.</given-names></name><name><surname>Starkey</surname><given-names>M.</given-names></name><name><surname>Webster</surname><given-names>M.J.</given-names></name><name><surname>Yolken</surname><given-names>R.H.</given-names></name><name><surname>Bahn</surname><given-names>S</given-names></name></person-group><article-title>Oligodendrocyte dysfunction in schizophrenia and bipolar disorder</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>798</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">13678875</pub-id></citation></ref><ref id="R8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montes</surname><given-names>G.</given-names></name><name><surname>Halterman</surname><given-names>J.S</given-names></name></person-group><article-title>Characteristics of school-age children with autism</article-title><source>J. Dev. Behav. Pediatr</source><year>2006</year><volume>27</volume><fpage>379</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">17041273</pub-id></citation></ref><ref id="R9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freitag</surname><given-names>C.M</given-names></name></person-group><article-title>The genetics of autistic disorders and its clinical relevance: a review of the literature</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>2</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17033636</pub-id></citation></ref><ref id="R10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.S.</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name></person-group><article-title>A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence</article-title><source>Int. J. Dev. Neurosci</source><year>2007</year><volume>25</volume><fpage>69</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">17236739</pub-id></citation></ref><ref id="R11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauritsen</surname><given-names>M.B.</given-names></name><name><surname>Als</surname><given-names>T.D.</given-names></name><name><surname>Dahl</surname><given-names>H.A.</given-names></name><name><surname>Flint</surname><given-names>T.J.</given-names></name><name><surname>Wang</surname><given-names>A.G.</given-names></name><name><surname>Vang</surname><given-names>M.</given-names></name><name><surname>Kruse</surname><given-names>T.A.</given-names></name><name><surname>Ewald</surname><given-names>H.</given-names></name><name><surname>Mors</surname><given-names>O</given-names></name></person-group><article-title>A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16205737</pub-id></citation></ref><ref id="R12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szatmari</surname><given-names>P.</given-names></name><name><surname>Paterson</surname><given-names>A.D.</given-names></name><name><surname>Zwaigenbaum</surname><given-names>L.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Brian</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.Q.</given-names></name><name><surname>Vincent</surname><given-names>J.B.</given-names></name><name><surname>Skaug</surname><given-names>J.L.</given-names></name><name><surname>Thompson</surname><given-names>A.P.</given-names></name><name><surname>Senman</surname><given-names>L.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Qian</surname><given-names>C.</given-names></name><name><surname>Bryson</surname><given-names>S.E.</given-names></name><name><surname>Jones</surname><given-names>M.B.</given-names></name><name><surname>Marshall</surname><given-names>C.R.</given-names></name><name><surname>Scherer</surname><given-names>S.W.</given-names></name><name><surname>Vieland</surname><given-names>V.J.</given-names></name><name><surname>Bartlett</surname><given-names>C.</given-names></name><name><surname>Mangin</surname><given-names>L.V.</given-names></name><name><surname>Goedken</surname><given-names>R.</given-names></name><name><surname>Segre</surname><given-names>A.</given-names></name><name><surname>Pericak-Vance</surname><given-names>M.A.</given-names></name><name><surname>Cuccaro</surname><given-names>M.L.</given-names></name><name><surname>Gilbert</surname><given-names>J.R.</given-names></name><name><surname>Wright</surname><given-names>H.H.</given-names></name><name><surname>Abramson</surname><given-names>R.K.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Bourgeron</surname><given-names>T.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name><name><surname>Buxbaum</surname><given-names>J.D.</given-names></name><name><surname>Davis</surname><given-names>K.L.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Silverman</surname><given-names>J.M.</given-names></name><name><surname>Hallmayer</surname><given-names>J.</given-names></name><name><surname>Lotspeich</surname><given-names>L.</given-names></name><name><surname>Sutcliffe</surname><given-names>J.S.</given-names></name><name><surname>Haines</surname><given-names>J.L.</given-names></name><name><surname>Folstein</surname><given-names>S.E.</given-names></name><name><surname>Piven</surname><given-names>J.</given-names></name><name><surname>Wassink</surname><given-names>T.H.</given-names></name><name><surname>Sheffield</surname><given-names>V.</given-names></name><name><surname>Geschwind</surname><given-names>D.H.</given-names></name><name><surname>Bucan</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name><name><surname>Cantor</surname><given-names>R.M.</given-names></name><name><surname>Constantino</surname><given-names>J.N.</given-names></name><name><surname>Gilliam</surname><given-names>T.C.</given-names></name><name><surname>Herbert</surname><given-names>M.</given-names></name><name><surname>Lajonchere</surname><given-names>C.</given-names></name><name><surname>Ledbetter</surname><given-names>D.H.</given-names></name><name><surname>Lese-Martin</surname><given-names>C.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>Nelson</surname><given-names>S.</given-names></name><name><surname>Samango-Sprouse</surname><given-names>C.A.</given-names></name><name><surname>Spence</surname><given-names>S.</given-names></name><name><surname>State</surname><given-names>M.</given-names></name><name><surname>Tanzi</surname><given-names>R.E.</given-names></name><name><surname>Coon</surname><given-names>H.</given-names></name><name><surname>Dawson</surname><given-names>G.</given-names></name><name><surname>Devlin</surname><given-names>B.</given-names></name><name><surname>Estes</surname><given-names>A.</given-names></name><name><surname>Flodman</surname><given-names>P.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>McMahon</surname><given-names>W.M.</given-names></name><name><surname>Minshew</surname><given-names>N.</given-names></name><name><surname>Munson</surname><given-names>J.</given-names></name><name><surname>Korvatska</surname><given-names>E.</given-names></name><name><surname>Rodier</surname><given-names>P.M.</given-names></name><name><surname>Schellenberg</surname><given-names>G.D.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name><name><surname>Spence</surname><given-names>M.A.</given-names></name><name><surname>Stodgell</surname><given-names>C.</given-names></name><name><surname>Tepper</surname><given-names>P.G.</given-names></name><name><surname>Wijsman</surname><given-names>E.M.</given-names></name><name><surname>Yu</surname><given-names>C.E.</given-names></name><name><surname>Roge</surname><given-names>B.</given-names></name><name><surname>Mantoulan</surname><given-names>C.</given-names></name><name><surname>Wittemeyer</surname><given-names>K.</given-names></name><name><surname>Poustka</surname><given-names>A.</given-names></name><name><surname>Felder</surname><given-names>B.</given-names></name><name><surname>Klauck</surname><given-names>S.M.</given-names></name><name><surname>Schuster</surname><given-names>C.</given-names></name><name><surname>Poustka</surname><given-names>F.</given-names></name><name><surname>Bolte</surname><given-names>S.</given-names></name><name><surname>Feineis-Matthews</surname><given-names>S.</given-names></name><name><surname>Herbrecht</surname><given-names>E.</given-names></name><name><surname>Schmotzer</surname><given-names>G.</given-names></name><name><surname>Tsiantis</surname><given-names>J.</given-names></name><name><surname>Papanikolaou</surname><given-names>K.</given-names></name><name><surname>Maestrini</surname><given-names>E.</given-names></name><name><surname>Bacchelli</surname><given-names>E.</given-names></name><name><surname>Blasi</surname><given-names>F.</given-names></name><name><surname>Carone</surname><given-names>S.</given-names></name><name><surname>Toma</surname><given-names>C.</given-names></name><name><surname>Van Engeland</surname><given-names>H.</given-names></name><name><surname>de Jonge</surname><given-names>M.</given-names></name><name><surname>Kemner</surname><given-names>C.</given-names></name><name><surname>Koop</surname><given-names>F.</given-names></name><name><surname>Langemeijer</surname><given-names>M.</given-names></name><name><surname>Hijimans</surname><given-names>C.</given-names></name><name><surname>Staal</surname><given-names>W.G.</given-names></name><name><surname>Baird</surname><given-names>G.</given-names></name><name><surname>Bolton</surname><given-names>P.F.</given-names></name><name><surname>Rutter</surname><given-names>M.L.</given-names></name><name><surname>Weisblatt</surname><given-names>E.</given-names></name><name><surname>Green</surname><given-names>J.</given-names></name><name><surname>Aldred</surname><given-names>C.</given-names></name><name><surname>Wilkinson</surname><given-names>J.A.</given-names></name><name><surname>Pickles</surname><given-names>A.</given-names></name><name><surname>Le Couteur</surname><given-names>A.</given-names></name><name><surname>Berney</surname><given-names>T.</given-names></name><name><surname>McConachie</surname><given-names>H.</given-names></name><name><surname>Bailey</surname><given-names>A.J.</given-names></name><name><surname>Francis</surname><given-names>K.</given-names></name><name><surname>Honeyman</surname><given-names>G.</given-names></name><name><surname>Hutchinson</surname><given-names>A.</given-names></name><name><surname>Parr</surname><given-names>J.R.</given-names></name><name><surname>Wallace</surname><given-names>S.</given-names></name><name><surname>Monaco</surname><given-names>A.P.</given-names></name><name><surname>Barnby</surname><given-names>G.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Lamb</surname><given-names>J.A.</given-names></name><name><surname>Sousa</surname><given-names>I.</given-names></name><name><surname>Sykes</surname><given-names>N.</given-names></name><name><surname>Cook</surname><given-names>E.H.</given-names></name><name><surname>Guter</surname><given-names>S.J.</given-names></name><name><surname>Leventhal</surname><given-names>B.L.</given-names></name><name><surname>Salt</surname><given-names>J.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Corsello</surname><given-names>C.</given-names></name><name><surname>Hus</surname><given-names>V.</given-names></name><name><surname>Weeks</surname><given-names>D.E.</given-names></name><name><surname>Volkmar</surname><given-names>F.</given-names></name><name><surname>Tauber</surname><given-names>M.</given-names></name><name><surname>Fombonne</surname><given-names>E.</given-names></name><name><surname>Shih</surname><given-names>A</given-names></name></person-group><article-title>Mapping autism risk loci using genetic linkage and chromosomal rearrangements</article-title><source>Nat. Genet</source><year>2007</year><volume>39</volume><fpage>319</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">17322880</pub-id></citation></ref><ref id="R13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J.</given-names></name><name><surname>Lakshmi</surname><given-names>B.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Troge</surname><given-names>J.</given-names></name><name><surname>Lese-Martin</surname><given-names>C.</given-names></name><name><surname>Walsh</surname><given-names>T.</given-names></name><name><surname>Yamrom</surname><given-names>B.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name><name><surname>Krasnitz</surname><given-names>A.</given-names></name><name><surname>Kendall</surname><given-names>J.</given-names></name><name><surname>Leotta</surname><given-names>A.</given-names></name><name><surname>Pai</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Hicks</surname><given-names>J.</given-names></name><name><surname>Spence</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>A.T.</given-names></name><name><surname>Puura</surname><given-names>K.</given-names></name><name><surname>Lehtimaki</surname><given-names>T.</given-names></name><name><surname>Ledbetter</surname><given-names>D.</given-names></name><name><surname>Gregersen</surname><given-names>P.K.</given-names></name><name><surname>Bregman</surname><given-names>J.</given-names></name><name><surname>Sutcliffe</surname><given-names>J.S.</given-names></name><name><surname>Jobanputra</surname><given-names>V.</given-names></name><name><surname>Chung</surname><given-names>W.</given-names></name><name><surname>Warburton</surname><given-names>D.</given-names></name><name><surname>King</surname><given-names>M.C.</given-names></name><name><surname>Skuse</surname><given-names>D.</given-names></name><name><surname>Geschwind</surname><given-names>D.H.</given-names></name><name><surname>Gilliam</surname><given-names>T.C.</given-names></name><name><surname>Ye</surname><given-names>K.</given-names></name><name><surname>Wigler</surname><given-names>M</given-names></name></person-group><article-title>Strong association of de novo copy number mutations with autism</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>445</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17363630</pub-id></citation></ref><ref id="R14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jablensky</surname><given-names>A.</given-names></name><name><surname>Sartorius</surname><given-names>N.</given-names></name><name><surname>Korten</surname><given-names>A.</given-names></name><name><surname>Ernberg</surname><given-names>G.</given-names></name><name><surname>Anker</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>J.E.</given-names></name><name><surname>Day</surname><given-names>R</given-names></name></person-group><article-title>Incidence worldwide of schizophrenia</article-title><source>Br. J. Psychiatry</source><year>1987</year><volume>151</volume><fpage>408</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3427300</pub-id></citation></ref><ref id="R15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>S.R.</given-names></name><name><surname>Opler</surname><given-names>L.A</given-names></name></person-group><article-title>The positive-negative dimension in schizophrenia: its validity and significance</article-title><source>Psychiatr. Dev</source><year>1987</year><volume>5</volume><fpage>79</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">2888108</pub-id></citation></ref><ref id="R16"><label>16</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>I</given-names></name></person-group><source>Schizophrenia genesis The origins of madness</source><year>1991</year><publisher-loc>New York</publisher-loc><publisher-name>W.H. Freeman and Company</publisher-name></citation></ref><ref id="R17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardno</surname><given-names>A.G.</given-names></name><name><surname>Marshall</surname><given-names>E.J.</given-names></name><name><surname>Coid</surname><given-names>B.</given-names></name><name><surname>Macdonald</surname><given-names>A.M.</given-names></name><name><surname>Ribchester</surname><given-names>T.R.</given-names></name><name><surname>Davies</surname><given-names>N.J.</given-names></name><name><surname>Venturi</surname><given-names>P.</given-names></name><name><surname>Jones</surname><given-names>L.A.</given-names></name><name><surname>Lewis</surname><given-names>S.W.</given-names></name><name><surname>Sham</surname><given-names>P.C.</given-names></name><name><surname>Gottesman</surname><given-names>I.I.</given-names></name><name><surname>Farmer</surname><given-names>A.E.</given-names></name><name><surname>McGuffin</surname><given-names>P.</given-names></name><name><surname>Reveley</surname><given-names>A.M.</given-names></name><name><surname>Murray</surname><given-names>R.M</given-names></name></person-group><article-title>Heritability estimates for psychotic disorders the Maudsley twin psychosis series</article-title><source>Arch. Gen. Psychiatry</source><year>1999</year><volume>56</volume><fpage>162</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10025441</pub-id></citation></ref><ref id="R18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C.A.</given-names></name><name><surname>Margolis</surname><given-names>R.L.</given-names></name><name><surname>Reading</surname><given-names>S.A.</given-names></name><name><surname>Pletnikov</surname><given-names>M.</given-names></name><name><surname>Coyle</surname><given-names>J.T</given-names></name></person-group><article-title>Neurobiology of schizophrenia</article-title><source>Neuron</source><year>2006</year><volume>52</volume><fpage>139</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">17015232</pub-id></citation></ref><ref id="R19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>M.J.</given-names></name><name><surname>Craddock</surname><given-names>N.</given-names></name><name><surname>O'Donovan</surname><given-names>M.C</given-names></name></person-group><article-title>Schizophrenia genes at last?</article-title><source>Trends Genet</source><year>2005</year><volume>21</volume><fpage>518</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16009449</pub-id></citation></ref><ref id="R20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lencz</surname><given-names>T.</given-names></name><name><surname>Morgan</surname><given-names>T.V.</given-names></name><name><surname>Athanasiou</surname><given-names>M.</given-names></name><name><surname>Dain</surname><given-names>B.</given-names></name><name><surname>Reed</surname><given-names>C.R.</given-names></name><name><surname>Kane</surname><given-names>J.M.</given-names></name><name><surname>Kucherlapati</surname><given-names>R.</given-names></name><name><surname>Malhotra</surname><given-names>A.K</given-names></name></person-group><article-title>Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>572</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17522711</pub-id></citation></ref><ref id="R21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>T</given-names></name></person-group><article-title>Molecular genetics of bipolar disorder and depression</article-title><source>Psychiatry Clin. Neurosci</source><year>2007</year><volume>61</volume><fpage>3</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">17239033</pub-id></citation></ref><ref id="R22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smoller</surname><given-names>J.W.</given-names></name><name><surname>Finn</surname><given-names>C.T</given-names></name></person-group><article-title>Family, twin, and adoption studies of bipolar disorder</article-title><source>Am. J. Med. Genet. C Semin. Med. Genet</source><year>2003</year><volume>123</volume><fpage>48</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">14601036</pub-id></citation></ref><ref id="R23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berrettini</surname><given-names>W</given-names></name></person-group><article-title>Evidence for shared susceptibility in bipolar disorder and schizophrenia</article-title><source>Am. J. Med. Genet. C Semin. Med. Genet</source><year>2003</year><volume>123</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">14601037</pub-id></citation></ref><ref id="R24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farmer</surname><given-names>A.</given-names></name><name><surname>Elkin</surname><given-names>A.</given-names></name><name><surname>McGuffin</surname><given-names>P</given-names></name></person-group><article-title>The genetics of bipolar affective disorder</article-title><source>Curr. Opin. Psychiatry</source><year>2007</year><volume>20</volume><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17143075</pub-id></citation></ref><ref id="R25"><label>25</label><citation citation-type="journal"><article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>661</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17554300</pub-id></citation></ref><ref id="R26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R.C.</given-names></name><name><surname>Berglund</surname><given-names>P.</given-names></name><name><surname>Demler</surname><given-names>O.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name><name><surname>Koretz</surname><given-names>D.</given-names></name><name><surname>Merikangas</surname><given-names>K.R.</given-names></name><name><surname>Rush</surname><given-names>A.J.</given-names></name><name><surname>Walters</surname><given-names>E.E.</given-names></name><name><surname>Wang</surname><given-names>P.S</given-names></name></person-group><article-title>The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>3095</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">12813115</pub-id></citation></ref><ref id="R27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kendler</surname><given-names>K.S.</given-names></name><name><surname>Karkowski-Shuman</surname><given-names>L</given-names></name></person-group><article-title>Stressful life events and genetic liability to major depression genetic control of exposure to the environment? </article-title><source>Psychol Med</source><year>1997</year><volume>27</volume><fpage>539</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9153675</pub-id></citation></ref><ref id="R28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massat</surname><given-names>I.</given-names></name><name><surname>Souery</surname><given-names>D.</given-names></name><name><surname>Del-Favero</surname><given-names>J.</given-names></name><name><surname>Nothen</surname><given-names>M.</given-names></name><name><surname>Blackwood</surname><given-names>D.</given-names></name><name><surname>Muir</surname><given-names>W.</given-names></name><name><surname>Kaneva</surname><given-names>R.</given-names></name><name><surname>Serretti</surname><given-names>A.</given-names></name><name><surname>Lorenzi</surname><given-names>C.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Milanova</surname><given-names>V.</given-names></name><name><surname>Papadimitriou</surname><given-names>G.N.</given-names></name><name><surname>Dikeos</surname><given-names>D.</given-names></name><name><surname>Van Broekhoven</surname><given-names>C.</given-names></name><name><surname>Mendlewicz</surname><given-names>J</given-names></name></person-group><article-title>Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>598</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">15583702</pub-id></citation></ref><ref id="R29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caspi</surname><given-names>A.</given-names></name><name><surname>Sugden</surname><given-names>K.</given-names></name><name><surname>Moffitt</surname><given-names>T.E.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Craig</surname><given-names>I.W.</given-names></name><name><surname>Harrington</surname><given-names>H.</given-names></name><name><surname>McClay</surname><given-names>J.</given-names></name><name><surname>Mill</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Braithwaite</surname><given-names>A.</given-names></name><name><surname>Poulton</surname><given-names>R</given-names></name></person-group><article-title>Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>386</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12869766</pub-id></citation></ref><ref id="R30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>J.</given-names></name><name><surname>Jamra</surname><given-names>R.A.</given-names></name><name><surname>Becker</surname><given-names>T.</given-names></name><name><surname>Ohlraun</surname><given-names>S.</given-names></name><name><surname>Klopp</surname><given-names>N.</given-names></name><name><surname>Binder</surname><given-names>E.B.</given-names></name><name><surname>Schulze</surname><given-names>T.G.</given-names></name><name><surname>Deschner</surname><given-names>M.</given-names></name><name><surname>Schmal</surname><given-names>C.</given-names></name><name><surname>Hofels</surname><given-names>S.</given-names></name><name><surname>Zobel</surname><given-names>A.</given-names></name><name><surname>Illig</surname><given-names>T.</given-names></name><name><surname>Propping</surname><given-names>P.</given-names></name><name><surname>Holsboer</surname><given-names>F.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name></person-group><article-title>Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression</article-title><source>Biol. Psychiatry</source><year>2005</year><volume>58</volume><fpage>307</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">16005437</pub-id></citation></ref><ref id="R31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surtees</surname><given-names>P.G.</given-names></name><name><surname>Wainwright</surname><given-names>N.W.</given-names></name><name><surname>Willis-Owen</surname><given-names>S.A.</given-names></name><name><surname>Sandhu</surname><given-names>M.S.</given-names></name><name><surname>Luben</surname><given-names>R.</given-names></name><name><surname>Day</surname><given-names>N.E.</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults</article-title><source>J. Psychiatr. Res</source><year>2007</year><volume>41</volume><fpage>404</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16497333</pub-id></citation></ref><ref id="R32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>N.A.</given-names></name><name><surname>Whitfield</surname><given-names>J.B.</given-names></name><name><surname>Williams</surname><given-names>B.</given-names></name><name><surname>Heath</surname><given-names>A.C.</given-names></name><name><surname>Martin</surname><given-names>N.G</given-names></name></person-group><article-title>The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression</article-title><source>Psychol. Med</source><year>2005</year><volume>35</volume><fpage>101</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15842033</pub-id></citation></ref><ref id="R33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>A.</given-names></name><name><surname>Postilnick</surname><given-names>D.</given-names></name><name><surname>Rockah</surname><given-names>R.</given-names></name><name><surname>Michaelovsky</surname><given-names>E.</given-names></name><name><surname>Postilnick</surname><given-names>S.</given-names></name><name><surname>Birman</surname><given-names>E.</given-names></name><name><surname>Laor</surname><given-names>N.</given-names></name><name><surname>Rauchverger</surname><given-names>B.</given-names></name><name><surname>Kreinin</surname><given-names>A.</given-names></name><name><surname>Poyurovsky</surname><given-names>M.</given-names></name><name><surname>Schneidman</surname><given-names>M.</given-names></name><name><surname>Modai</surname><given-names>I.</given-names></name><name><surname>Weizman</surname><given-names>R</given-names></name></person-group><article-title>Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways</article-title><source>Mol. Psychiatry</source><year>1999</year><volume>4</volume><fpage>389</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">10483058</pub-id></citation></ref><ref id="R34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E</given-names></name></person-group><article-title>Clinical and molecular genetics of ADHD and Tourette syndrome Two related polygenic disorders</article-title><source> Ann. N. Y. Acad. Sci</source><year>2001</year><volume>931</volume><fpage>50</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11462757</pub-id></citation></ref><ref id="R35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>S.V.</given-names></name><name><surname>Sergeant</surname><given-names>J.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name></person-group><article-title>The worldwide prevalence of ADHD: is it an American condition?</article-title><source>World Psychiatry</source><year>2003</year><volume>2</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">16946911</pub-id></citation></ref><ref id="R36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>S.V.</given-names></name><name><surname>Khan</surname><given-names>S.A</given-names></name></person-group><article-title>Candidate gene studies of attention-deficit/hyperactivity disorder</article-title><source>J. Clin. Psychiatry</source><year>2006</year><volume>67</volume><issue>Suppl 8</issue><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16961425</pub-id></citation></ref><ref id="R37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brookes</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>K.</given-names></name><name><surname>Neale</surname><given-names>B.</given-names></name><name><surname>Lowe</surname><given-names>N.</given-names></name><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Franke</surname><given-names>B.</given-names></name><name><surname>Gill</surname><given-names>M.</given-names></name><name><surname>Ebstein</surname><given-names>R.</given-names></name><name><surname>Buitelaar</surname><given-names>J.</given-names></name><name><surname>Sham</surname><given-names>P.</given-names></name><name><surname>Campbell</surname><given-names>D.</given-names></name><name><surname>Knight</surname><given-names>J.</given-names></name><name><surname>Andreou</surname><given-names>P.</given-names></name><name><surname>Altink</surname><given-names>M.</given-names></name><name><surname>Arnold</surname><given-names>R.</given-names></name><name><surname>Boer</surname><given-names>F.</given-names></name><name><surname>Buschgens</surname><given-names>C.</given-names></name><name><surname>Butler</surname><given-names>L.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>Feldman</surname><given-names>L.</given-names></name><name><surname>Fleischman</surname><given-names>K.</given-names></name><name><surname>Fliers</surname><given-names>E.</given-names></name><name><surname>Howe-Forbes</surname><given-names>R.</given-names></name><name><surname>Goldfarb</surname><given-names>A.</given-names></name><name><surname>Heise</surname><given-names>A.</given-names></name><name><surname>Gabriels</surname><given-names>I.</given-names></name><name><surname>Korn-Lubetzki</surname><given-names>I.</given-names></name><name><surname>Johansson</surname><given-names>L.</given-names></name><name><surname>Marco</surname><given-names>R.</given-names></name><name><surname>Medad</surname><given-names>S.</given-names></name><name><surname>Minderaa</surname><given-names>R.</given-names></name><name><surname>Mulas</surname><given-names>F.</given-names></name><name><surname>Muller</surname><given-names>U.</given-names></name><name><surname>Mulligan</surname><given-names>A.</given-names></name><name><surname>Rabin</surname><given-names>K.</given-names></name><name><surname>Rommelse</surname><given-names>N.</given-names></name><name><surname>Sethna</surname><given-names>V.</given-names></name><name><surname>Sorohan</surname><given-names>J.</given-names></name><name><surname>Uebel</surname><given-names>H.</given-names></name><name><surname>Psychogiou</surname><given-names>L.</given-names></name><name><surname>Weeks</surname><given-names>A.</given-names></name><name><surname>Barrett</surname><given-names>R.</given-names></name><name><surname>Craig</surname><given-names>I.</given-names></name><name><surname>Banaschewski</surname><given-names>T.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E.</given-names></name><name><surname>Eisenberg</surname><given-names>J.</given-names></name><name><surname>Kuntsi</surname><given-names>J.</given-names></name><name><surname>Manor</surname><given-names>I.</given-names></name><name><surname>McGuffin</surname><given-names>P.</given-names></name><name><surname>Miranda</surname><given-names>A.</given-names></name><name><surname>Oades</surname><given-names>R.D.</given-names></name><name><surname>Plomin</surname><given-names>R.</given-names></name><name><surname>Roeyers</surname><given-names>H.</given-names></name><name><surname>Rothenberger</surname><given-names>A.</given-names></name><name><surname>Sergeant</surname><given-names>J.</given-names></name><name><surname>Steinhausen</surname><given-names>H.C.</given-names></name><name><surname>Taylor</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>M.</given-names></name><name><surname>Faraone</surname><given-names>S.V.</given-names></name><name><surname>Asherson</surname><given-names>P</given-names></name></person-group><article-title>The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder association signals in DRD4, DAT1 and 16 other genes</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>934</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16894395</pub-id></citation></ref><ref id="R38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>M.M</given-names></name></person-group><article-title>Diagnosing Tourette syndrome: is it a common disorder?</article-title><source>J.Psychosom. Res</source><year>2003</year><volume>55</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12842225</pub-id></citation></ref><ref id="R39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>D.L</given-names></name></person-group><article-title>An update on the genetics of Gilles de la Tourette syndrome</article-title><source>J. Psychosom. Res</source><year>2003</year><volume>55</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">12842226</pub-id></citation></ref><ref id="R40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname><given-names>D.E.</given-names></name><name><surname>Leckman</surname><given-names>J.F.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Kidd</surname><given-names>K.K.</given-names></name><name><surname>Pakstis</surname><given-names>A.J.</given-names></name><name><surname>Chang</surname><given-names>F.M.</given-names></name><name><surname>Buxbaum</surname><given-names>J.D.</given-names></name><name><surname>Cohen</surname><given-names>D.J.</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name></person-group><article-title>Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test</article-title><source>Am. J. Hum. Genet</source><year>1996</year><volume>59</volume><fpage>644</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">8751866</pub-id></citation></ref><ref id="R41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarnok</surname><given-names>Z.</given-names></name><name><surname>Ronai</surname><given-names>Z.</given-names></name><name><surname>Gervai</surname><given-names>J.</given-names></name><name><surname>Kereszturi</surname><given-names>E.</given-names></name><name><surname>Gadoros</surname><given-names>J.</given-names></name><name><surname>Sasvari-Szekely</surname><given-names>M.</given-names></name><name><surname>Nemoda</surname><given-names>Z</given-names></name></person-group><article-title>Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3' UTR polymorphism of the dopamine transporter gene</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2007</year><volume>144</volume><fpage>900</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17508355</pub-id></citation></ref><ref id="R42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E.</given-names></name><name><surname>Comings</surname><given-names>B.G.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Dietz</surname><given-names>G.</given-names></name><name><surname>Shahbahrami</surname><given-names>B.</given-names></name><name><surname>Tast</surname><given-names>D.</given-names></name><name><surname>Knell</surname><given-names>E.</given-names></name><name><surname>Kocsis</surname><given-names>P.</given-names></name><name><surname>Baumgarten</surname><given-names>R.</given-names></name><name><surname>Kovacs</surname><given-names>B.W.</given-names></name><name><surname>Levy</surname><given-names>D.L.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name><name><surname>Kane</surname><given-names>J.M.</given-names></name><name><surname>Lieberman</surname><given-names>J.A.</given-names></name><name><surname>KLein</surname><given-names>D.N.</given-names></name><name><surname>MacMurray</surname><given-names>J.</given-names></name><name><surname>Tosk</surname><given-names>J.</given-names></name><name><surname>Sverd</surname><given-names>J.</given-names></name><name><surname>Gysin</surname><given-names>R.</given-names></name><name><surname>Flanagan</surname><given-names>S</given-names></name></person-group><article-title>The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders</article-title><source>Jama</source><year>1991</year><volume>266</volume><fpage>1793</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">1832466</pub-id></citation></ref><ref id="R43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>D.Y.</given-names></name><name><surname>Rippel</surname><given-names>C.A.</given-names></name><name><surname>Kobets</surname><given-names>A.J.</given-names></name><name><surname>Morris</surname><given-names>C.M.</given-names></name><name><surname>Lee</surname><given-names>J.E.</given-names></name><name><surname>Williams</surname><given-names>P.N.</given-names></name><name><surname>Bridges</surname><given-names>D.D.</given-names></name><name><surname>Vandenbergh</surname><given-names>D.J.</given-names></name><name><surname>Shugart</surname><given-names>Y.Y.</given-names></name><name><surname>Singer</surname><given-names>H.S</given-names></name></person-group><article-title>Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3)</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2007</year><volume>144</volume><fpage>605</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">17171650</pub-id></citation></ref><ref id="R44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Dietz</surname><given-names>G.</given-names></name><name><surname>Dino</surname><given-names>M.</given-names></name><name><surname>LeGro</surname><given-names>R.</given-names></name><name><surname>Gade</surname><given-names>R</given-names></name></person-group><article-title>Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene</article-title><source>Lancet</source><year>1993</year><volume>341</volume><fpage>906</fpage><pub-id pub-id-type="pmid">8096616</pub-id></citation></ref><ref id="R45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>D.C.</given-names></name><name><surname>Stever</surname><given-names>C.</given-names></name><name><surname>Gard</surname><given-names>J.M.</given-names></name><name><surname>Cleveland</surname><given-names>H.H.</given-names></name><name><surname>Sanders</surname><given-names>M.L.</given-names></name><name><surname>Abramowitz</surname><given-names>A.</given-names></name><name><surname>Kozol</surname><given-names>S.T.</given-names></name><name><surname>Mohr</surname><given-names>J.H.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>Waldman</surname><given-names>I.D</given-names></name></person-group><article-title>The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children</article-title><source>Behav. Genet</source><year>1998</year><volume>28</volume><fpage>215</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9670597</pub-id></citation></ref><ref id="R46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Ring</surname><given-names>R.H.</given-names></name><name><surname>Gade</surname><given-names>R.</given-names></name><name><surname>Ahn</surname><given-names>C.</given-names></name><name><surname>MacMurray</surname><given-names>J.P.</given-names></name><name><surname>Dietz</surname><given-names>G.</given-names></name><name><surname>Muhleman</surname><given-names>D</given-names></name></person-group><article-title>Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1</article-title><source>Am. J. Med. Genet</source><year>1996</year><volume>67</volume><fpage>264</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">8725745</pub-id></citation></ref><ref id="R47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gade</surname><given-names>R.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Blake</surname><given-names>H.</given-names></name><name><surname>MacMurray</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>P.</given-names></name><name><surname>Verde</surname><given-names>R.</given-names></name><name><surname>Saucier</surname><given-names>G.</given-names></name><name><surname>Comings</surname><given-names>D.E</given-names></name></person-group><article-title>Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse</article-title><source>Mol. Psychiatry</source><year>1998</year><volume>3</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9491813</pub-id></citation></ref><ref id="R48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>Pakstis</surname><given-names>A.J.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Gancher</surname><given-names>S.T.</given-names></name><name><surname>Civelli</surname><given-names>O.</given-names></name><name><surname>Grandy</surname><given-names>D.</given-names></name><name><surname>Kidd</surname><given-names>K.K</given-names></name></person-group><article-title>Gilles de la Tourette syndrome is not linked to D2-dopamine receptor</article-title><source>Arch. Gen. Psychiatry</source><year>1990</year><volume>47</volume><fpage>1073</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1978653</pub-id></citation></ref><ref id="R49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>Kennedy</surname><given-names>J.L.</given-names></name><name><surname>Grandy</surname><given-names>D.K.</given-names></name><name><surname>Zhou</surname><given-names>Q.Y.</given-names></name><name><surname>Civelli</surname><given-names>O.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Pakstis</surname><given-names>A.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Sunahara</surname><given-names>R.K.</given-names></name><name><surname>Niznik</surname><given-names>H.B.</given-names></name><name><surname>O'Dowd</surname><given-names>B.</given-names></name><name><surname>Seeman</surname><given-names>P.</given-names></name><name><surname>Kidd</surname><given-names>K.K</given-names></name></person-group><article-title>Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor</article-title><source>Am. J. Psychiatry</source><year>1993</year><volume>150</volume><fpage>449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">8434661</pub-id></citation></ref><ref id="R50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>C.L.</given-names></name><name><surname>Wigg</surname><given-names>K.G.</given-names></name><name><surname>Zovko</surname><given-names>E.</given-names></name><name><surname>Sandor</surname><given-names>P.</given-names></name><name><surname>Tsui</surname><given-names>L.C</given-names></name></person-group><article-title>No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families</article-title><source>Am. J. Med. Genet</source><year>1996</year><volume>67</volume><fpage>301</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8725747</pub-id></citation></ref><ref id="R51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brett</surname><given-names>P.</given-names></name><name><surname>Robertson</surname><given-names>M.</given-names></name><name><surname>Gurling</surname><given-names>H.</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name></person-group><article-title>Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette's syndrome</article-title><source>Lancet</source><year>1993</year><volume>341</volume><fpage>1225</fpage><pub-id pub-id-type="pmid">8098124</pub-id></citation></ref><ref id="R52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>C.L.</given-names></name><name><surname>Wigg</surname><given-names>K.G.</given-names></name><name><surname>Zovko</surname><given-names>E.</given-names></name><name><surname>Sandor</surname><given-names>P.</given-names></name><name><surname>Tsui</surname><given-names>L.C</given-names></name></person-group><article-title>Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome</article-title><source>Am. J. Med. Genet</source><year>1997</year><volume>74</volume><fpage>58</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9034008</pub-id></citation></ref><ref id="R53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brett</surname><given-names>P.M.</given-names></name><name><surname>Curtis</surname><given-names>D.</given-names></name><name><surname>Robertson</surname><given-names>M.M.</given-names></name><name><surname>Gurling</surname><given-names>H.M</given-names></name></person-group><article-title>The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase</article-title><source>Biol. Psychiatry</source><year>1995</year><volume>37</volume><fpage>533</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">7619976</pub-id></citation></ref><ref id="R54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abelson</surname><given-names>J.F.</given-names></name><name><surname>Kwan</surname><given-names>K.Y.</given-names></name><name><surname>O'Roak</surname><given-names>B.J.</given-names></name><name><surname>Baek</surname><given-names>D.Y.</given-names></name><name><surname>Stillman</surname><given-names>A.A.</given-names></name><name><surname>Morgan</surname><given-names>T.M.</given-names></name><name><surname>Mathews</surname><given-names>C.A.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Rasin</surname><given-names>M.R.</given-names></name><name><surname>Gunel</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>N.R.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A.G.</given-names></name><name><surname>Guez</surname><given-names>D.H.</given-names></name><name><surname>Spertus</surname><given-names>J.A.</given-names></name><name><surname>Leckman</surname><given-names>J.F.</given-names></name><name><surname>Dure</surname><given-names>L.S.t</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name><name><surname>Singer</surname><given-names>H.S.</given-names></name><name><surname>Gilbert</surname><given-names>D.L.</given-names></name><name><surname>Farhi</surname><given-names>A.</given-names></name><name><surname>Louvi</surname><given-names>A.</given-names></name><name><surname>Lifton</surname><given-names>R.P.</given-names></name><name><surname>Sestan</surname><given-names>N.</given-names></name><name><surname>State</surname><given-names>M.W</given-names></name></person-group><article-title>Sequence variants in SLITRK1 are associated with Tourette's syndrome</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>317</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16224024</pub-id></citation></ref><ref id="R55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaywitz</surname><given-names>S.E.</given-names></name><name><surname>Shaywitz</surname><given-names>B.A.</given-names></name><name><surname>Fletcher</surname><given-names>J.M.</given-names></name><name><surname>Escobar</surname><given-names>M.D</given-names></name></person-group><article-title>Prevalence of reading disability in boys and girls Results of the Connecticut Longitudinal Study</article-title><source>Jama</source><year>1990</year><volume>264</volume><fpage>998</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">2376893</pub-id></citation></ref><ref id="R56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caylak</surname><given-names>E</given-names></name></person-group><article-title>A review of association and linkage studies for genetical analyses of learning disorders</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2007</year><volume>144</volume><fpage>923</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">17510947</pub-id></citation></ref><ref id="R57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taipale</surname><given-names>M.</given-names></name><name><surname>Kaminen</surname><given-names>N.</given-names></name><name><surname>Nopola-Hemmi</surname><given-names>J.</given-names></name><name><surname>Haltia</surname><given-names>T.</given-names></name><name><surname>Myllyluoma</surname><given-names>B.</given-names></name><name><surname>Lyytinen</surname><given-names>H.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Kaaranen</surname><given-names>M.</given-names></name><name><surname>Lindsberg</surname><given-names>P.J.</given-names></name><name><surname>Hannula-Jouppi</surname><given-names>K.</given-names></name><name><surname>Kere</surname><given-names>J</given-names></name></person-group><article-title>A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>11553</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12954984</pub-id></citation></ref><ref id="R58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannula-Jouppi</surname><given-names>K.</given-names></name><name><surname>Kaminen-Ahola</surname><given-names>N.</given-names></name><name><surname>Taipale</surname><given-names>M.</given-names></name><name><surname>Eklund</surname><given-names>R.</given-names></name><name><surname>Nopola-Hemmi</surname><given-names>J.</given-names></name><name><surname>Kaariainen</surname><given-names>H.</given-names></name><name><surname>Kere</surname><given-names>J</given-names></name></person-group><article-title>The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia</article-title><source>PLoS Genet</source><year>2005</year><volume>1</volume><fpage>e50</fpage><pub-id pub-id-type="pmid">16254601</pub-id></citation></ref><ref id="R59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>H.</given-names></name><name><surname>Smith</surname><given-names>S.D.</given-names></name><name><surname>Hager</surname><given-names>K.</given-names></name><name><surname>Held</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Olson</surname><given-names>R.K.</given-names></name><name><surname>Pennington</surname><given-names>B.F.</given-names></name><name><surname>DeFries</surname><given-names>J.C.</given-names></name><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>O'Reilly-Pol</surname><given-names>T.</given-names></name><name><surname>Somlo</surname><given-names>S.</given-names></name><name><surname>Skudlarski</surname><given-names>P.</given-names></name><name><surname>Shaywitz</surname><given-names>S.E.</given-names></name><name><surname>Shaywitz</surname><given-names>B.A.</given-names></name><name><surname>Marchione</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Paramasivam</surname><given-names>M.</given-names></name><name><surname>LoTurco</surname><given-names>J.J.</given-names></name><name><surname>Page</surname><given-names>G.P.</given-names></name><name><surname>Gruen</surname><given-names>J.R</given-names></name></person-group><article-title>DCDC2 is associated with reading disability and modulates neuronal development in the brain</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>17053</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16278297</pub-id></citation></ref><ref id="R60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kjeldsen</surname><given-names>M.J.</given-names></name><name><surname>Kyvik</surname><given-names>K.O.</given-names></name><name><surname>Friis</surname><given-names>M.L.</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name></person-group><article-title>Genetic and environmental factors in febrile seizures: a Danish population-based twin study</article-title><source>Epilepsy Res</source><year>2002</year><volume>51</volume><fpage>167</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12350392</pub-id></citation></ref><ref id="R61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.W.</given-names></name><name><surname>Dubovsky</surname><given-names>J.</given-names></name><name><surname>Rich</surname><given-names>S.S.</given-names></name><name><surname>O'Donovan</surname><given-names>C.A.</given-names></name><name><surname>Orr</surname><given-names>H.T.</given-names></name><name><surname>Anderson</surname><given-names>V.E.</given-names></name><name><surname>Gil-Nagel</surname><given-names>A.</given-names></name><name><surname>Ahmann</surname><given-names>P.</given-names></name><name><surname>Dokken</surname><given-names>C.G.</given-names></name><name><surname>Schneider</surname><given-names>D.T.</given-names></name><name><surname>Weber</surname><given-names>J.L</given-names></name></person-group><article-title>Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest</article-title><source>Hum. Mol. Genet</source><year>1998</year><volume>7</volume><fpage>63</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9384604</pub-id></citation></ref><ref id="R62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peiffer</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>J.</given-names></name><name><surname>Charlier</surname><given-names>C.</given-names></name><name><surname>Otterud</surname><given-names>B.</given-names></name><name><surname>Varvil</surname><given-names>T.</given-names></name><name><surname>Pappas</surname><given-names>C.</given-names></name><name><surname>Barnitz</surname><given-names>C.</given-names></name><name><surname>Gruenthal</surname><given-names>K.</given-names></name><name><surname>Kuhn</surname><given-names>R.</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name></person-group><article-title>A locus for febrile seizures (FEB3) maps to chromosome 2q23-24</article-title><source>Ann. Neurol</source><year>1999</year><volume>46</volume><fpage>671</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10514109</pub-id></citation></ref><ref id="R63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>J.</given-names></name><name><surname>Hamano</surname><given-names>K.</given-names></name><name><surname>Iwasaki</surname><given-names>N.</given-names></name><name><surname>Nakahara</surname><given-names>S.</given-names></name><name><surname>Horigome</surname><given-names>Y.</given-names></name><name><surname>Saitoh</surname><given-names>H.</given-names></name><name><surname>Aoki</surname><given-names>T.</given-names></name><name><surname>Maki</surname><given-names>T.</given-names></name><name><surname>Kikuchi</surname><given-names>M.</given-names></name><name><surname>Migita</surname><given-names>T.</given-names></name><name><surname>Ohto</surname><given-names>T.</given-names></name><name><surname>Yokouchi</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Hasegawa</surname><given-names>M.</given-names></name><name><surname>Matsui</surname><given-names>A.</given-names></name><name><surname>Hamaguchi</surname><given-names>H.</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name></person-group><article-title>Significant evidence for linkage of febrile seizures to chromosome 5q14-q15</article-title><source>Hum. Mol. Genet</source><year>2000</year><volume>9</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10587582</pub-id></citation></ref><ref id="R64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>J.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Hamano</surname><given-names>K.</given-names></name><name><surname>Iwasaki</surname><given-names>N.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name><name><surname>Nakahara</surname><given-names>S.</given-names></name><name><surname>Matsui</surname><given-names>A.</given-names></name><name><surname>Noguchi</surname><given-names>E.</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name></person-group><article-title>Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>1803</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15557493</pub-id></citation></ref><ref id="R65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yinan</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Zhiyue</surname><given-names>C.</given-names></name><name><surname>Jianjun</surname><given-names>L.</given-names></name><name><surname>Lie</surname><given-names>H.</given-names></name><name><surname>Liping</surname><given-names>Z.</given-names></name><name><surname>Jianhui</surname><given-names>Z.</given-names></name><name><surname>Fang</surname><given-names>S.</given-names></name><name><surname>Dingfang</surname><given-names>B.</given-names></name><name><surname>Qing</surname><given-names>L.</given-names></name><name><surname>Xiru</surname><given-names>W</given-names></name></person-group><article-title>Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population</article-title><source>Neurosci. Lett</source><year>2004</year><volume>368</volume><fpage>2</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15342122</pub-id></citation></ref><ref id="R66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feucht</surname><given-names>M.</given-names></name><name><surname>Fuchs</surname><given-names>K.</given-names></name><name><surname>Pichlbauer</surname><given-names>E.</given-names></name><name><surname>Hornik</surname><given-names>K.</given-names></name><name><surname>Scharfetter</surname><given-names>J.</given-names></name><name><surname>Goessler</surname><given-names>R.</given-names></name><name><surname>Fureder</surname><given-names>T.</given-names></name><name><surname>Cvetkovic</surname><given-names>N.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Kasper</surname><given-names>S.</given-names></name><name><surname>Aschauer</surname><given-names>H</given-names></name></person-group><article-title>Possible association between childhood absence epilepsy and the gene encoding GABRB3</article-title><source>Biol. Psychiatry</source><year>1999</year><volume>46</volume><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">10509183</pub-id></citation></ref><ref id="R67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinlein</surname><given-names>O.</given-names></name><name><surname>Sander</surname><given-names>T.</given-names></name><name><surname>Stoodt</surname><given-names>J.</given-names></name><name><surname>Kretz</surname><given-names>R.</given-names></name><name><surname>Janz</surname><given-names>D.</given-names></name><name><surname>Propping</surname><given-names>P</given-names></name></person-group><article-title>Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit alpha4 with common idiopathic generalized epilepsies</article-title><source>Am. J. Med. Genet</source><year>1997</year><volume>74</volume><fpage>445</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9259383</pub-id></citation></ref><ref id="R68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanemoto</surname><given-names>K.</given-names></name><name><surname>Kawasaki</surname><given-names>J.</given-names></name><name><surname>Miyamoto</surname><given-names>T.</given-names></name><name><surname>Obayashi</surname><given-names>H.</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name></person-group><article-title>Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy</article-title><source>Ann. Neurol</source><year>2000</year><volume>47</volume><fpage>571</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10805326</pub-id></citation></ref><ref id="R69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>F.J.</given-names></name><name><surname>Hsieh</surname><given-names>Y.Y.</given-names></name><name><surname>Chang</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Tsai</surname><given-names>C.H</given-names></name></person-group><article-title>Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions</article-title><source>Arch. Pediatr. Adolesc. Med</source><year>2002</year><volume>156</volume><fpage>545</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12038885</pub-id></citation></ref><ref id="R70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baulac</surname><given-names>S.</given-names></name><name><surname>Huberfeld</surname><given-names>G.</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I.</given-names></name><name><surname>Mitropoulou</surname><given-names>G.</given-names></name><name><surname>Beranger</surname><given-names>A.</given-names></name><name><surname>Prud'homme</surname><given-names>J.F.</given-names></name><name><surname>Baulac</surname><given-names>M.</given-names></name><name><surname>Brice</surname><given-names>A.</given-names></name><name><surname>Bruzzone</surname><given-names>R.</given-names></name><name><surname>LeGuern</surname><given-names>E</given-names></name></person-group><article-title>First genetic evidence of GABA(A) receptor dysfunction in epilepsy a mutation in the gamma2-subunit gene</article-title><source>Nat. Genet</source><year>2001</year><volume>28</volume><fpage>46</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11326274</pub-id></citation></ref><ref id="R71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>J.</given-names></name><name><surname>Hamano</surname><given-names>K.</given-names></name><name><surname>Noguchi</surname><given-names>E.</given-names></name><name><surname>Horiuchi</surname><given-names>Y.</given-names></name><name><surname>Iwasaki</surname><given-names>N.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name><name><surname>Nakahara</surname><given-names>S.</given-names></name><name><surname>Naoi</surname><given-names>T.</given-names></name><name><surname>Matsui</surname><given-names>A.</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name></person-group><article-title>Failure to find causal mutations in the GABA(A)-receptor gamma2 subunit (GABRG2) gene in Japanese febrile seizure patients</article-title><source>Neurosci. Lett</source><year>2003</year><volume>343</volume><fpage>117</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12759178</pub-id></citation></ref><ref id="R72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tilgen</surname><given-names>N.</given-names></name><name><surname>Pfeiffer</surname><given-names>H.</given-names></name><name><surname>Cobilanschi</surname><given-names>J.</given-names></name><name><surname>Rau</surname><given-names>B.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><name><surname>Elger</surname><given-names>C.E.</given-names></name><name><surname>Propping</surname><given-names>P.</given-names></name><name><surname>Heils</surname><given-names>A</given-names></name></person-group><article-title>Association analysis between the human interleukin 1beta (-511) gene polymorphism and susceptibility to febrile convulsions</article-title><source>Neurosci. Lett</source><year>2002</year><volume>334</volume><fpage>68</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12431777</pub-id></citation></ref><ref id="R73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulley</surname><given-names>J.</given-names></name><name><surname>Heron</surname><given-names>S.</given-names></name><name><surname>Scheffer</surname><given-names>I.</given-names></name><name><surname>Berkovic</surname><given-names>S</given-names></name></person-group><article-title>Febrile convulsions and genetic susceptibility: role of the neuronal nicotinic acetylcholine receptor alpha 4 subunit</article-title><source>Epilepsia</source><year>2004</year><volume>45</volume><fpage>561</fpage><lpage>2</lpage><comment>author reply</comment><pub-id pub-id-type="pmid">15101840</pub-id></citation></ref><ref id="R74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haspolat</surname><given-names>S.</given-names></name><name><surname>Baysal</surname><given-names>Y.</given-names></name><name><surname>Duman</surname><given-names>O.</given-names></name><name><surname>Coskun</surname><given-names>M.</given-names></name><name><surname>Tosun</surname><given-names>O.</given-names></name><name><surname>Yegin</surname><given-names>O</given-names></name></person-group><article-title>Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures</article-title><source>J. Child Neurol</source><year>2005</year><volume>20</volume><fpage>565</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16159520</pub-id></citation></ref><ref id="R75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hempelmann</surname><given-names>A.</given-names></name><name><surname>Cobilanschi</surname><given-names>J.</given-names></name><name><surname>Heils</surname><given-names>A.</given-names></name><name><surname>Muhle</surname><given-names>H.</given-names></name><name><surname>Stephani</surname><given-names>U.</given-names></name><name><surname>Weber</surname><given-names>Y.</given-names></name><name><surname>Lerche</surname><given-names>H.</given-names></name><name><surname>Sander</surname><given-names>T</given-names></name></person-group><article-title>Lack of evidence of an allelic association of a functional GABRB3 exon 1a promoter polymorphism with idiopathic generalized epilepsy</article-title><source>Epilepsy Res</source><year>2007</year><volume>74</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17215107</pub-id></citation></ref><ref id="R76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>Mandel</surname><given-names>J.L</given-names></name></person-group><article-title>Monogenic causes of X-linked mental retardation</article-title><source>Nat. Rev. Genet</source><year>2001</year><volume>2</volume><fpage>669</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11533716</pub-id></citation></ref><ref id="R77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batshaw</surname><given-names>M.L</given-names></name></person-group><article-title>Mental retardation</article-title><source>Pediatr. Clin. North Am</source><year>1993</year><volume>40</volume><fpage>507</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8493062</pub-id></citation></ref><ref id="R78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>B.</given-names></name><name><surname>Kyllerman</surname><given-names>M</given-names></name></person-group><article-title>Epidemiology of mental retardation--a Swedish survey</article-title><source>Brain Dev</source><year>1983</year><volume>5</volume><fpage>441</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6686416</pub-id></citation></ref><ref id="R79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gecz</surname><given-names>J.</given-names></name><name><surname>Gedeon</surname><given-names>A.K.</given-names></name><name><surname>Sutherland</surname><given-names>G.R.</given-names></name><name><surname>Mulley</surname><given-names>J.C</given-names></name></person-group><article-title>Identification of the gene FMR2, associated with FRAXE mental retardation</article-title><source>Nat. Genet</source><year>1996</year><volume>13</volume><fpage>105</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8673085</pub-id></citation></ref><ref id="R80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Billuart</surname><given-names>P.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Ronce</surname><given-names>N.</given-names></name><name><surname>des Portes</surname><given-names>V.</given-names></name><name><surname>Vinet</surname><given-names>M.C.</given-names></name><name><surname>Zemni</surname><given-names>R.</given-names></name><name><surname>Roest Crollius</surname><given-names>H.</given-names></name><name><surname>Carrie</surname><given-names>A.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><name><surname>Cherry</surname><given-names>M.</given-names></name><name><surname>Briault</surname><given-names>S.</given-names></name><name><surname>Hamel</surname><given-names>B.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Beldjord</surname><given-names>C.</given-names></name><name><surname>Kahn</surname><given-names>A.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>Chelly</surname><given-names>J</given-names></name></person-group><article-title>Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>923</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9582072</pub-id></citation></ref><ref id="R81"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>K.M.</given-names></name><name><surname>Gleeson</surname><given-names>J.G.</given-names></name><name><surname>Bagrodia</surname><given-names>S.</given-names></name><name><surname>Partington</surname><given-names>M.W.</given-names></name><name><surname>MacMillan</surname><given-names>J.C.</given-names></name><name><surname>Cerione</surname><given-names>R.A.</given-names></name><name><surname>Mulley</surname><given-names>J.C.</given-names></name><name><surname>Walsh</surname><given-names>C.A</given-names></name></person-group><article-title>PAK3 mutation in nonsyndromic X-linked mental retardation</article-title><source>Nat. Genet</source><year>1998</year><volume>20</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">9731525</pub-id></citation></ref><ref id="R82"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Adamo</surname><given-names>P.</given-names></name><name><surname>Menegon</surname><given-names>A.</given-names></name><name><surname>Lo Nigro</surname><given-names>C.</given-names></name><name><surname>Grasso</surname><given-names>M.</given-names></name><name><surname>Gulisano</surname><given-names>M.</given-names></name><name><surname>Tamanini</surname><given-names>F.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Gedeon</surname><given-names>A.K.</given-names></name><name><surname>Oostra</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>S.K.</given-names></name><name><surname>Tandon</surname><given-names>A.</given-names></name><name><surname>Valtorta</surname><given-names>F.</given-names></name><name><surname>Balch</surname><given-names>W.E.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>Toniolo</surname><given-names>D</given-names></name></person-group><article-title>Mutations in GDI1 are responsible for X-linked non-specific mental retardation</article-title><source>Nat. Genet</source><year>1998</year><volume>19</volume><fpage>134</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9620768</pub-id></citation></ref><ref id="R83"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kutsche</surname><given-names>K.</given-names></name><name><surname>Yntema</surname><given-names>H.</given-names></name><name><surname>Brandt</surname><given-names>A.</given-names></name><name><surname>Jantke</surname><given-names>I.</given-names></name><name><surname>Nothwang</surname><given-names>H.G.</given-names></name><name><surname>Orth</surname><given-names>U.</given-names></name><name><surname>Boavida</surname><given-names>M.G.</given-names></name><name><surname>David</surname><given-names>D.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>Ropers</surname><given-names>H.H.</given-names></name><name><surname>Hamel</surname><given-names>B.C.</given-names></name><name><surname>van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Gal</surname><given-names>A</given-names></name></person-group><article-title>Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation</article-title><source>Nat. Genet</source><year>2000</year><volume>26</volume><fpage>247</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11017088</pub-id></citation></ref><ref id="R84"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merienne</surname><given-names>K.</given-names></name><name><surname>Jacquot</surname><given-names>S.</given-names></name><name><surname>Pannetier</surname><given-names>S.</given-names></name><name><surname>Zeniou</surname><given-names>M.</given-names></name><name><surname>Bankier</surname><given-names>A.</given-names></name><name><surname>Gecz</surname><given-names>J.</given-names></name><name><surname>Mandel</surname><given-names>J.L.</given-names></name><name><surname>Mulley</surname><given-names>J.</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P.</given-names></name><name><surname>Hanauer</surname><given-names>A</given-names></name></person-group><article-title>A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation</article-title><source>Nat. Genet</source><year>1999</year><volume>22</volume><fpage>13</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10319851</pub-id></citation></ref><ref id="R85"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carrie</surname><given-names>A.</given-names></name><name><surname>Jun</surname><given-names>L.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Vinet</surname><given-names>M.C.</given-names></name><name><surname>McDonell</surname><given-names>N.</given-names></name><name><surname>Couvert</surname><given-names>P.</given-names></name><name><surname>Zemni</surname><given-names>R.</given-names></name><name><surname>Cardona</surname><given-names>A.</given-names></name><name><surname>Van Buggenhout</surname><given-names>G.</given-names></name><name><surname>Frints</surname><given-names>S.</given-names></name><name><surname>Hamel</surname><given-names>B.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>Ropers</surname><given-names>H.H.</given-names></name><name><surname>Strom</surname><given-names>T.</given-names></name><name><surname>Howell</surname><given-names>G.R.</given-names></name><name><surname>Whittaker</surname><given-names>A.</given-names></name><name><surname>Ross</surname><given-names>M.T.</given-names></name><name><surname>Kahn</surname><given-names>A.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Beldjord</surname><given-names>C.</given-names></name><name><surname>Marynen</surname><given-names>P.</given-names></name><name><surname>Chelly</surname><given-names>J</given-names></name></person-group><article-title>A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation</article-title><source>Nat. Genet</source><year>1999</year><volume>23</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">10471494</pub-id></citation></ref><ref id="R86"><label>86</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zemni</surname><given-names>R.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Vinet</surname><given-names>M.C.</given-names></name><name><surname>Sefiani</surname><given-names>A.</given-names></name><name><surname>Carrie</surname><given-names>A.</given-names></name><name><surname>Billuart</surname><given-names>P.</given-names></name><name><surname>McDonell</surname><given-names>N.</given-names></name><name><surname>Couvert</surname><given-names>P.</given-names></name><name><surname>Francis</surname><given-names>F.</given-names></name><name><surname>Chafey</surname><given-names>P.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><name><surname>Friocourt</surname><given-names>G.</given-names></name><name><surname>des Portes</surname><given-names>V.</given-names></name><name><surname>Cardona</surname><given-names>A.</given-names></name><name><surname>Frints</surname><given-names>S.</given-names></name><name><surname>Meindl</surname><given-names>A.</given-names></name><name><surname>Brandau</surname><given-names>O.</given-names></name><name><surname>Ronce</surname><given-names>N.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>van Bokhoven</surname><given-names>H.</given-names></name><name><surname>Ropers</surname><given-names>H.H.</given-names></name><name><surname>Sudbrak</surname><given-names>R.</given-names></name><name><surname>Kahn</surname><given-names>A.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Beldjord</surname><given-names>C.</given-names></name><name><surname>Chelly</surname><given-names>J.A</given-names></name></person-group><article-title> new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation</article-title><source>Nat. Genet</source><year>2000</year><volume>24</volume><fpage>167</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10655063</pub-id></citation></ref><ref id="R87"><label>87</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Couvert</surname><given-names>P.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Aquaviva</surname><given-names>C.</given-names></name><name><surname>Poirier</surname><given-names>K.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>Gendrot</surname><given-names>C.</given-names></name><name><surname>Verloes</surname><given-names>A.</given-names></name><name><surname>Andres</surname><given-names>C.</given-names></name><name><surname>Le Fevre</surname><given-names>A.C.</given-names></name><name><surname>Souville</surname><given-names>I.</given-names></name><name><surname>Steffann</surname><given-names>J.</given-names></name><name><surname>des Portes</surname><given-names>V.</given-names></name><name><surname>Ropers</surname><given-names>H.H.</given-names></name><name><surname>Yntema</surname><given-names>H.G.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Briault</surname><given-names>S.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>Cherif</surname><given-names>B</given-names></name></person-group><article-title>MECP2 is highly mutated in X-linked mental retardation</article-title><source>Hum. Mol. Genet</source><year>2001</year><volume>10</volume><fpage>941</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11309367</pub-id></citation></ref><ref id="R88"><label>88</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meloni</surname><given-names>I.</given-names></name><name><surname>Muscettola</surname><given-names>M.</given-names></name><name><surname>Raynaud</surname><given-names>M.</given-names></name><name><surname>Longo</surname><given-names>I.</given-names></name><name><surname>Bruttini</surname><given-names>M.</given-names></name><name><surname>Moizard</surname><given-names>M.P.</given-names></name><name><surname>Gomot</surname><given-names>M.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>des Portes</surname><given-names>V.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Ropers</surname><given-names>H.H.</given-names></name><name><surname>Magi</surname><given-names>B.</given-names></name><name><surname>Bellan</surname><given-names>C.</given-names></name><name><surname>Volpi</surname><given-names>N.</given-names></name><name><surname>Yntema</surname><given-names>H.G.</given-names></name><name><surname>Lewis</surname><given-names>S.E.</given-names></name><name><surname>Schaffer</surname><given-names>J.E.</given-names></name><name><surname>Renieri</surname><given-names>A</given-names></name></person-group><article-title>FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation</article-title><source>Nat. Genet</source><year>2002</year><volume>30</volume><fpage>436</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11889465</pub-id></citation></ref><ref id="R89"><label>89</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stromme</surname><given-names>P.</given-names></name><name><surname>Mangelsdorf</surname><given-names>M.E.</given-names></name><name><surname>Shaw</surname><given-names>M.A.</given-names></name><name><surname>Lower</surname><given-names>K.M.</given-names></name><name><surname>Lewis</surname><given-names>S.M.</given-names></name><name><surname>Bruyere</surname><given-names>H.</given-names></name><name><surname>Lutcherath</surname><given-names>V.</given-names></name><name><surname>Gedeon</surname><given-names>A.K.</given-names></name><name><surname>Wallace</surname><given-names>R.H.</given-names></name><name><surname>Scheffer</surname><given-names>I.E.</given-names></name><name><surname>Turner</surname><given-names>G.</given-names></name><name><surname>Partington</surname><given-names>M.</given-names></name><name><surname>Frints</surname><given-names>S.G.</given-names></name><name><surname>Fryns</surname><given-names>J.P.</given-names></name><name><surname>Sutherland</surname><given-names>G.R.</given-names></name><name><surname>Mulley</surname><given-names>J.C.</given-names></name><name><surname>Gecz</surname><given-names>J</given-names></name></person-group><article-title>Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy</article-title><source>Nat. Genet</source><year>2002</year><volume>30</volume><fpage>441</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11889467</pub-id></citation></ref><ref id="R90"><label>90</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiroi</surname><given-names>N.</given-names></name><name><surname>Agatsuma</surname><given-names>S</given-names></name></person-group><article-title>Genetic susceptibility to substance dependence</article-title><source>Mol. Psychiatry</source><year>2005</year><volume>10</volume><fpage>336</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">15583701</pub-id></citation></ref><ref id="R91"><label>91</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P.F.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>The genetic epidemiology of smoking</article-title><source>Nicotine Tob. Res</source><year>1999</year><volume>1</volume><issue>Suppl 2</issue><fpage>S51</fpage><lpage>7</lpage><comment>discussion S69-70</comment><pub-id pub-id-type="pmid">11768187</pub-id></citation></ref><ref id="R92"><label>92</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guindalini</surname><given-names>C.</given-names></name><name><surname>Howard</surname><given-names>M.</given-names></name><name><surname>Haddley</surname><given-names>K.</given-names></name><name><surname>Laranjeira</surname><given-names>R.</given-names></name><name><surname>Collier</surname><given-names>D.</given-names></name><name><surname>Ammar</surname><given-names>N.</given-names></name><name><surname>Craig</surname><given-names>I.</given-names></name><name><surname>O'Gara</surname><given-names>C.</given-names></name><name><surname>Bubb</surname><given-names>V.J.</given-names></name><name><surname>Greenwood</surname><given-names>T.</given-names></name><name><surname>Kelsoe</surname><given-names>J.</given-names></name><name><surname>Asherson</surname><given-names>P.</given-names></name><name><surname>Murray</surname><given-names>R.M.</given-names></name><name><surname>Castelo</surname><given-names>A.</given-names></name><name><surname>Quinn</surname><given-names>J.P.</given-names></name><name><surname>Vallada</surname><given-names>H.</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name></person-group><article-title>A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>4552</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16537431</pub-id></citation></ref><ref id="R93"><label>93</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>S</given-names></name></person-group><article-title>Dopamine transporter gene polymorphism and alcoholism</article-title><source>Biochem. Biophys. Res. Commun</source><year>1995</year><volume>211</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">7779096</pub-id></citation></ref><ref id="R94"><label>94</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timberlake</surname><given-names>D.S.</given-names></name><name><surname>Haberstick</surname><given-names>B.C.</given-names></name><name><surname>Lessem</surname><given-names>J.M.</given-names></name><name><surname>Smolen</surname><given-names>A.</given-names></name><name><surname>Ehringer</surname><given-names>M.</given-names></name><name><surname>Hewitt</surname><given-names>J.K.</given-names></name><name><surname>Hopfer</surname><given-names>C</given-names></name></person-group><article-title>An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health</article-title><source>Health Psychol</source><year>2006</year><volume>25</volume><fpage>190</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16569110</pub-id></citation></ref><ref id="R95"><label>95</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>E.P.</given-names></name><name><surname>Blum</surname><given-names>K.</given-names></name><name><surname>Khalsa</surname><given-names>M.E.</given-names></name><name><surname>Ritchie</surname><given-names>T.</given-names></name><name><surname>Montgomery</surname><given-names>A.</given-names></name><name><surname>Wood</surname><given-names>R.C.</given-names></name><name><surname>Fitch</surname><given-names>R.J.</given-names></name><name><surname>Ozkaragoz</surname><given-names>T.</given-names></name><name><surname>Sheridan</surname><given-names>P.J.</given-names></name><name><surname>Anglin</surname><given-names>M.D.</given-names></name><name><surname>Parades</surname><given-names>A.</given-names></name><name><surname>Treiman</surname><given-names>L.J.</given-names></name><name><surname>Sparkes</surname><given-names>R.S</given-names></name></person-group><article-title>Allelic association of the D2 dopamine receptor gene with cocaine dependence</article-title><source>Drug Alcohol Depend</source><year>1993</year><volume>33</volume><fpage>271</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">8261891</pub-id></citation></ref><ref id="R96"><label>96</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>K.</given-names></name><name><surname>Noble</surname><given-names>E.P.</given-names></name><name><surname>Sheridan</surname><given-names>P.J.</given-names></name><name><surname>Montgomery</surname><given-names>A.</given-names></name><name><surname>Ritchie</surname><given-names>T.</given-names></name><name><surname>Jagadeeswaran</surname><given-names>P.</given-names></name><name><surname>Nogami</surname><given-names>H.</given-names></name><name><surname>Briggs</surname><given-names>A.H.</given-names></name><name><surname>Cohn</surname><given-names>J.B</given-names></name></person-group><article-title>Allelic association of human dopamine D2 receptor gene in alcoholism</article-title><source>JAMA</source><year>1990</year><volume>263</volume><fpage>2055</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">1969501</pub-id></citation></ref><ref id="R97"><label>97</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Lichtermann</surname><given-names>D.</given-names></name><name><surname>Lipsky</surname><given-names>R.H.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Schwab</surname><given-names>S.G.</given-names></name><name><surname>Wildenauer</surname><given-names>D.B.</given-names></name><name><surname>Bau</surname><given-names>C.H.</given-names></name><name><surname>Ferro</surname><given-names>E.</given-names></name><name><surname>Astor</surname><given-names>W.</given-names></name><name><surname>Finch</surname><given-names>T.</given-names></name><name><surname>Terry</surname><given-names>J.</given-names></name><name><surname>Taubman</surname><given-names>J.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name></person-group><article-title>Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations</article-title><source>Arch. Gen. Psychiatry</source><year>2004</year><volume>61</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">15184239</pub-id></citation></ref><ref id="R98"><label>98</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duaux</surname><given-names>E.</given-names></name><name><surname>Gorwood</surname><given-names>P.</given-names></name><name><surname>Griffon</surname><given-names>N.</given-names></name><name><surname>Bourdel</surname><given-names>M.C.</given-names></name><name><surname>Sautel</surname><given-names>F.</given-names></name><name><surname>Sokoloff</surname><given-names>P.</given-names></name><name><surname>Schwartz</surname><given-names>J.C.</given-names></name><name><surname>Ades</surname><given-names>J.</given-names></name><name><surname>Loo</surname><given-names>H.</given-names></name><name><surname>Poirier</surname><given-names>M.F</given-names></name></person-group><article-title>Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence</article-title><source>Mol. Psychiatry</source><year>1998</year><volume>3</volume><fpage>333</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9702742</pub-id></citation></ref><ref id="R99"><label>99</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E.</given-names></name><name><surname>Gonzalez</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Saucier</surname><given-names>G.</given-names></name><name><surname>Johnson</surname><given-names>P.</given-names></name><name><surname>Verde</surname><given-names>R.</given-names></name><name><surname>MacMurray</surname><given-names>J.P</given-names></name></person-group><article-title>Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence</article-title><source>Mol. Psychiatry</source><year>1999</year><volume>4</volume><fpage>484</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10523822</pub-id></citation></ref><ref id="R100"><label>100</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiihonen</surname><given-names>J.</given-names></name><name><surname>Hallikainen</surname><given-names>T.</given-names></name><name><surname>Lachman</surname><given-names>H.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><name><surname>Volavka</surname><given-names>J.</given-names></name><name><surname>Kauhanen</surname><given-names>J.</given-names></name><name><surname>Salonen</surname><given-names>J.T.</given-names></name><name><surname>Ryynanen</surname><given-names>O.P.</given-names></name><name><surname>Koulu</surname><given-names>M.</given-names></name><name><surname>Karvonen</surname><given-names>M.K.</given-names></name><name><surname>Pohjalainen</surname><given-names>T.</given-names></name><name><surname>Syvalahti</surname><given-names>E.</given-names></name><name><surname>Hietala</surname><given-names>J</given-names></name></person-group><article-title>Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism</article-title><source>Mol. Psychiatry</source><year>1999</year><volume>4</volume><fpage>286</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10395222</pub-id></citation></ref><ref id="R101"><label>101</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname><given-names>R.</given-names></name><name><surname>Kotler</surname><given-names>M.</given-names></name><name><surname>Shufman</surname><given-names>E.</given-names></name><name><surname>Aharoni</surname><given-names>S.</given-names></name><name><surname>Kremer</surname><given-names>I.</given-names></name><name><surname>Cohen</surname><given-names>H.</given-names></name><name><surname>Ebstein</surname><given-names>R.P</given-names></name></person-group><article-title>Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study</article-title><source>Am. J. Med. Genet</source><year>2000</year><volume>96</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">11054766</pub-id></citation></ref><ref id="R102"><label>102</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munafo</surname><given-names>M.</given-names></name><name><surname>Clark</surname><given-names>T.</given-names></name><name><surname>Johnstone</surname><given-names>E.</given-names></name><name><surname>Murphy</surname><given-names>M.</given-names></name><name><surname>Walton</surname><given-names>R</given-names></name></person-group><article-title>The genetic basis for smoking behavior: a systematic review and meta-analysis</article-title><source>Nicotine Tob. Res</source><year>2004</year><volume>6</volume><fpage>583</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15370155</pub-id></citation></ref><ref id="R103"><label>103</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munafo</surname><given-names>M.R.</given-names></name><name><surname>Matheson</surname><given-names>I.J.</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias</article-title><source>Mol. Psychiatry</source><year>2007</year><volume>12</volume><fpage>454</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17453061</pub-id></citation></ref><ref id="R104"><label>104</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>R.F.</given-names></name><name><surname>Stoler</surname><given-names>J.M</given-names></name></person-group><article-title>Alcohol dehydrogenase 1B genotype and fetal alcohol syndrome: a HuGE minireview</article-title><source>Am. J. Obstet. Gynecol</source><year>2007</year><volume>197</volume><fpage>12</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">17618743</pub-id></citation></ref><ref id="R105"><label>105</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasheed</surname><given-names>A.</given-names></name><name><surname>Hines</surname><given-names>R.N.</given-names></name><name><surname>McCarver-May</surname><given-names>D.G</given-names></name></person-group><article-title>Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome?</article-title><source>Toxicol.Appl. Pharmacol</source><year>1997</year><volume>144</volume><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">9194424</pub-id></citation></ref><ref id="R106"><label>106</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boutelet-Bochan</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Juchau</surname><given-names>M.R</given-names></name></person-group><article-title>Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: implications for the fetal alcohol syndrome</article-title><source>Biochem. Biophys. Res. Commun</source><year>1997</year><volume>238</volume><fpage>443</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9299528</pub-id></citation></ref><ref id="R107"><label>107</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R.C.</given-names></name><name><surname>McGonagle</surname><given-names>K.A.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Nelson</surname><given-names>C.B.</given-names></name><name><surname>Hughes</surname><given-names>M.</given-names></name><name><surname>Eshleman</surname><given-names>S.</given-names></name><name><surname>Wittchen</surname><given-names>H.U.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States.Results from the National Comorbidity Survey</article-title><source>Arch. Gen. Psychiatry</source><year>1994</year><volume>51</volume><fpage>8</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">8279933</pub-id></citation></ref><ref id="R108"><label>108</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hettema</surname><given-names>J.M.</given-names></name><name><surname>Neale</surname><given-names>M.C.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>A review and meta-analysis of the genetic epidemiology of anxiety disorders</article-title><source>Am. J. Psychiatry</source><year>2001</year><volume>158</volume><fpage>1568</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">11578982</pub-id></citation></ref><ref id="R109"><label>109</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>S.P.</given-names></name><name><surname>Fyer</surname><given-names>A.J.</given-names></name><name><surname>Durner</surname><given-names>M.</given-names></name><name><surname>Heiman</surname><given-names>G.A.</given-names></name><name><surname>Baisre de Leon</surname><given-names>A.</given-names></name><name><surname>Hodge</surname><given-names>S.E.</given-names></name><name><surname>Knowles</surname><given-names>J.A.</given-names></name><name><surname>Weissman</surname><given-names>M.M</given-names></name></person-group><article-title>Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>2550</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12604791</pub-id></citation></ref><ref id="R110"><label>110</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thorgeirsson</surname><given-names>T.E.</given-names></name><name><surname>Oskarsson</surname><given-names>H.</given-names></name><name><surname>Desnica</surname><given-names>N.</given-names></name><name><surname>Kostic</surname><given-names>J.P.</given-names></name><name><surname>Stefansson</surname><given-names>J.G.</given-names></name><name><surname>Kolbeinsson</surname><given-names>H.</given-names></name><name><surname>Lindal</surname><given-names>E.</given-names></name><name><surname>Gagunashvili</surname><given-names>N.</given-names></name><name><surname>Frigge</surname><given-names>M.L.</given-names></name><name><surname>Kong</surname><given-names>A.</given-names></name><name><surname>Stefansson</surname><given-names>K.</given-names></name><name><surname>Gulcher</surname><given-names>J.R</given-names></name></person-group><article-title>Anxiety with panic disorder linked to chromosome 9q in Iceland</article-title><source>Am. J. Hum. Genet</source><year>2003</year><volume>72</volume><fpage>1221</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">12679899</pub-id></citation></ref><ref id="R111"><label>111</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>G.L.</given-names></name><name><surname>Veenstra-Vanderweele</surname><given-names>J.</given-names></name><name><surname>Cox</surname><given-names>N.J.</given-names></name><name><surname>Van Etten</surname><given-names>M.</given-names></name><name><surname>Fischer</surname><given-names>D.J.</given-names></name><name><surname>Himle</surname><given-names>J.A.</given-names></name><name><surname>Bivens</surname><given-names>N.C.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Roe</surname><given-names>C.A.</given-names></name><name><surname>Hennessy</surname><given-names>K.A.</given-names></name><name><surname>Dickel</surname><given-names>D.E.</given-names></name><name><surname>Leventhal</surname><given-names>B.L.</given-names></name><name><surname>Cook</surname><given-names>E.H. Jr</given-names></name></person-group><article-title>Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder</article-title><source>Biol. Psychiatry</source><year>2007</year><volume>62</volume><fpage>856</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">17544380</pub-id></citation></ref><ref id="R112"><label>112</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>G.L.</given-names></name><name><surname>Veenstra-VanderWeele</surname><given-names>J.</given-names></name><name><surname>Cox</surname><given-names>N.J.</given-names></name><name><surname>Boehnke</surname><given-names>M.</given-names></name><name><surname>Himle</surname><given-names>J.A.</given-names></name><name><surname>Curtis</surname><given-names>G.C.</given-names></name><name><surname>Leventhal</surname><given-names>B.L.</given-names></name><name><surname>Cook</surname><given-names>E.H. Jr</given-names></name></person-group><article-title>Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands</article-title><source>Am. J. Med. Genet</source><year>2002</year><volume>114</volume><fpage>541</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">12116192</pub-id></citation></ref><ref id="R113"><label>113</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuels</surname><given-names>J.</given-names></name><name><surname>Shugart</surname><given-names>Y.Y.</given-names></name><name><surname>Grados</surname><given-names>M.A.</given-names></name><name><surname>Willour</surname><given-names>V.L.</given-names></name><name><surname>Bienvenu</surname><given-names>O.J.</given-names></name><name><surname>Greenberg</surname><given-names>B.D.</given-names></name><name><surname>Knowles</surname><given-names>J.A.</given-names></name><name><surname>McCracken</surname><given-names>J.T.</given-names></name><name><surname>Rauch</surname><given-names>S.L.</given-names></name><name><surname>Murphy</surname><given-names>D.L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>Fyer</surname><given-names>A.J.</given-names></name><name><surname>Piacentini</surname><given-names>J.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Cullen</surname><given-names>B.</given-names></name><name><surname>Rasmussen</surname><given-names>S.A.</given-names></name><name><surname>Hoehn-Saric</surname><given-names>R.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>K.Y.</given-names></name><name><surname>Riddle</surname><given-names>M.A.</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name></person-group><article-title>Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study</article-title><source>Am. J. Psychiatry</source><year>2007</year><volume>164</volume><fpage>493</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17329475</pub-id></citation></ref><ref id="R114"><label>114</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shugart</surname><given-names>Y.Y.</given-names></name><name><surname>Samuels</surname><given-names>J.</given-names></name><name><surname>Willour</surname><given-names>V.L.</given-names></name><name><surname>Grados</surname><given-names>M.A.</given-names></name><name><surname>Greenberg</surname><given-names>B.D.</given-names></name><name><surname>Knowles</surname><given-names>J.A.</given-names></name><name><surname>McCracken</surname><given-names>J.T.</given-names></name><name><surname>Rauch</surname><given-names>S.L.</given-names></name><name><surname>Murphy</surname><given-names>D.L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>Fyer</surname><given-names>A.J.</given-names></name><name><surname>Piacentini</surname><given-names>J.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Cullen</surname><given-names>B.</given-names></name><name><surname>Page</surname><given-names>J.</given-names></name><name><surname>Rasmussen</surname><given-names>S.A.</given-names></name><name><surname>Bienvenu</surname><given-names>O.J.</given-names></name><name><surname>Hoehn-Saric</surname><given-names>R.</given-names></name><name><surname>Valle</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>K.Y.</given-names></name><name><surname>Riddle</surname><given-names>M.A.</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name></person-group><article-title>Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>763</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16755275</pub-id></citation></ref><ref id="R115"><label>115</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>Page</surname><given-names>G.P.</given-names></name><name><surname>Bonvicini</surname><given-names>K.</given-names></name><name><surname>Woods</surname><given-names>S.W.</given-names></name><name><surname>Pauls</surname><given-names>D.L.</given-names></name><name><surname>Kruger</surname><given-names>S</given-names></name></person-group><article-title>A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan</article-title><source>Mol. Psychiatry</source><year>2003</year><volume>8</volume><fpage>71</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12556910</pub-id></citation></ref><ref id="R116"><label>116</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>Page</surname><given-names>G.P.</given-names></name><name><surname>Stein</surname><given-names>M.B.</given-names></name><name><surname>Woods</surname><given-names>S.W</given-names></name></person-group><article-title>Genome-wide linkage scan for loci predisposing to social phobia evidence for a chromosome 16 risk locus</article-title><source>Am. J. Psychiatry</source><year>2004</year><volume>161</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">14702251</pub-id></citation></ref><ref id="R117"><label>117</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fullerton</surname><given-names>J.</given-names></name><name><surname>Cubin</surname><given-names>M.</given-names></name><name><surname>Tiwari</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Bomhra</surname><given-names>A.</given-names></name><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><name><surname>Fairburn</surname><given-names>C.</given-names></name><name><surname>Goodwin</surname><given-names>G.</given-names></name><name><surname>Neale</surname><given-names>M.C.</given-names></name><name><surname>Fiddy</surname><given-names>S.</given-names></name><name><surname>Mott</surname><given-names>R.</given-names></name><name><surname>Allison</surname><given-names>D.B.</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism</article-title><source>Am. J. Hum. Genet</source><year>2003</year><volume>72</volume><fpage>879</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12612864</pub-id></citation></ref><ref id="R118"><label>118</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cloninger</surname><given-names>C.R.</given-names></name><name><surname>Van Eerdewegh</surname><given-names>P.</given-names></name><name><surname>Goate</surname><given-names>A.</given-names></name><name><surname>Edenberg</surname><given-names>H.J.</given-names></name><name><surname>Blangero</surname><given-names>J.</given-names></name><name><surname>Hesselbrock</surname><given-names>V.</given-names></name><name><surname>Reich</surname><given-names>T.</given-names></name><name><surname>Nurnberger J</surname><given-names>Jr.</given-names></name><name><surname>Schuckit</surname><given-names>M.</given-names></name><name><surname>Porjesz</surname><given-names>B.</given-names></name><name><surname>Crowe</surname><given-names>R.</given-names></name><name><surname>Rice</surname><given-names>J.P.</given-names></name><name><surname>Foroud</surname><given-names>T.</given-names></name><name><surname>Przybeck</surname><given-names>T.R.</given-names></name><name><surname>Almasy</surname><given-names>L.</given-names></name><name><surname>Bucholz</surname><given-names>K.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Shears</surname><given-names>S.</given-names></name><name><surname>Carr</surname><given-names>K.</given-names></name><name><surname>Crose</surname><given-names>C.</given-names></name><name><surname>Willig</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Tischfield</surname><given-names>J.A.</given-names></name><name><surname>Li</surname><given-names>T.K.</given-names></name><name><surname>Conneally</surname><given-names>P.M.</given-names></name><name><surname>Begleiter</surname><given-names>H</given-names></name></person-group><article-title>Anxiety proneness linked to epistatic loci in genome scan of human personality traits</article-title><source>Am. J. Med. Genet</source><year>1998</year><volume>81</volume><fpage>313</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9674977</pub-id></citation></ref><ref id="R119"><label>119</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Middeldorp</surname><given-names>C.M.</given-names></name><name><surname>Hottenga</surname><given-names>J.J.</given-names></name><name><surname>Slagboom</surname><given-names>P.E.</given-names></name><name><surname>Sullivan</surname><given-names>P.F.</given-names></name><name><surname>de Geus</surname><given-names>E.J.</given-names></name><name><surname>Posthuma</surname><given-names>D.</given-names></name><name><surname>Willemsen</surname><given-names>G.</given-names></name><name><surname>Boomsma</surname><given-names>D.I</given-names></name></person-group><article-title>Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype</article-title><source>Mol. Psychiatry</source><year>2008</year><volume>13</volume><fpage>84</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17700576</pub-id></citation></ref><ref id="R120"><label>120</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaabi</surname><given-names>B.</given-names></name><name><surname>Gelernter</surname><given-names>J.</given-names></name><name><surname>Woods</surname><given-names>S.W.</given-names></name><name><surname>Goddard</surname><given-names>A.</given-names></name><name><surname>Page</surname><given-names>G.P.</given-names></name><name><surname>Elston</surname><given-names>R.C</given-names></name></person-group><article-title>Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus</article-title><source>Am. J. Hum. Genet</source><year>2006</year><volume>78</volume><fpage>543</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16532386</pub-id></citation></ref><ref id="R121"><label>121</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname><given-names>C.</given-names></name><name><surname>Gutknecht</surname><given-names>L.</given-names></name><name><surname>Freitag</surname><given-names>C.</given-names></name><name><surname>Tauber</surname><given-names>R.</given-names></name><name><surname>Mossner</surname><given-names>R.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Wagner</surname><given-names>G.</given-names></name><name><surname>Peikert</surname><given-names>G.</given-names></name><name><surname>Wenda</surname><given-names>B.</given-names></name><name><surname>Sand</surname><given-names>P.</given-names></name><name><surname>Jacob</surname><given-names>C.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Garritsen</surname><given-names>H.</given-names></name><name><surname>Fimmers</surname><given-names>R.</given-names></name><name><surname>Deckert</surname><given-names>J.</given-names></name><name><surname>Lesch</surname><given-names>K.P</given-names></name></person-group><article-title>Association of a functional 1019C&#x0003e;G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia</article-title><source>Int. J. Neuropsychopharmacol</source><year>2004</year><volume>7</volume><fpage>189</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14984628</pub-id></citation></ref><ref id="R122"><label>122</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inada</surname><given-names>Y.</given-names></name><name><surname>Yoneda</surname><given-names>H.</given-names></name><name><surname>Koh</surname><given-names>J.</given-names></name><name><surname>Sakai</surname><given-names>J.</given-names></name><name><surname>Himei</surname><given-names>A.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><name><surname>Akabame</surname><given-names>K.</given-names></name><name><surname>Hiraoka</surname><given-names>Y.</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name></person-group><article-title>Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene</article-title><source>Psychiatry Res</source><year>2003</year><volume>118</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12759158</pub-id></citation></ref><ref id="R123"><label>123</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Domschke</surname><given-names>K.</given-names></name><name><surname>Freitag</surname><given-names>C.M.</given-names></name><name><surname>Kuhlenbaumer</surname><given-names>G.</given-names></name><name><surname>Schirmacher</surname><given-names>A.</given-names></name><name><surname>Sand</surname><given-names>P.</given-names></name><name><surname>Nyhuis</surname><given-names>P.</given-names></name><name><surname>Jacob</surname><given-names>C.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Rietschel</surname><given-names>M.</given-names></name><name><surname>Garritsen</surname><given-names>H.S.</given-names></name><name><surname>Fimmers</surname><given-names>R.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Lesch</surname><given-names>K.P.</given-names></name><name><surname>Stogbauer</surname><given-names>F.</given-names></name><name><surname>Deckert</surname><given-names>J</given-names></name></person-group><article-title>Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women</article-title><source>Int. J. Neuropsychopharmacol</source><year>2004</year><volume>7</volume><fpage>183</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15009906</pub-id></citation></ref><ref id="R124"><label>124</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyasaka</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Matsushita</surname><given-names>S.</given-names></name><name><surname>Higuchi</surname><given-names>S.</given-names></name><name><surname>Shirakawa</surname><given-names>O.</given-names></name><name><surname>Shimokata</surname><given-names>H.</given-names></name><name><surname>Funakoshi</surname><given-names>A</given-names></name></person-group><article-title>Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2004</year><volume>127</volume><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15108185</pub-id></citation></ref><ref id="R125"><label>125</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deckert</surname><given-names>J.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Delmo</surname><given-names>C.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Beckmann</surname><given-names>H.</given-names></name><name><surname>Propping</surname><given-names>P</given-names></name></person-group><article-title>Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease</article-title><source>Mol. Psychiatry</source><year>1998</year><volume>3</volume><fpage>81</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9491818</pub-id></citation></ref><ref id="R126"><label>126</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deckert</surname><given-names>J.</given-names></name><name><surname>Catalano</surname><given-names>M.</given-names></name><name><surname>Syagailo</surname><given-names>Y.V.</given-names></name><name><surname>Bosi</surname><given-names>M.</given-names></name><name><surname>Okladnova</surname><given-names>O.</given-names></name><name><surname>Di Bella</surname><given-names>D.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Maffei</surname><given-names>P.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Propping</surname><given-names>P.</given-names></name><name><surname>Beckmann</surname><given-names>H.</given-names></name><name><surname>Bellodi</surname><given-names>L.</given-names></name><name><surname>Lesch</surname><given-names>K.P</given-names></name></person-group><article-title>Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder</article-title><source>Hum. Mol. Genet</source><year>1999</year><volume>8</volume><fpage>621</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10072430</pub-id></citation></ref><ref id="R127"><label>127</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Domschke</surname><given-names>K.</given-names></name><name><surname>Kuhlenbaumer</surname><given-names>G.</given-names></name><name><surname>Schirmacher</surname><given-names>A.</given-names></name><name><surname>Lorenzi</surname><given-names>C.</given-names></name><name><surname>Armengol</surname><given-names>L.</given-names></name><name><surname>DiBella</surname><given-names>D.</given-names></name><name><surname>Gratacos</surname><given-names>M.</given-names></name><name><surname>Garritsen</surname><given-names>H.S.</given-names></name><name><surname>Nothen</surname><given-names>M.M.</given-names></name><name><surname>Franke</surname><given-names>P.</given-names></name><name><surname>Sand</surname><given-names>P.</given-names></name><name><surname>Fritze</surname><given-names>J.</given-names></name><name><surname>Perez</surname><given-names>G.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Sibrowski</surname><given-names>W.</given-names></name><name><surname>Estivill</surname><given-names>X.</given-names></name><name><surname>Bellodi</surname><given-names>L.</given-names></name><name><surname>Ringelstein</surname><given-names>E.B.</given-names></name><name><surname>Arolt</surname><given-names>V.</given-names></name><name><surname>Martin-Santos</surname><given-names>R.</given-names></name><name><surname>Catalano</surname><given-names>M.</given-names></name><name><surname>Stogbauer</surname><given-names>F.</given-names></name><name><surname>Deckert</surname><given-names>J</given-names></name></person-group><article-title>Human nuclear transcription factor gene CREM genomic organization, mutation screening, and association analysis in panic disorder</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2003</year><volume>117</volume><fpage>70</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12555239</pub-id></citation></ref><ref id="R128"><label>128</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Iwayama</surname><given-names>Y.</given-names></name><name><surname>Toyota</surname><given-names>T.</given-names></name><name><surname>Furukawa</surname><given-names>A.</given-names></name><name><surname>Takimoto</surname><given-names>T.</given-names></name><name><surname>Terayama</surname><given-names>H.</given-names></name><name><surname>Iwahashi</surname><given-names>K.</given-names></name><name><surname>Takei</surname><given-names>N.</given-names></name><name><surname>Minabe</surname><given-names>Y.</given-names></name><name><surname>Sekine</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Iwata</surname><given-names>Y.</given-names></name><name><surname>Pillai</surname><given-names>A.</given-names></name><name><surname>Nakamoto</surname><given-names>Y.</given-names></name><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Yoshii</surname><given-names>M.</given-names></name><name><surname>Fukunishi</surname><given-names>I.</given-names></name><name><surname>Yoshikawa</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name></person-group><article-title>Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2006</year><volume>141</volume><fpage>222</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16511838</pub-id></citation></ref><ref id="R129"><label>129</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hettema</surname><given-names>J.M.</given-names></name><name><surname>An</surname><given-names>S.S.</given-names></name><name><surname>Neale</surname><given-names>M.C.</given-names></name><name><surname>Bukszar</surname><given-names>J.</given-names></name><name><surname>van den Oord</surname><given-names>E.J.</given-names></name><name><surname>Kendler</surname><given-names>K.S.</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism</article-title><source>Mol. Psychiatry</source><year>2006</year><volume>11</volume><fpage>752</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16718280</pub-id></citation></ref><ref id="R130"><label>130</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thoeringer</surname><given-names>C.K.</given-names></name><name><surname>Binder</surname><given-names>E.B.</given-names></name><name><surname>Salyakina</surname><given-names>D.</given-names></name><name><surname>Erhardt</surname><given-names>A.</given-names></name><name><surname>Ising</surname><given-names>M.</given-names></name><name><surname>Unschuld</surname><given-names>P.G.</given-names></name><name><surname>Kern</surname><given-names>N.</given-names></name><name><surname>Lucae</surname><given-names>S.</given-names></name><name><surname>Brueckl</surname><given-names>T.M.</given-names></name><name><surname>Mueller</surname><given-names>M.B.</given-names></name><name><surname>Fuchs</surname><given-names>B.</given-names></name><name><surname>Puetz</surname><given-names>B.</given-names></name><name><surname>Lieb</surname><given-names>R.</given-names></name><name><surname>Uhr</surname><given-names>M.</given-names></name><name><surname>Holsboer</surname><given-names>F.</given-names></name><name><surname>Mueller-Myhsok</surname><given-names>B.</given-names></name><name><surname>Keck</surname><given-names>M.E</given-names></name></person-group><article-title>Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks</article-title><source>J. Psychiatr. Res</source><year>2007</year><volume>41</volume><fpage>579</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16904689</pub-id></citation></ref><ref id="R131"><label>131</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erhardt</surname><given-names>A.</given-names></name><name><surname>Lucae</surname><given-names>S.</given-names></name><name><surname>Unschuld</surname><given-names>P.G.</given-names></name><name><surname>Ising</surname><given-names>M.</given-names></name><name><surname>Kern</surname><given-names>N.</given-names></name><name><surname>Salyakina</surname><given-names>D.</given-names></name><name><surname>Lieb</surname><given-names>R.</given-names></name><name><surname>Uhr</surname><given-names>M.</given-names></name><name><surname>Binder</surname><given-names>E.B.</given-names></name><name><surname>Keck</surname><given-names>M.E.</given-names></name><name><surname>Muller-Myhsok</surname><given-names>B.</given-names></name><name><surname>Holsboer</surname><given-names>F</given-names></name></person-group><article-title>Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders</article-title><source>J. Affect. Disord</source><year>2007</year><volume>101</volume><fpage>159</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17197037</pub-id></citation></ref><ref id="R132"><label>132</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>M.</given-names></name><name><surname>Annerbrink</surname><given-names>K.</given-names></name><name><surname>Westberg</surname><given-names>L.</given-names></name><name><surname>Melke</surname><given-names>J.</given-names></name><name><surname>Baghaei</surname><given-names>F.</given-names></name><name><surname>Rosmond</surname><given-names>R.</given-names></name><name><surname>Holm</surname><given-names>G.</given-names></name><name><surname>Andersch</surname><given-names>S.</given-names></name><name><surname>Allgulander</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>E</given-names></name></person-group><article-title>Angiotensin-related genes in patients with panic disorder</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2004</year><volume>127</volume><fpage>81</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15108186</pub-id></citation></ref><ref id="R133"><label>133</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maron</surname><given-names>E.</given-names></name><name><surname>Nikopensius</surname><given-names>T.</given-names></name><name><surname>Koks</surname><given-names>S.</given-names></name><name><surname>Altmae</surname><given-names>S.</given-names></name><name><surname>Heinaste</surname><given-names>E.</given-names></name><name><surname>Vabrit</surname><given-names>K.</given-names></name><name><surname>Tammekivi</surname><given-names>V.</given-names></name><name><surname>Hallast</surname><given-names>P.</given-names></name><name><surname>Koido</surname><given-names>K.</given-names></name><name><surname>Kurg</surname><given-names>A.</given-names></name><name><surname>Metspalu</surname><given-names>A.</given-names></name><name><surname>Vasar</surname><given-names>E.</given-names></name><name><surname>Vasar</surname><given-names>V.</given-names></name><name><surname>Shlik</surname><given-names>J</given-names></name></person-group><article-title>Association study of 90 candidate gene polymorphisms in panic disorder</article-title><source>Psychiatr. Genet</source><year>2005</year><volume>15</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15722953</pub-id></citation></ref><ref id="R134"><label>134</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camarena</surname><given-names>B.</given-names></name><name><surname>Aguilar</surname><given-names>A.</given-names></name><name><surname>Loyzaga</surname><given-names>C.</given-names></name><name><surname>Nicolini</surname><given-names>H</given-names></name></person-group><article-title>A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder</article-title><source>Int. J. Neuropsychopharmacol</source><year>2004</year><volume>7</volume><fpage>49</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">14731309</pub-id></citation></ref><ref id="R135"><label>135</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lochner</surname><given-names>C.</given-names></name><name><surname>Hemmings</surname><given-names>S.M.</given-names></name><name><surname>Kinnear</surname><given-names>C.J.</given-names></name><name><surname>Moolman-Smook</surname><given-names>J.C.</given-names></name><name><surname>Corfield</surname><given-names>V.A.</given-names></name><name><surname>Knowles</surname><given-names>J.A.</given-names></name><name><surname>Niehaus</surname><given-names>D.J.</given-names></name><name><surname>Stein</surname><given-names>D.J</given-names></name></person-group><article-title>Gender in obsessive-compulsive disorder: clinical and genetic findings</article-title><source>Eur. Neuropsychopharmacol</source><year>2004</year><volume>14</volume><fpage>105</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">15013025</pub-id></citation></ref><ref id="R136"><label>136</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meira-Lima</surname><given-names>I.</given-names></name><name><surname>Shavitt</surname><given-names>R.G.</given-names></name><name><surname>Miguita</surname><given-names>K.</given-names></name><name><surname>Ikenaga</surname><given-names>E.</given-names></name><name><surname>Miguel</surname><given-names>E.C.</given-names></name><name><surname>Vallada</surname><given-names>H</given-names></name></person-group><article-title>Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder</article-title><source>Genes Brain Behav</source><year>2004</year><volume>3</volume><fpage>75</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15005715</pub-id></citation></ref><ref id="R137"><label>137</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>K.P.</given-names></name><name><surname>Bengel</surname><given-names>D.</given-names></name><name><surname>Heils</surname><given-names>A.</given-names></name><name><surname>Sabol</surname><given-names>S.Z.</given-names></name><name><surname>Greenberg</surname><given-names>B.D.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name><name><surname>Benjamin</surname><given-names>J.</given-names></name><name><surname>Muller</surname><given-names>C.R.</given-names></name><name><surname>Hamer</surname><given-names>D.H.</given-names></name><name><surname>Murphy</surname><given-names>D.L</given-names></name></person-group><article-title>Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region</article-title><source>Science</source><year>1996</year><volume>274</volume><fpage>1527</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8929413</pub-id></citation></ref><ref id="R138"><label>138</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schinka</surname><given-names>J.A.</given-names></name><name><surname>Busch</surname><given-names>R.M.</given-names></name><name><surname>Robichaux-Keene</surname><given-names>N</given-names></name></person-group><article-title>A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety</article-title><source>Mol. Psychiatry</source><year>2004</year><volume>9</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">14966478</pub-id></citation></ref><ref id="R139"><label>139</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>S.</given-names></name><name><surname>Burmeister</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name></person-group><article-title>Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2004</year><volume>127</volume><fpage>85</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15108187</pub-id></citation></ref><ref id="R140"><label>140</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tadic</surname><given-names>A.</given-names></name><name><surname>Rujescu</surname><given-names>D.</given-names></name><name><surname>Szegedi</surname><given-names>A.</given-names></name><name><surname>Giegling</surname><given-names>I.</given-names></name><name><surname>Singer</surname><given-names>P.</given-names></name><name><surname>Moller</surname><given-names>H.J.</given-names></name><name><surname>Dahmen</surname><given-names>N</given-names></name></person-group><article-title>Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2003</year><volume>117</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12555227</pub-id></citation></ref><ref id="R141"><label>141</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eley</surname><given-names>T.C.</given-names></name><name><surname>Tahir</surname><given-names>E.</given-names></name><name><surname>Angleitner</surname><given-names>A.</given-names></name><name><surname>Harriss</surname><given-names>K.</given-names></name><name><surname>McClay</surname><given-names>J.</given-names></name><name><surname>Plomin</surname><given-names>R.</given-names></name><name><surname>Riemann</surname><given-names>R.</given-names></name><name><surname>Spinath</surname><given-names>F.</given-names></name><name><surname>Craig</surname><given-names>I</given-names></name></person-group><article-title>Association analysis of MAOA and COMT with neuroticism assessed by peers</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2003</year><volume>120</volume><fpage>90</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12815746</pub-id></citation></ref><ref id="R142"><label>142</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>M.</given-names></name><name><surname>Kawachi</surname><given-names>I.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name><name><surname>Colditz</surname><given-names>G.A.</given-names></name><name><surname>Hunter</surname><given-names>D.J.</given-names></name><name><surname>De Vivo</surname><given-names>I</given-names></name></person-group><article-title>Association between catechol-O-methyltransferase and phobic anxiety</article-title><source>Am. J. Psychiatry</source><year>2004</year><volume>161</volume><fpage>1703</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15337664</pub-id></citation></ref><ref id="R143"><label>143</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunnerkopf</surname><given-names>R.</given-names></name><name><surname>Strobel</surname><given-names>A.</given-names></name><name><surname>Gutknecht</surname><given-names>L.</given-names></name><name><surname>Brocke</surname><given-names>B.</given-names></name><name><surname>Lesch</surname><given-names>K.P</given-names></name></person-group><article-title>Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits</article-title><source>Neuropsychopharmacology</source><year>2007</year><volume>32</volume><fpage>2552</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17392738</pub-id></citation></ref><ref id="R144"><label>144</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>U.E.</given-names></name><name><surname>Hellweg</surname><given-names>R.</given-names></name><name><surname>Kalus</surname><given-names>P.</given-names></name><name><surname>Bajbouj</surname><given-names>M.</given-names></name><name><surname>Lenzen</surname><given-names>K.P.</given-names></name><name><surname>Sander</surname><given-names>T.</given-names></name><name><surname>Kunz</surname><given-names>D.</given-names></name><name><surname>Gallinat</surname><given-names>J</given-names></name></person-group><article-title>Association of a functional BDNF polymorphism and anxiety-related personality traits</article-title><source>Psychopharmacology (Berl)</source><year>2005</year><volume>180</volume><fpage>95</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15918078</pub-id></citation></ref><ref id="R145"><label>145</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemeroff</surname><given-names>C.B.</given-names></name><name><surname>Bremner</surname><given-names>J.D.</given-names></name><name><surname>Foa</surname><given-names>E.B.</given-names></name><name><surname>Mayberg</surname><given-names>H.S.</given-names></name><name><surname>North</surname><given-names>C.S.</given-names></name><name><surname>Stein</surname><given-names>M.B</given-names></name></person-group><article-title>Posttraumatic stress disorder: a state-of-the-science review</article-title><source>J. Psychiatr. Res</source><year>2006</year><volume>40</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16242154</pub-id></citation></ref><ref id="R146"><label>146</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breslau</surname><given-names>N.</given-names></name><name><surname>Kessler</surname><given-names>R.C.</given-names></name><name><surname>Chilcoat</surname><given-names>H.D.</given-names></name><name><surname>Schultz</surname><given-names>L.R.</given-names></name><name><surname>Davis</surname><given-names>G.C.</given-names></name><name><surname>Andreski</surname><given-names>P</given-names></name></person-group><article-title>Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma</article-title><source>Arch. Gen. Psychiatry</source><year>1998</year><volume>55</volume><fpage>626</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9672053</pub-id></citation></ref><ref id="R147"><label>147</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R.C.</given-names></name><name><surname>Sonnega</surname><given-names>A.</given-names></name><name><surname>Bromet</surname><given-names>E.</given-names></name><name><surname>Hughes</surname><given-names>M.</given-names></name><name><surname>Nelson</surname><given-names>C.B</given-names></name></person-group><article-title>Posttraumatic stress disorder in the National Comorbidity Survey</article-title><source>Arch. Gen. Psychiatry</source><year>1995</year><volume>52</volume><fpage>1048</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">7492257</pub-id></citation></ref><ref id="R148"><label>148</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>True</surname><given-names>W.R.</given-names></name><name><surname>Rice</surname><given-names>J.</given-names></name><name><surname>Eisen</surname><given-names>S.A.</given-names></name><name><surname>Heath</surname><given-names>A.C.</given-names></name><name><surname>Goldberg</surname><given-names>J.</given-names></name><name><surname>Lyons</surname><given-names>M.J.</given-names></name><name><surname>Nowak</surname><given-names>J.A</given-names></name></person-group><article-title>twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms</article-title><source>Arch. Gen. Psychiatry</source><year>1993</year><volume>50</volume><fpage>257</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">8466386</pub-id></citation></ref><ref id="R149"><label>149</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ozbay</surname><given-names>F.</given-names></name><name><surname>Lappalainen</surname><given-names>J.</given-names></name><name><surname>Kranzler</surname><given-names>H.R.</given-names></name><name><surname>van Dyck</surname><given-names>C.H.</given-names></name><name><surname>Charney</surname><given-names>D.S.</given-names></name><name><surname>Price</surname><given-names>L.H.</given-names></name><name><surname>Southwick</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>B.Z.</given-names></name><name><surname>Rasmussen</surname><given-names>A.</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name></person-group><article-title>Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2006</year><volume>141</volume><fpage>387</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16649215</pub-id></citation></ref><ref id="R150"><label>150</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname><given-names>J.</given-names></name><name><surname>Kranzler</surname><given-names>H.R.</given-names></name><name><surname>Malison</surname><given-names>R.</given-names></name><name><surname>Price</surname><given-names>L.H.</given-names></name><name><surname>Van Dyck</surname><given-names>C.</given-names></name><name><surname>Rosenheck</surname><given-names>R.A.</given-names></name><name><surname>Cramer</surname><given-names>J.</given-names></name><name><surname>Southwick</surname><given-names>S.</given-names></name><name><surname>Charney</surname><given-names>D.</given-names></name><name><surname>Krystal</surname><given-names>J.</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name></person-group><article-title>A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States</article-title><source>Arch. Gen. Psychiatry</source><year>2002</year><volume>59</volume><fpage>825</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12215082</pub-id></citation></ref><ref id="R151"><label>151</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bachmann</surname><given-names>A.W.</given-names></name><name><surname>Sedgley</surname><given-names>T.L.</given-names></name><name><surname>Jackson</surname><given-names>R.V.</given-names></name><name><surname>Gibson</surname><given-names>J.N.</given-names></name><name><surname>Young</surname><given-names>R.M.</given-names></name><name><surname>Torpy</surname><given-names>D.J</given-names></name></person-group><article-title>Glucocorticoid receptor polymorphisms and post-traumatic stress disorder</article-title><source>Psychoneuroendocrinology</source><year>2005</year><volume>30</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">15511603</pub-id></citation></ref><ref id="R152"><label>152</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name><name><surname>Kang</surname><given-names>R.H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.D.</given-names></name><name><surname>Kee</surname><given-names>B.S.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Kim</surname><given-names>J.B.</given-names></name><name><surname>Yeon</surname><given-names>B.K.</given-names></name><name><surname>Oh</surname><given-names>K.S.</given-names></name><name><surname>Oh</surname><given-names>B.H.</given-names></name><name><surname>Yoon</surname><given-names>J.S.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Jung</surname><given-names>H.Y.</given-names></name><name><surname>Chee</surname><given-names>I.S.</given-names></name><name><surname>Paik</surname><given-names>I.H</given-names></name></person-group><article-title>Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder</article-title><source>Depress. Anxiety</source><year>2005</year><volume>21</volume><fpage>135</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15965993</pub-id></citation></ref><ref id="R153"><label>153</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D.E.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Gysin</surname><given-names>R</given-names></name></person-group><article-title>Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication</article-title><source>Biol. Psychiatry</source><year>1996</year><volume>40</volume><fpage>368</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">8874837</pub-id></citation></ref><ref id="R154"><label>154</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulik</surname><given-names>C.M.</given-names></name><name><surname>Sullivan</surname><given-names>P.F.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>Heritability of binge-eating and broadly defined bulimia nervosa</article-title><source>Biol. Psychiatry</source><year>1998</year><volume>44</volume><fpage>1210</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9861464</pub-id></citation></ref><ref id="R155"><label>155</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klump</surname><given-names>K.L.</given-names></name><name><surname>Miller</surname><given-names>K.B.</given-names></name><name><surname>Keel</surname><given-names>P.K.</given-names></name><name><surname>McGue</surname><given-names>M.</given-names></name><name><surname>Iacono</surname><given-names>W.G</given-names></name></person-group><article-title>Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample</article-title><source>Psychol. Med</source><year>2001</year><volume>31</volume><fpage>737</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11352375</pub-id></citation></ref><ref id="R156"><label>156</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kortegaard</surname><given-names>L.S.</given-names></name><name><surname>Hoerder</surname><given-names>K.</given-names></name><name><surname>Joergensen</surname><given-names>J.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Kyvik</surname><given-names>K.O</given-names></name></person-group><article-title>A preliminary population-based twin study of self-reported eating disorder</article-title><source>Psychol. Med</source><year>2001</year><volume>31</volume><fpage>361</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11232922</pub-id></citation></ref><ref id="R157"><label>157</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kendler</surname><given-names>K.S.</given-names></name><name><surname>MacLean</surname><given-names>C.</given-names></name><name><surname>Neale</surname><given-names>M.</given-names></name><name><surname>Kessler</surname><given-names>R.</given-names></name><name><surname>Heath</surname><given-names>A.</given-names></name><name><surname>Eaves</surname><given-names>L</given-names></name></person-group><article-title>The genetic epidemiology of bulimia nervosa</article-title><source>Am. J. Psychiatry</source><year>1991</year><volume>148</volume><fpage>1627</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">1842216</pub-id></citation></ref><ref id="R158"><label>158</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>D.A.</given-names></name><name><surname>Arranz</surname><given-names>M.J.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Mupita</surname><given-names>D.</given-names></name><name><surname>Brown</surname><given-names>N.</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name></person-group><article-title>Association between 5-HT2A gene promoter polymorphism and anorexia nervosa</article-title><source>Lancet</source><year>1997</year><volume>350</volume><fpage>412</fpage><pub-id pub-id-type="pmid">9259661</pub-id></citation></ref><ref id="R159"><label>159</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westberg</surname><given-names>L.</given-names></name><name><surname>Bah</surname><given-names>J.</given-names></name><name><surname>Rastam</surname><given-names>M.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Wentz</surname><given-names>E.</given-names></name><name><surname>Melke</surname><given-names>J.</given-names></name><name><surname>Hellstrand</surname><given-names>M.</given-names></name><name><surname>Eriksson</surname><given-names>E</given-names></name></person-group><article-title>Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls</article-title><source>Neuropsychopharmacology</source><year>2002</year><volume>26</volume><fpage>789</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">12007749</pub-id></citation></ref><ref id="R160"><label>160</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Bella</surname><given-names>D.D.</given-names></name><name><surname>Catalano</surname><given-names>M.</given-names></name><name><surname>Cavallini</surname><given-names>M.C.</given-names></name><name><surname>Riboldi</surname><given-names>C.</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name></person-group><article-title>Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa</article-title><source>Mol. Psychiatry</source><year>2000</year><volume>5</volume><fpage>233</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10889521</pub-id></citation></ref><ref id="R161"><label>161</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>D.A.</given-names></name><name><surname>Sundaramurthy</surname><given-names>D.</given-names></name><name><surname>Markham</surname><given-names>A.F.</given-names></name><name><surname>Pieri</surname><given-names>L.F</given-names></name></person-group><article-title>Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>499</fpage><pub-id pub-id-type="pmid">9482450</pub-id></citation></ref><ref id="R162"><label>162</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burnet</surname><given-names>P.W.</given-names></name><name><surname>Smith</surname><given-names>K.A.</given-names></name><name><surname>Cowen</surname><given-names>P.J.</given-names></name><name><surname>Fairburn</surname><given-names>C.G.</given-names></name><name><surname>Harrison</surname><given-names>P.J</given-names></name></person-group><article-title>Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder</article-title><source>Psychiatr. Genet</source><year>1999</year><volume>9</volume><fpage>101</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10412190</pub-id></citation></ref><ref id="R163"><label>163</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Itoh</surname><given-names>K.</given-names></name><name><surname>Nakazato</surname><given-names>M.</given-names></name><name><surname>Shimizu</surname><given-names>E.</given-names></name><name><surname>Ohgake</surname><given-names>S.</given-names></name><name><surname>Koike</surname><given-names>K.</given-names></name><name><surname>Okamura</surname><given-names>N.</given-names></name><name><surname>Matsushita</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Murayama</surname><given-names>M.</given-names></name><name><surname>Higuchi</surname><given-names>S.</given-names></name><name><surname>Iyo</surname><given-names>M</given-names></name></person-group><article-title>Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders</article-title><source>Am. J. Med. Genet. B Neuropsychiatr. Genet</source><year>2004</year><volume>127</volume><fpage>125</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15108194</pub-id></citation></ref><ref id="R164"><label>164</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribases</surname><given-names>M.</given-names></name><name><surname>Gratacos</surname><given-names>M.</given-names></name><name><surname>Fernandez-Aranda</surname><given-names>F.</given-names></name><name><surname>Bellodi</surname><given-names>L.</given-names></name><name><surname>Boni</surname><given-names>C.</given-names></name><name><surname>Anderluh</surname><given-names>M.</given-names></name><name><surname>Cavallini</surname><given-names>M.C.</given-names></name><name><surname>Cellini</surname><given-names>E.</given-names></name><name><surname>Di Bella</surname><given-names>D.</given-names></name><name><surname>Erzegovesi</surname><given-names>S.</given-names></name><name><surname>Foulon</surname><given-names>C.</given-names></name><name><surname>Gabrovsek</surname><given-names>M.</given-names></name><name><surname>Gorwood</surname><given-names>P.</given-names></name><name><surname>Hebebrand</surname><given-names>J.</given-names></name><name><surname>Hinney</surname><given-names>A.</given-names></name><name><surname>Holliday</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Karwautz</surname><given-names>A.</given-names></name><name><surname>Kipman</surname><given-names>A.</given-names></name><name><surname>Komel</surname><given-names>R.</given-names></name><name><surname>Nacmias</surname><given-names>B.</given-names></name><name><surname>Remschmidt</surname><given-names>H.</given-names></name><name><surname>Ricca</surname><given-names>V.</given-names></name><name><surname>Sorbi</surname><given-names>S.</given-names></name><name><surname>Wagner</surname><given-names>G.</given-names></name><name><surname>Treasure</surname><given-names>J.</given-names></name><name><surname>Collier</surname><given-names>D.A.</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name></person-group><article-title>Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations</article-title><source>Hum. Mol. Genet</source><year>2004</year><volume>13</volume><fpage>1205</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15115760</pub-id></citation></ref><ref id="R165"><label>165</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyasaka</surname><given-names>K.</given-names></name><name><surname>Hosoya</surname><given-names>H.</given-names></name><name><surname>Sekime</surname><given-names>A.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name><name><surname>Amono</surname><given-names>H.</given-names></name><name><surname>Matsushita</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Higuchi</surname><given-names>S.</given-names></name><name><surname>Funakoshi</surname><given-names>A</given-names></name></person-group><article-title>Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population</article-title><source>J. Neural Transm</source><year>2006</year><volume>113</volume><fpage>1279</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16362631</pub-id></citation></ref><ref id="R166"><label>166</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frieling</surname><given-names>H.</given-names></name><name><surname>Romer</surname><given-names>K.D.</given-names></name><name><surname>Wilhelm</surname><given-names>J.</given-names></name><name><surname>Hillemacher</surname><given-names>T.</given-names></name><name><surname>Kornhuber</surname><given-names>J.</given-names></name><name><surname>de Zwaan</surname><given-names>M.</given-names></name><name><surname>Jacoby</surname><given-names>G.E.</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name></person-group><article-title>Association of catecholamine-O-methyltransferase and 5-HTTLPR genotype with eating disorder-related behavior and attitudes in females with eating disorders</article-title><source>Psychiatr. Genet</source><year>2006</year><volume>16</volume><fpage>205</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16969275</pub-id></citation></ref><ref id="R167"><label>167</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mikolajczyk</surname><given-names>E.</given-names></name><name><surname>Smiarowska</surname><given-names>M.</given-names></name><name><surname>Grzywacz</surname><given-names>A.</given-names></name><name><surname>Samochowiec</surname><given-names>J</given-names></name></person-group><article-title>Association of eating disorders with catechol-o-methyltransferase gene functional polymorphism</article-title><source>Neuropsychobiology</source><year>2006</year><volume>54</volume><fpage>82</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17028449</pub-id></citation></ref><ref id="R168"><label>168</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>L.</given-names></name><name><surname>Hauser</surname><given-names>W.A</given-names></name></person-group><article-title>Epidemiology of neural tube defects</article-title><source>Epilepsia</source><year>2003</year><volume>44</volume><issue>Suppl 3</issue><fpage>4</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">12790881</pub-id></citation></ref><ref id="R169"><label>169</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>R</given-names></name></person-group><article-title>Etiology, pathogenesis and prevention of neural tube defects</article-title><source>Congenit. Anom. (Kyoto)</source><year>2006</year><volume>46</volume><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">16732763</pub-id></citation></ref><ref id="R170"><label>170</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname><given-names>A.S.</given-names></name><name><surname>Gallagher</surname><given-names>P.</given-names></name><name><surname>Mills</surname><given-names>J.L.</given-names></name><name><surname>Kirke</surname><given-names>P.N.</given-names></name><name><surname>Burke</surname><given-names>H.</given-names></name><name><surname>Molloy</surname><given-names>A.M.</given-names></name><name><surname>Weir</surname><given-names>D.G.</given-names></name><name><surname>Shields</surname><given-names>D.C.</given-names></name><name><surname>Scott</surname><given-names>J.M</given-names></name></person-group><article-title>A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects</article-title><source>Qjm</source><year>1995</year><volume>88</volume><fpage>763</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8542260</pub-id></citation></ref><ref id="R171"><label>171</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Linden</surname><given-names>I.J.</given-names></name><name><surname>den Heijer</surname><given-names>M.</given-names></name><name><surname>Afman</surname><given-names>L.A.</given-names></name><name><surname>Gellekink</surname><given-names>H.</given-names></name><name><surname>Vermeulen</surname><given-names>S.H.</given-names></name><name><surname>Kluijtmans</surname><given-names>L.A.</given-names></name><name><surname>Blom</surname><given-names>H.J</given-names></name></person-group><article-title>The methionine synthase reductase 66A&#x0003e;G polymorphism is a maternal risk factor for spina bifida</article-title><source>J. Mol. Med</source><year>2006</year><volume>84</volume><fpage>1047</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17024475</pub-id></citation></ref><ref id="R172"><label>172</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Wicker</surname><given-names>N.J.</given-names></name><name><surname>Volcik</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shaw</surname><given-names>G.M.</given-names></name><name><surname>Lammer</surname><given-names>E.J.</given-names></name><name><surname>Suarez</surname><given-names>L.</given-names></name><name><surname>Canfield</surname><given-names>M.</given-names></name><name><surname>Finnell</surname><given-names>R.H</given-names></name></person-group><article-title>Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects</article-title><source>Mol. Genet. Metab</source><year>2004</year><volume>81</volume><fpage>127</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">14741194</pub-id></citation></ref><ref id="R173"><label>173</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>K.S.</given-names></name><name><surname>Cook</surname><given-names>M.</given-names></name><name><surname>Hoess</surname><given-names>K.</given-names></name><name><surname>Whitehead</surname><given-names>A.S.</given-names></name><name><surname>Mitchell</surname><given-names>L.E</given-names></name></person-group><article-title>Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus</article-title><source>Birth Defects Res. A Clin. Mol. Teratol</source><year>2004</year><volume>70</volume><fpage>101</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15039923</pub-id></citation></ref><ref id="R174"><label>174</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shaw</surname><given-names>G.M.</given-names></name><name><surname>Lammer</surname><given-names>E.J.</given-names></name><name><surname>Finnell</surname><given-names>R.H</given-names></name></person-group><article-title>A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida</article-title><source>Mol. Genet. Metab</source><year>2006</year><volume>87</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16256389</pub-id></citation></ref><ref id="R175"><label>175</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Enaw</surname><given-names>J.O.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Shaw</surname><given-names>G.M.</given-names></name><name><surname>Lammer</surname><given-names>E.J.</given-names></name><name><surname>Finnell</surname><given-names>R.H</given-names></name></person-group><article-title>Association between CFL1 gene polymorphisms and spina bifida risk in a California population</article-title><source>BMC Med. Genet</source><year>2007</year><volume>8</volume><fpage>12</fpage><pub-id pub-id-type="pmid">17352815</pub-id></citation></ref><ref id="R176"><label>176</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernell</surname><given-names>E.</given-names></name><name><surname>Hagberg</surname><given-names>B.</given-names></name><name><surname>Hagberg</surname><given-names>G.</given-names></name><name><surname>von Wendt</surname><given-names>L</given-names></name></person-group><article-title>Epidemiology of infantile hydrocephalus in Sweden.I. Birth prevalence and general data</article-title><source>Acta Paediatr. Scand</source><year>1986</year><volume>75</volume><fpage>975</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">3564981</pub-id></citation></ref><ref id="R177"><label>177</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halliday</surname><given-names>J.</given-names></name><name><surname>Chow</surname><given-names>C.W.</given-names></name><name><surname>Wallace</surname><given-names>D.</given-names></name><name><surname>Danks</surname><given-names>D.M</given-names></name></person-group><article-title>X linked hydrocephalus: a survey of a 20 year period in Victoria, Australia</article-title><source>J. Med. Genet</source><year>1986</year><volume>23</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">3950933</pub-id></citation></ref><ref id="R178"><label>178</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willems</surname><given-names>P.J</given-names></name></person-group><article-title>Heterogeneity in familial hydrocephalus</article-title><source>Am. J. Med. Genet</source><year>1988</year><volume>31</volume><fpage>471</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">3232710</pub-id></citation></ref><ref id="R179"><label>179</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>C.</given-names></name><name><surname>Alembik</surname><given-names>Y.</given-names></name><name><surname>Dott</surname><given-names>B.</given-names></name><name><surname>Roth</surname><given-names>M.P</given-names></name></person-group><article-title>An epidemiologic study of environmental and genetic factors in congenital hydrocephalus</article-title><source>Eur. J. Epidemiol</source><year>1992</year><volume>8</volume><fpage>797</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">1294384</pub-id></citation></ref><ref id="R180"><label>180</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haverkamp</surname><given-names>F.</given-names></name><name><surname>Wolfle</surname><given-names>J.</given-names></name><name><surname>Aretz</surname><given-names>M.</given-names></name><name><surname>Kramer</surname><given-names>A.</given-names></name><name><surname>Hohmann</surname><given-names>B.</given-names></name><name><surname>Fahnenstich</surname><given-names>H.</given-names></name><name><surname>Zerres</surname><given-names>K</given-names></name></person-group><article-title>Congenital hydrocephalus internus and aqueduct stenosis: aetiology and implications for genetic counselling</article-title><source>Eur. J. Pediatr</source><year>1999</year><volume>158</volume><fpage>474</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10378395</pub-id></citation></ref><ref id="R181"><label>181</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>M.A.</given-names></name><name><surname>Rigamonti</surname><given-names>D</given-names></name></person-group><article-title>Genetics of human hydrocephalus</article-title><source>J. Neurol</source><year>2006</year><volume>253</volume><fpage>1255</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">16773266</pub-id></citation></ref><ref id="R182"><label>182</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>S.R</given-names></name></person-group><article-title>Mental retardation and developmental disabilities influenced by environmental neurotoxic insults</article-title><source>Environ. Health Perspect</source><year>2000</year><volume>108</volume><issue>Suppl 3</issue><fpage>395</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10852834</pub-id></citation></ref><ref id="R183"><label>183</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S.H.</given-names></name><name><surname>Earle</surname><given-names>J.</given-names></name><name><surname>Kanodia</surname><given-names>R.</given-names></name><name><surname>Kist</surname><given-names>D.</given-names></name><name><surname>Emamian</surname><given-names>E.S.</given-names></name><name><surname>Patterson</surname><given-names>P.H.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Sidwell</surname><given-names>R</given-names></name></person-group><article-title>Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia</article-title><source>Cell. Mol. Neurobiol</source><year>2002</year><volume>22</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12064515</pub-id></citation></ref><ref id="R184"><label>184</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boog</surname><given-names>G</given-names></name></person-group><article-title>Obstetrical complications and subsequent schizophrenia in adolescent and young adult offsprings is there a relationship?</article-title><source>Eur. J. Obstet. Gynecol. Reprod. Biol</source><year>2004</year><volume>114</volume><fpage>130</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15140504</pub-id></citation></ref><ref id="R185"><label>185</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curatolo</surname><given-names>P.</given-names></name><name><surname>Arpino</surname><given-names>C.</given-names></name><name><surname>Stazi</surname><given-names>M.A.</given-names></name><name><surname>Medda</surname><given-names>E</given-names></name></person-group><article-title>Risk factors for the co-occurrence of partial epilepsy, cerebral palsy and mental retardation</article-title><source>Dev. Med. Child Neurol</source><year>1995</year><volume>37</volume><fpage>776</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">7589860</pub-id></citation></ref><ref id="R186"><label>186</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torrey</surname><given-names>E.F.</given-names></name><name><surname>Rawlings</surname><given-names>R.R.</given-names></name><name><surname>Ennis</surname><given-names>J.M.</given-names></name><name><surname>Merrill</surname><given-names>D.D.</given-names></name><name><surname>Flores</surname><given-names>D.S</given-names></name></person-group><article-title>Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths</article-title><source>Schizophr. Res</source><year>1996</year><volume>21</volume><fpage>141</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8885042</pub-id></citation></ref><ref id="R187"><label>187</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torrey</surname><given-names>E.F.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>Rawlings</surname><given-names>R.</given-names></name><name><surname>Yolken</surname><given-names>R.H</given-names></name></person-group><article-title>Seasonality of births in schizophrenia and bipolar disorder: a review of the literature</article-title><source>Schizophr. Res</source><year>1997</year><volume>28</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">9428062</pub-id></citation></ref><ref id="R188"><label>188</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mortensen</surname><given-names>P.B.</given-names></name><name><surname>Pedersen</surname><given-names>C.B.</given-names></name><name><surname>Westergaard</surname><given-names>T.</given-names></name><name><surname>Wohlfahrt</surname><given-names>J.</given-names></name><name><surname>Ewald</surname><given-names>H.</given-names></name><name><surname>Mors</surname><given-names>O.</given-names></name><name><surname>Andersen</surname><given-names>P.K.</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name></person-group><article-title>Effects of family history and place and season of birth on the risk of schizophrenia</article-title><source>N. Engl. J. Med</source><year>1999</year><volume>340</volume><fpage>603</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10029644</pub-id></citation></ref><ref id="R189"><label>189</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yearwood</surname><given-names>E.L.</given-names></name><name><surname>Crawford</surname><given-names>S.</given-names></name><name><surname>Kelly</surname><given-names>M.</given-names></name><name><surname>Moreno</surname><given-names>N</given-names></name></person-group><article-title>Immigrant youth at risk for disorders of mood: recognizing complex dynamics</article-title><source>Arch. Psychiatr. Nurs</source><year>2007</year><volume>21</volume><fpage>162</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17556109</pub-id></citation></ref><ref id="R190"><label>190</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cantor-Graae</surname><given-names>E.</given-names></name><name><surname>Pedersen</surname><given-names>C.B</given-names></name></person-group><article-title>Risk for schizophrenia in intercountry adoptees: a Danish population-based cohort study</article-title><source>J. Child Psychol. Psychiatry</source><year>2007</year><volume>48</volume><fpage>1053</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">18030684</pub-id></citation></ref><ref id="R191"><label>191</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caspi</surname><given-names>A.</given-names></name><name><surname>Moffitt</surname><given-names>T.E.</given-names></name><name><surname>Cannon</surname><given-names>M.</given-names></name><name><surname>McClay</surname><given-names>J.</given-names></name><name><surname>Murray</surname><given-names>R.</given-names></name><name><surname>Harrington</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>A.</given-names></name><name><surname>Arseneault</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>B.</given-names></name><name><surname>Braithwaite</surname><given-names>A.</given-names></name><name><surname>Poulton</surname><given-names>R.</given-names></name><name><surname>Craig</surname><given-names>I.W</given-names></name></person-group><article-title>Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction</article-title><source>Biol. Psychiatry</source><year>2005</year><volume>57</volume><fpage>1117</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15866551</pub-id></citation></ref><ref id="R192"><label>192</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolffe</surname><given-names>A.P.</given-names></name><name><surname>Matzke</surname><given-names>M.A</given-names></name></person-group><article-title>Epigenetics: regulation through repression</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>481</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10521337</pub-id></citation></ref><ref id="R193"><label>193</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reik</surname><given-names>W.</given-names></name><name><surname>Romer</surname><given-names>I.</given-names></name><name><surname>Barton</surname><given-names>S.C.</given-names></name><name><surname>Surani</surname><given-names>M.A.</given-names></name><name><surname>Howlett</surname><given-names>S.K.</given-names></name><name><surname>Klose</surname><given-names>J</given-names></name></person-group><article-title>Adult phenotype in the mouse can be affected by epigenetic events in the early embryo</article-title><source>Development</source><year>1993</year><volume>119</volume><fpage>933</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">8187648</pub-id></citation></ref><ref id="R194"><label>194</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rideout W.M.</surname><given-names>3rd</given-names></name><name><surname>Eggan</surname><given-names>K.</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group><article-title>Nuclear cloning and epigenetic reprogramming of the genome</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>1093</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11498580</pub-id></citation></ref><ref id="R195"><label>195</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R.E.</given-names></name><name><surname>Van den Veyver</surname><given-names>I.B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C.Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H.Y</given-names></name></person-group><article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title><source>Nat. Genet</source><year>1999</year><volume>23</volume><fpage>185</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10508514</pub-id></citation></ref><ref id="R196"><label>196</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G.L.</given-names></name><name><surname>Bestor</surname><given-names>T.H.</given-names></name><name><surname>Bourc'his</surname><given-names>D.</given-names></name><name><surname>Hsieh</surname><given-names>C.L.</given-names></name><name><surname>Tommerup</surname><given-names>N.</given-names></name><name><surname>Bugge</surname><given-names>M.</given-names></name><name><surname>Hulten</surname><given-names>M.</given-names></name><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>Russo</surname><given-names>J.J.</given-names></name><name><surname>Viegas-Pequignot</surname><given-names>E</given-names></name></person-group><article-title>Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene</article-title><source>Nature</source><year>1999</year><volume>402</volume><fpage>187</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10647011</pub-id></citation></ref><ref id="R197"><label>197</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>R.J.</given-names></name><name><surname>McDowell</surname><given-names>T.L.</given-names></name><name><surname>Raman</surname><given-names>S.</given-names></name><name><surname>O'Rourke</surname><given-names>D.M.</given-names></name><name><surname>Garrick</surname><given-names>D.</given-names></name><name><surname>Ayyub</surname><given-names>H.</given-names></name><name><surname>Higgs</surname><given-names>D.R</given-names></name></person-group><article-title>Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation</article-title><source>Nat. Genet</source><year>2000</year><volume>24</volume><fpage>368</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10742099</pub-id></citation></ref><ref id="R198"><label>198</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Warren</surname><given-names>S.T</given-names></name></person-group><article-title>Understanding the molecular basis of fragile X syndrome</article-title><source>Hum. Mol. Genet</source><year>2000</year><volume>9</volume><fpage>901</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10767313</pub-id></citation></ref><ref id="R199"><label>199</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitkin</surname><given-names>R.M</given-names></name></person-group><article-title>Folate and neural tube defects</article-title><source>Am. J. Clin. Nutr</source><year>2007</year><volume>85</volume><fpage>285S</fpage><lpage>288S</lpage><pub-id pub-id-type="pmid">17209211</pub-id></citation></ref><ref id="R200"><label>200</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herran</surname><given-names>A.</given-names></name><name><surname>Garcia-Unzueta</surname><given-names>M.T.</given-names></name><name><surname>Amado</surname><given-names>J.A.</given-names></name><name><surname>Lopez-Cordovilla</surname><given-names>J.J.</given-names></name><name><surname>Diez-Manrique</surname><given-names>J.F.</given-names></name><name><surname>Vazquez-Barquero</surname><given-names>J.L</given-names></name></person-group><article-title>Folate levels in psychiatric outpatients</article-title><source>Psychiatry Clin. Neurosci</source><year>1999</year><volume>53</volume><fpage>531</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10498238</pub-id></citation></ref><ref id="R201"><label>201</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><name><surname>Carboni</surname><given-names>G.</given-names></name><name><surname>Ruzicka</surname><given-names>W.B.</given-names></name><name><surname>Mitchell</surname><given-names>C.P.</given-names></name><name><surname>Sugaya</surname><given-names>I.</given-names></name><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Grayson</surname><given-names>D.R.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A</given-names></name></person-group><article-title>An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>17095</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12481028</pub-id></citation></ref><ref id="R202"><label>202</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>I.C.</given-names></name><name><surname>Cervoni</surname><given-names>N.</given-names></name><name><surname>Champagne</surname><given-names>F.A.</given-names></name><name><surname>D'Alessio</surname><given-names>A.C.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Seckl</surname><given-names>J.R.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name><name><surname>Meaney</surname><given-names>M.J</given-names></name></person-group><article-title>Epigenetic programming by maternal behavior</article-title><source>Nat. Neurosci</source><year>2004</year><volume>7</volume><fpage>847</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15220929</pub-id></citation></ref><ref id="R203"><label>203</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>I.I.</given-names></name><name><surname>Gould</surname><given-names>T.D</given-names></name></person-group><article-title>The endophenotype concept in psychiatry etymology and strategic intentions</article-title><source>Am. J. Psychiatry</source><year>2003</year><volume>160</volume><fpage>636</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12668349</pub-id></citation></ref><ref id="R204"><label>204</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>J.</given-names></name><name><surname>Munafo</surname><given-names>M.R</given-names></name></person-group><article-title>The endophenotype concept in psychiatric genetics</article-title><source>Psychol. Med</source><year>2007</year><volume>37</volume><fpage>163</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">16978446</pub-id></citation></ref><ref id="R205"><label>205</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N</given-names></name></person-group><article-title>Linkage strategies for genetically complex traits I. Multilocus models</article-title><source>Am. J. Hum. Genet</source><year>1990</year><volume>46</volume><fpage>222</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2301392</pub-id></citation></ref><ref id="R206"><label>206</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Kimmel</surname><given-names>M</given-names></name></person-group><article-title>Simulations provide support for the common disease-common variant hypothesis</article-title><source>Genetics</source><year>2007</year><volume>175</volume><fpage>763</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">17151262</pub-id></citation></ref><ref id="R207"><label>207</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>D.E.</given-names></name><name><surname>Lander</surname><given-names>E.S</given-names></name></person-group><article-title>On the allelic spectrum of human disease</article-title><source>Trends Genet</source><year>2001</year><volume>17</volume><fpage>502</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11525833</pub-id></citation></ref><ref id="R208"><label>208</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>J.K</given-names></name></person-group><article-title>Are rare variants responsible for susceptibility to complex diseases?</article-title><source>Am. J. Hum. Genet</source><year>2001</year><volume>69</volume><fpage>124</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11404818</pub-id></citation></ref><ref id="R209"><label>209</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slager</surname><given-names>S.L.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Vieland</surname><given-names>V.J</given-names></name></person-group><article-title>Effect of allelic heterogeneity on the power of the transmission disequilibrium test</article-title><source>Genet. Epidemiol</source><year>2000</year><volume>18</volume><fpage>143</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10642427</pub-id></citation></ref><ref id="R210"><label>210</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wollstein</surname><given-names>A.</given-names></name><name><surname>Herrmann</surname><given-names>A.</given-names></name><name><surname>Wittig</surname><given-names>M.</given-names></name><name><surname>Nothnagel</surname><given-names>M.</given-names></name><name><surname>Franke</surname><given-names>A.</given-names></name><name><surname>Nurnberg</surname><given-names>P.</given-names></name><name><surname>Schreiber</surname><given-names>S.</given-names></name><name><surname>Krawczak</surname><given-names>M.</given-names></name><name><surname>Hampe</surname><given-names>J</given-names></name></person-group><article-title>Efficacy assessment of SNP sets for genome-wide disease association studies</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>e113</fpage><pub-id pub-id-type="pmid">17726055</pub-id></citation></ref><ref id="R211"><label>211</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cargill</surname><given-names>M.</given-names></name><name><surname>Altshuler</surname><given-names>D.</given-names></name><name><surname>Ireland</surname><given-names>J.</given-names></name><name><surname>Sklar</surname><given-names>P.</given-names></name><name><surname>Ardlie</surname><given-names>K.</given-names></name><name><surname>Patil</surname><given-names>N.</given-names></name><name><surname>Shaw</surname><given-names>N.</given-names></name><name><surname>Lane</surname><given-names>C.R.</given-names></name><name><surname>Lim</surname><given-names>E.P.</given-names></name><name><surname>Kalyanaraman</surname><given-names>N.</given-names></name><name><surname>Nemesh</surname><given-names>J.</given-names></name><name><surname>Ziaugra</surname><given-names>L.</given-names></name><name><surname>Friedland</surname><given-names>L.</given-names></name><name><surname>Rolfe</surname><given-names>A.</given-names></name><name><surname>Warrington</surname><given-names>J.</given-names></name><name><surname>Lipshutz</surname><given-names>R.</given-names></name><name><surname>Daley</surname><given-names>G.Q.</given-names></name><name><surname>Lander</surname><given-names>E.S</given-names></name></person-group><article-title>Characterization of single-nucleotide polymorphisms in coding regions of human genes</article-title><source>Nat. Genet</source><year>1999</year><volume>22</volume><fpage>231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10391209</pub-id></citation></ref><ref id="R212"><label>212</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jorde</surname><given-names>L.B.</given-names></name><name><surname>Fineman</surname><given-names>R.M.</given-names></name><name><surname>Martin</surname><given-names>R.A</given-names></name></person-group><article-title>Epidemiology and genetics of neural tube defects an application of the Utah Genealogical Data Base</article-title><source>Am. J. Phys. Anthropol</source><year>1983</year><volume>62</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">6353932</pub-id></citation></ref><ref id="R213"><label>213</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawke</surname><given-names>J.L.</given-names></name><name><surname>Wadsworth</surname><given-names>S.J.</given-names></name><name><surname>DeFries</surname><given-names>J.C</given-names></name></person-group><article-title>Genetic influences on reading difficulties in boys and girls the Colorado twin study</article-title><source>Dyslexia</source><year>2006</year><volume>12</volume><fpage>21</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16512171</pub-id></citation></ref><ref id="R214"><label>214</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fyer</surname><given-names>A.J.</given-names></name><name><surname>Hamilton</surname><given-names>S.P.</given-names></name><name><surname>Durner</surname><given-names>M.</given-names></name><name><surname>Haghighi</surname><given-names>F.</given-names></name><name><surname>Heiman</surname><given-names>G.A.</given-names></name><name><surname>Costa</surname><given-names>R.</given-names></name><name><surname>Evgrafov</surname><given-names>O.</given-names></name><name><surname>Adams</surname><given-names>P.</given-names></name><name><surname>de Leon</surname><given-names>A.B.</given-names></name><name><surname>Taveras</surname><given-names>N.</given-names></name><name><surname>Klein</surname><given-names>D.F.</given-names></name><name><surname>Hodge</surname><given-names>S.E.</given-names></name><name><surname>Weissman</surname><given-names>M.M.</given-names></name><name><surname>Knowles</surname><given-names>J.A</given-names></name></person-group><article-title>A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci</article-title><source>Biol. Psychiatry</source><year>2006</year><volume>60</volume><fpage>388</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">16919526</pub-id></citation></ref><ref id="R215"><label>215</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clifford</surname><given-names>C.A.</given-names></name><name><surname>Murray</surname><given-names>R.M.</given-names></name><name><surname>Fulker</surname><given-names>D.W</given-names></name></person-group><article-title>Genetic and environmental influences on obsessional traits and symptoms</article-title><source>Psychol. Med</source><year>1984</year><volume>14</volume><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">6545413</pub-id></citation></ref><ref id="R216"><label>216</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonnal</surname><given-names>A.H.</given-names></name><name><surname>Gardner</surname><given-names>C.O.</given-names></name><name><surname>Prescott</surname><given-names>C.A.</given-names></name><name><surname>Kendler</surname><given-names>K.S</given-names></name></person-group><article-title>Obsessive and compulsive symptoms in a general population sample of female twins</article-title><source>Am. J. Med. Genet</source><year>2000</year><volume>96</volume><fpage>791</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11121183</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>Neurodevelopmental Disorders and their Genetic Aetiologies</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">Disorder</th><th rowspan="1" colspan="1">Genetic Aetiology</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">I (Aneuploidy)</td><td align="center" rowspan="1" colspan="1">Down&#x02019;s syndrome</td><td align="center" rowspan="1" colspan="1">Trisomy of chromosome 21 (OMIM #190685).</td></tr><tr><td rowspan="4" align="center" valign="middle" colspan="1">II (Micro-deletion)</td><td align="center" rowspan="1" colspan="1">Prader-Willi syndrome / Angelman syndrome</td><td align="center" rowspan="1" colspan="1">~4 Mb deletion (~7 genes) of chromosome 15q11-q13 (OMIM #176270 and #105830).</td></tr><tr><td align="center" rowspan="1" colspan="1">Smith-Magenis syndrome</td><td align="center" rowspan="1" colspan="1">Deletion (3.7 Mb) of chromosome 17p11.2 (OMIM #182290).</td></tr><tr><td align="center" rowspan="1" colspan="1">DiGeorge/velo-cardio-facial syndrome</td><td align="center" rowspan="1" colspan="1">Hemizygous deletion (1.5 to 3.0-Mb) of chromosome 22q11.2 (OMIM #188400 and #192430).</td></tr><tr><td align="center" rowspan="1" colspan="1">William&#x02019;s-Beuren syndrome</td><td align="center" rowspan="1" colspan="1">Deletion of chromosomal region 7q11.2 (OMIM #194050).</td></tr><tr><td rowspan="7" align="center" valign="middle" colspan="1">III (Single-gene defect)</td><td align="center" rowspan="1" colspan="1">ATR-X syndrome</td><td align="center" rowspan="1" colspan="1">Mutations in the ATR-X gene on the X-chromosome (OMIM #301040)</td></tr><tr><td align="center" rowspan="1" colspan="1">Barth syndrome (X-linked cardioskeletal myopathy and neutropenia)</td><td align="center" rowspan="1" colspan="1">Mitochondrial functional impairments due to the tafazzin (TAZ) gene on chromosome Xq28 (OMIM #302060).</td></tr><tr><td align="center" rowspan="1" colspan="1">Fragile-X syndrome</td><td align="center" rowspan="1" colspan="1">CCG repeat expansion of the FMR1 gene (OMIM #300624).</td></tr><tr><td align="center" rowspan="1" colspan="1">ICF syndrome</td><td align="center" rowspan="1" colspan="1">Mutations in the DNA methyltransferase 3B (DNMT3B) gene on chromosome 20 (OMIM #242860).</td></tr><tr><td align="center" rowspan="1" colspan="1">Neurofibromatosis</td><td align="center" rowspan="1" colspan="1">Mutations or deletion (~1.5 Mb) in the neurofibromin gene on chromosome 17q11.2 (OMIM +162200).</td></tr><tr><td align="center" rowspan="1" colspan="1">Rett syndrome</td><td align="center" rowspan="1" colspan="1">Mutations in the MeCP2 gene on the X-chromosome (OMIM #312750).</td></tr><tr><td align="center" rowspan="1" colspan="1">Smith-Lemli-Opitz syndrome</td><td align="center" rowspan="1" colspan="1">Mutations in the gene encoding sterol delta-7-reductase (DHCR7) on chromosome 11q12-q13 (OMIM #270400).</td></tr><tr><td align="center" rowspan="16" valign="middle" colspan="1">IV (Multifactorial)</td><td align="center" rowspan="1" colspan="1">Addictive disorders</td><td align="center" rowspan="16" valign="middle" colspan="1">Multiple genes (?)</td></tr><tr><td align="center" rowspan="1" colspan="1">Attention deficit (hyperactivity) disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">Anxiety disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">Asperger&#x02019;s disorder</td></tr><tr><td align="center" rowspan="1" colspan="1">Autistic disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">Depressive illness</td></tr><tr><td align="center" rowspan="1" colspan="1">Dyslexia (reading disability)</td></tr><tr><td align="center" rowspan="1" colspan="1">Eating disorders</td></tr><tr><td align="center" rowspan="1" colspan="1">Epilepsy (seizure disorder)</td></tr><tr><td align="center" rowspan="1" colspan="1">Fetal alcohol syndrome</td></tr><tr><td align="center" rowspan="1" colspan="1">Hydrocephalus</td></tr><tr><td align="center" rowspan="1" colspan="1">Manic depressive illness (bipolar disorder)</td></tr><tr><td align="center" rowspan="1" colspan="1">Mental retardation</td></tr><tr><td align="center" rowspan="1" colspan="1">Schizophrenia</td></tr><tr><td align="center" rowspan="1" colspan="1">Spina bifida</td></tr><tr><td align="center" rowspan="1" colspan="1">Tourette&#x02019;s syndrome</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2.</label><caption><p>Estimated Heritability of Complex Neurodevelopmental Disorders</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Disorder</th><th rowspan="1" colspan="1">Estimated Heritability</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Autism</td><td align="center" rowspan="1" colspan="1">&#x0003e;90%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R9">9</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Schizophrenia</td><td align="center" rowspan="1" colspan="1">80%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R17">17</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">ADHD</td><td align="center" rowspan="1" colspan="1">70%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R36">36</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Epilepsy </td><td align="center" rowspan="1" colspan="1">70%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R60">60</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Drug addiction</td><td align="center" rowspan="1" colspan="1">70%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R91">91</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Spina bifida</td><td align="center" rowspan="1" colspan="1">70%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R212">212</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Bipolar disorder</td><td align="center" rowspan="1" colspan="1">63%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R22">22</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Eating disorders</td><td align="center" rowspan="1" colspan="1">48-74%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R35">154</xref>, <xref ref-type="bibr" rid="R156">156</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Dyslexia </td><td align="center" rowspan="1" colspan="1">50-70%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R213">213</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Alcohol addiction</td><td align="center" rowspan="1" colspan="1">50-60%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R90">90</xref>]					</td></tr><tr><td align="center" rowspan="1" colspan="1">Panic disorder</td><td align="center" rowspan="1" colspan="1">30-46% </td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R214">214</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Posttraumatic stress disorder</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R148">148</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Obsessive-compulsive disorder</td><td align="center" rowspan="1" colspan="1">26-47%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R215">215</xref>, <xref ref-type="bibr" rid="R216">216</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Anxiety disorders</td><td align="center" rowspan="1" colspan="1">30-40%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R108">108</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">Depressive illness</td><td align="center" rowspan="1" colspan="1">37%</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="R27">27</xref>]</td></tr></tbody></table></table-wrap></floats-wrap></article>